Cereal grains with thickened aleurone

JP2023551713A5Inactive Publication Date: 2024-12-05COMMONWEALTH SCI & IND RES ORG +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023533403
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-12-01
Filing Date
2021-11-30
Publication Date
2024-12-05
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

There is a need for cereal grains with thickened aleurone that are also agriculturally useful, as existing mutants often exhibit reduced viability, abnormal growth, or poor agronomic traits.

Method used

Genetic modifications in cereal grains to reduce the levels and/or activity of mitochondrial single-stranded DNA binding (mtSSB), RECA3, or TWINKLE polypeptides, resulting in grains with thickened aleurone and improved nutritional properties.

Benefits of technology

The modified grains exhibit increased fat, fiber, mineral, and antioxidant content, along with higher germination rates and alpha-amylase activity, while maintaining agricultural viability and productivity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000109_0000
    Figure 00000109_0000
  • Figure 00000109_0001
    Figure 00000109_0001
  • Figure 00000109_0002
    Figure 00000109_0002
Patent Text Reader

Abstract

The present invention relates to cereal grains comprising aleurone, germ, starchy endosperm, and reduced levels and / or activity of a mitochondrial single-stranded DNA binding (mtSSB) polypeptide, a RECA3 polypeptide, or a TWINKLE polypeptide. The grains of the present invention or aleurone therefrom have improved nutritional properties and are therefore particularly useful in human and animal feed products.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a grain comprising aleurone, an embryo, starchy endosperm, and a mitochondrial single-stranded DNA-binding (mtSSB) polypeptide, RECA3 polypeptide, or TWINKLE polypeptide at a reduced level and / or activity. The grain or aleurone therefrom of the present invention has improved nutritional properties and is thus particularly useful in human and animal feed products.

Background Art

[0002] Worldwide, cereal grains such as wheat, rice, maize, and to a lesser extent barley, rye, and triticale are major sources of human calorie intake from the starch content of the grain. Cereal grains are also important in the supply of other nutritional components such as proteins, vitamins, minerals, and dietary fiber. Different parts of the grain contribute differently to these nutritional components. Starch is stored within the starchy endosperm of the grain, and other nutritional components are more concentrated within the embryo and bran (Buri et al., 2004). However, bran is often removed prior to use in food, particularly in rice, and the rice is then eaten as white rice.

[0003] Cereal grains develop from a double fertilization event between the maternal and paternal gametophytes. One of the two sperm cells from the pollen tube fuses with the egg to produce a zygote, which develops into an embryo, and the other sperm cell fuses with the diploid central cell of the female gametophyte to produce a primary endosperm nucleus, from which a genetically triploid endosperm develops. Thus, the endosperm containing aleurone is triploid and has two copies of the maternal haploid genome and one copy of the paternal haploid genome. In dicotyledonous seeds, the endosperm is consumed by the developing embryo, and in monocotyledonous plants such as rice, the endosperm persists and constitutes the majority of the mature grain.

[0004] The mature endosperm of cereals has four distinct cell types: a starchy endosperm characterized by its rich content of starch granules and storage proteins; an epidermal-like alleuron, more frequently having the thickness of a single cell layer that surrounds most of the starchy endosperm; transport cells at the base of the seed above the major maternal vascular structure; and a layer of embryo-enveloping cells that forms the lining for the embryo early in grain development, but thereafter can surround only the stalk connecting the embryo and the starchy endosperm (Becraft et al., 2001a). The embryo forms within a cavity in the starchy endosperm. Thus, the cereal alleuron tissue contains the outermost layer of endosperm within the grain and surrounds the starchy endosperm and a portion of the embryo.

[0005] Aleuron cells are distinguished from starchy endosperm cells by their morphology, biochemical composition, and gene expression profile (Becraft and Yi, 2011). Aleuron cells are generally rich in oils and proteins and secrete enzymes that enable the mobilization of endosperm storage during seed germination. Each aleuron cell is enclosed within a fibrous cell wall, which is thicker than the endosperm cell wall, mainly composed of varying ratios of arabinoxylan and beta-glucan, and is highly autofluorescent. The aleuron layer is the only layer of endosperm in cereals, often colored with anthocyanins.

[0006] Cereal alleurons have only one cell layer thickness in wheat and wild-type maize (Buttrose 1963, Walbot, 1994), and are mostly one cell layer thickness, but have up to three cell layer thicknesses in the dorsal region of the endosperm in rice (Hoshikawa, 1993), and three cell layer thicknesses in wild-type barley (Jones, 1969). In normal endosperm, alleurons are very regular, and the pattern of cell division is highly organized. Wild-type mature alleuron cells have a nearly cubic cross-section with dense cytoplasm, which contains granules, small vacuoles, and inclusion bodies, which are made of proteins, lipids, and phytic acid, or proteins plus carbohydrates. In mature grains, alleurons are the only endosperm tissue that remains alive, although in a dormant, dried form. During water absorption, the embryo produces gibberellin, which induces the synthesis of amylase and other hydrolases by allureons. Amylase and other hydrolases are then released into the starchy endosperm, where they break down storage compounds to form sugars and amino acids necessary for the early growth of the embryo into a seedling.

[0007] The regulation of aleuron development within grains has been outlined by Becraft and Yi (2011). Multiple levels of genetic regulation control aleuron cell fate, differentiation, and tissue, and many genes are involved in the process, only some of which have been identified. For example, the maize defective grain 1 (dek1) loss-of-function mutant lacks an aleuron layer, indicating that the wild-type Dek1 polypeptide is required to identify the outer cell layer as an aleuron (Becraft et al., 2002). The Dek1 polypeptide is a large membrane-bound protein, which has 21 transmembrane domains and a cytoplasmic domain containing an active calpain protease. Another gene in maize, CRINKLY4 (CR4), encodes a receptor kinase, which functions as a positive regulator of aleuron fate, and cr4 mutants have reduced aleurons (Becraft et al., 2001b).

[0008] Although several cases of thickened alleurons in cereal grain mutants have been reported in the literature, none have been found to be useful due to directional effects or agricultural and production problems.

[0009] Shen et al. (2003) reported the identification of maize mutants within the supernumerary aleuron layer 1 (sal1) gene, in which, within different mutants, the sal1 gene produced two to three or even up to seven layers of aleuron cells instead of the usual single layer. The SAL1 polypeptide was identified as a class E vacuolar localized protein. Homozygous sal1-1 mutant grains had defective embryos that could not germinate and had a much reduced starchy endosperm. Less complete mutants that were homozygous for the sal1-2 allele showed two cell layers of aleuron. However, the mutant plants grew to only 30% of the height of the wild type, had reduced root mass, and were poor at fruiting (Shen et al. 2003). These plants were not agrochemically useful.

[0010] Yi et al. (2011) reported the identification of a thick aleuron 1 (thk1) mutant in maize. The mutant grains exhibited multilayer aleurons. However, the mutant grains lacked well-developed embryos and did not germinate when sown. The wild-type Thk1 gene encodes the Thk1 polypeptide, which acts downstream of the Dek1 polypeptide, required for aleuron development in maize (Becraft et al., 2002).

[0011] Maize surplus cell layer (Xcl) gene mutants were identified by the effect of Xcl gene mutations on leaf morphology. Xcl gene mutations produced a double aleurone layer and multilayered leaf epidermis (Kessler et al., 2002). The Xcl mutations were semi-dominant, disrupting the cell division and differentiation patterns within maize, resulting in thick, narrow leaves with an abnormal glossy appearance.

[0012] Maize mutants in the disorgal1 and disorgal2 (dil1 and dil2) genes exhibited allureons with a variable number of layers and cells of irregular shape and size (Lid et al., 2004). However, homozygous dil1 and dil2 mutant grains shrank due to reduced starch accumulation, and mature mutant grains germinated at a low rate and did not develop into viable plants.

[0013] Within barley, the elo2 mutant similarly exhibited disordered and irregular cells in the aleurone layer, which resulted from abnormal parallel cell division (Lewis et al., 2009). The plants also showed an increased cell layer within the leaf epidermis, with raised and distorted cells on the epidermis. Importantly, the homozygous mutant plants were dwarfed, producing less than 60% of the grain weight of the wild type, and were not useful for grain production.

[0014] Within the rice cell fate, two transcription factors that regulate seed storage protein expression also influence alleuron cell fate (Kawakatsu et al., 2009). Co-repression of the gene encoding the rice prolamin box-binding factor (RPBF) polypeptide, located within the DOF zinc finger transcription factor class, resulted in sporadic multilayer alleurons consisting of large, disordered cells. Significant reductions in seed storage protein expression and accumulation were also observed, with starch and lipids accumulating at substantially reduced levels. Expression of rice homologs of the maize Dek1, CR4, and SAL1 genes was also reduced, indicating that the RPBF and RISBZ1 factors operated within the same regulatory pathway as these genes.

[0015] More recently, it has been determined that the mutant ROS1a gene can induce thickened allulons in rice (WO2017 / 083920).

[0016] Agriculturally useful plants, particularly grains from rice plants that possess thickened allureons, are needed. [Overview of the project]

[0017] The inventors identified numerous genes and the proteins encoded by them that influence aleurone development within grains.

[0018] Accordingly, in one embodiment, the present invention provides a grain comprising an allureon, an embryo, a starchy endosperm, and at least one mitochondrial polypeptide at a reduced level and / or activity compared to the corresponding wild-type grain, wherein the mitochondrial polypeptide at a reduced level and / or activity is at least one of mitochondrial single-stranded DNA-binding (mtSSB) polypeptide, RECA3 polypeptide, and TWINKLE polypeptide.

[0019] In a preferred embodiment, the grain includes a genetic variant that reduces the level and / or activity of at least one mitochondrial polypeptide within the grain compared to the corresponding wild-type grain. In an example of this embodiment, the grain includes two or more genetic variants that reduce the level and / or activity of at least one mitochondrial polypeptide within the grain compared to the corresponding wild-type grain. In another example of this embodiment, the grain includes two or more genetic variants that reduce the level and / or activity of two or three of the mitochondrial polypeptides within the grain compared to the corresponding wild-type grain.

[0020] In one embodiment, the genetic variation includes a mutation in an endogenous gene, the endogenous gene encoding a mitochondrial polypeptide, and thereby the mutation results in a reduced level and / or activity of the mitochondrial polypeptide.

[0021] In one embodiment, the genetic alteration comprises an exogenous polynucleotide encoding a silencing RNA molecule, wherein the silencing RNA molecule and / or processed RNA molecule produced from the silencing RNA molecule reduce the expression of endogenous genes, and preferably the exogenous polynucleotide comprises a DNA region encoding the silencing RNA molecule, and the silencing RNA molecule is operably ligated to a promoter expressed in a developing grain of a cereal plant, and the promoter preferably comprises the exogenous polynucleotide, which is expressed at least between pollination and 30 days post-pollination.

[0022] In one embodiment, the genetic variation is a splice site mutation resulting in modified splicing, preferably reduced splicing, of the RNA transcript of an endogenous gene encoding a mitochondrial polypeptide, wherein the splice site mutation is preferably a single nucleotide substitution at the splice site, more preferably an adenine nucleotide at the position corresponding to nucleotide number 2126 of SEQ ID NO: 4.

[0023] In one embodiment, the genetic variation comprises a deletion or insertion in an endogenous gene encoding a mitochondrial polypeptide, preferably a deletion introduced by mutagenesis of a progenitor cereal plant cell.

[0024] In one embodiment, the genetic variation comprises a premature translational stop codon within the protein-coding region of an endogenous gene encoding a mitochondrial polypeptide.

[0025] In one embodiment, the genetic variation is a mutation within an endogenous gene, wherein the endogenous gene encodes a mitochondrial polypeptide, whereby the endogenous gene encodes a polypeptide having reduced activity relative to the wild-type polypeptide, preferably the mutation is a nucleotide substitution within the endogenous gene, whereby the endogenous gene containing the mutation encodes a polypeptide having an amino acid substitution relative to SEQ ID NO: 3.

[0026] In one embodiment, the genetic variation is a mutation within an endogenous gene, wherein the endogenous gene encodes a mitochondrial polypeptide, whereby when the gene having the mutation is expressed, the gene produces a reduced level of polypeptide relative to the corresponding wild-type gene. For example, the genetic variation comprises a splice-site mutation that results in a reduced level of gene expression, or the gene comprises a mutation within the promoter of the gene that results in a reduced expression of the gene.

[0027] In one embodiment, the genetic variation is an introduced genetic variation.

[0028] In one embodiment, the grain is heterozygous for the genetic variation. In one embodiment, the grain is homozygous for the genetic variation.

[0029] In a preferred embodiment, the grain has thickened aleurone. In one embodiment, the grain has thickened aleurone on the 20th day after pollination. In one embodiment, the thickened aleurone comprises at least two, at least three, at least four, or at least five cell layers, about three, about four, about five, or about six cell layers, or two to eight, two to seven, two to six, two to five, or three to five cell layers, or two to eight, two to seven, or two to six cell layers.

[0030] In one embodiment, the grain, compared to the corresponding wild-type grain, on a weight basis each, has the following: i) A higher fat content, ii) A higher ash content, iii) A higher fiber content, iv) A lower starch content, v) A higher mineral content, preferably a higher mineral content where the mineral content is the content of one or more or all of calcium, iron, zinc, potassium, magnesium, phosphorus, and sulfur, vi) A higher antioxidant content, vii) A higher phytate content, viii) A higher content of one or more or all of vitamin B3, B6, and B9, ix) A higher sucrose content, x) A higher neutral non-starch polysaccharide content, and xi) One or more or all of a higher monosaccharide content.

[0031] In one embodiment, the grain contains a higher degree of chalkiness compared to the corresponding wild-type grain.

[0032] In one embodiment, the grain contains a higher number of aleurone cells compared to the corresponding wild-type grain.

[0033] In one embodiment, the grain is a whole grain or a cracked grain.

[0034] In one embodiment, the grains have a germination rate of about 40 to about 100% compared to the germination rate of the corresponding wild-type grains.

[0035] In one embodiment, the grain has increased α-amylase activity during germination compared to the corresponding wild-type grain.

[0036] In one embodiment, the grain has a looser filling of irregularly shaped starch granules compared to the corresponding wild-type grain.

[0037] In one embodiment, the grain has approximately the same length, width, thickness, protein level, and one or more of the glume morphology as the corresponding wild-type grain.

[0038] In one embodiment, the grains are processed so that they can no longer germinate, preferably by heat treatment, and more preferably by cooking.

[0039] In one embodiment, the polypeptide is expressed in one or more or all of the developing endosperm, seed coat, alleuron, and embryo of the developing grain.

[0040] In one embodiment, the outer layer of the grain is colored.

[0041] Examples of grains of the present invention include, but are not limited to, rice grains, wheat grains, barley grains, corn grains, sorghum grains, or wild oat grains. In one embodiment, the grain is a rice grain. In another embodiment, the grain is a brown rice grain or a black rice grain.

[0042] In one embodiment, the wild-type grain comprises an mtSSB polypeptide, the mtSSB polypeptide comprising an amino acid sequence provided by SEQ ID NO: 3 or any one of SEQ ID NOs: 15-39, or an amino acid sequence that is at least 75%, at least 80%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identical to one or more of SEQ ID NOs: 3 or any one of SEQ ID NOs: 15-39.

[0043] In one embodiment, the mtSSB polypeptide is the mtSSB-1a polypeptide. In one embodiment, the wild-type grain contains the mtSSB-1a polypeptide, which contains an amino acid sequence that is at least 75%, at least 80%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identical to the amino acid sequence provided by SEQ ID NO: 3 or any one of SEQ ID NO: 15-23.

[0044] In one embodiment, the wild-type grain comprises an mtSSB-1a polypeptide, the mtSSB-1a polypeptide comprising an amino acid sequence provided in SEQ ID NO: 3, or an amino acid sequence that is at least 75%, at least 80%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identical to SEQ ID NO: 3.

[0045] In one embodiment, the wild-type grain contains an mtSSB polypeptide, the mtSSB polypeptide containing one or more or all of the following motifs: FRGVHRAI(I / L)CGKVGQ(V / A)P(V / L)QKILRNG(R / H)T(V / I)T(V / I)FT(V / I)GTGGMFDQR (SEQ ID NO: 45), P(K / M)PAQWHRI(A / S)(V / I)H(N / S)(D / E) (SEQ ID NO: 46), AVQ(K / Q)L(V / T)KNS(A / S)VY(V / I)EG(D / E)IE(T / I)R(V / I)YND (SEQ ID NO: 47), and IC(L / V / I)R(R / G)DGKI (SEQ ID NO: 48).

[0046] In one embodiment, the grain contains an endogenous gene that encodes a truncated mtSSB polypeptide, preferably a truncated mtSSB-1a polypeptide. In one embodiment, the truncated mtSSB polypeptide is C-terminally truncated. In one embodiment, the truncated mtSSB polypeptide is less than 200 amino acids long. Examples of the truncated mtSSB polypeptide of the grain of the present invention include, but are not limited to, those consisting of amino acid sequences selected from SEQ ID NOs: 8, 9, and 10, or truncated versions of any one of them.

[0047] In one embodiment, the reduced mtSSB activity is i) Reduced ability to bind to single-stranded DNA, ii) Reduced ability to bind to RECA3 polypeptide, and iii) One or more of the reduced ability to bind to the TWINKLE polypeptide.

[0048] In one embodiment, the wild-type grain comprises a RECA3 polypeptide, the RECA3 polypeptide comprising an amino acid sequence that is at least 75%, at least 80%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identical to one or more of the amino acid sequences provided by SEQ ID NOs: 61, 67, 69, 71, 73, 75, 77, or 79.

[0049] In one embodiment, the wild-type grain comprises a RECA3 polypeptide, the RECA3 polypeptide comprising an amino acid sequence provided in SEQ ID NO: 61, or an amino acid sequence that is at least 75%, at least 80%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identical to SEQ ID NO: 61.

[0050] In one embodiment, the reduced RECA3 polypeptide activity is i) Reduced ability to bind to mtSSB polypeptide, and ii) One or both of the reduced recombinase activity.

[0051] In one embodiment, the wild-type grain comprises a TWINKLE polypeptide, the TWINKLE polypeptide comprising an amino acid sequence that is at least 75%, at least 80%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identical to one or more of the SEQ ID NOs: 64, 80, 82, 84, 86, 88, 90, 92, 94, or 96.

[0052] In one embodiment, the wild-type grain comprises a TWINKLE polypeptide, the TWINKLE polypeptide comprising an amino acid sequence provided in SEQ ID NO: 64, or an amino acid sequence that is at least 75%, at least 80%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% identical to SEQ ID NO: 64.

[0053] In one embodiment, the reduced TWINKLE polypeptide activity is i) Reduced ability to bind to mtSSB polypeptide, and ii) One or both of the reduced helicase activity.

[0054] Furthermore, there are provided mutant mitochondrial single-stranded DNA-binding (mtSSB) polypeptide, mutant RECA3 polypeptide, or mutant TWINKLE polypeptide, each having an amino acid sequence different from the amino acid sequence of the corresponding wild-type mitochondrial single-stranded DNA-binding (mtSSB) polypeptide, RECA3 polypeptide, or TWINKLE polypeptide, and having reduced activity compared to the corresponding wild-type polypeptide, and preferably encoded by an endogenous gene of a cereal plant containing the genetic variation of the present invention.

[0055] In another embodiment, the present invention provides polynucleotides encoding endogenous genes of cereal plants, including the mutant mitochondrial single-stranded DNA-binding (mtSSB) polypeptide, RECA3 polypeptide, or TWINKLE polypeptide of the present invention.

[0056] In one embodiment, a polynucleotide is operably linked to a promoter expressed in the grain of a cereal plant.

[0057] In a further embodiment, the present invention provides isolated and / or exogenous polynucleotides that reduce the expression of genes encoding mitochondrial single-stranded DNA-binding (mtSSB) polypeptides, RECA3 polypeptides, or TWINKLE polypeptides when present in grains of cereal plants.

[0058] In one embodiment, a polynucleotide is operably linked to a promoter expressed in the grain of a cereal plant.

[0059] Furthermore, the above-described polynucleotide is provided for use in reducing gene expression within grains during the development of cereal plants, at least between the time of pollination and 30 days after pollination.

[0060] Those skilled in the art are well aware of the different types of polynucleotides that can be used to reduce the expression of target genes, and how these polynucleotides can be designed. Examples include, but are not limited to, double-stranded RNA (dsRNA) molecules or their processed RNA products, microRNAs, antisense polynucleotides, sense polynucleotides, or catalytic polynucleotides.

[0061] In one embodiment, the polynucleotide is a dsRNA molecule or a processed RNA product thereof, the dsRNA molecule or the processed RNA product thereof comprising at least 19, at least 20, or at least 21 consecutive nucleotides, the at least 19, at least 20, or at least 21 consecutive nucleotides being at least 95% identical to the complement of a gene encoding a cereal mitochondrial single-stranded DNA-binding (mtSSB) polypeptide, a RECA3 polypeptide, or a TWINKLE polypeptide (where thymine (T) is uracil (U)), or at least 95% identical to the complement of an mRNA encoding a cereal mitochondrial single-stranded DNA-binding (mtSSB) polypeptide, a RECA3 polypeptide, or a TWINKLE polypeptide. For example, in one embodiment, the polynucleotide is a dsRNA molecule or a processed RNA product thereof, the dsRNA molecule or the processed RNA product thereof comprising at least 19 consecutive nucleotides, the at least 19 consecutive nucleotides being at least 95% identical to the complement of SEQ ID NO: 1 (where thymine (T) is uracil (U)) or at least 95% identical to the complement of mRNA encoding an mtSSB polypeptide comprising the amino acid sequence provided as SEQ ID NO: 3.

[0062] In another embodiment, the dsRNA molecule is a microRNA (miRNA) precursor, and / or its processed RNA product is a miRNA.

[0063] In another aspect, the present invention provides a nucleic acid construct and / or vector encoding a polynucleotide, wherein the nucleic acid construct or vector comprises a DNA region encoding a polynucleotide, the polynucleotide being operably linked to a promoter, the promoter being expressed in a developing grain of a cereal plant at least between the time of pollination and 30 days post-pollination.

[0064] In another embodiment, the present invention provides cells, tissues, organs, plant parts, or plants comprising the polynucleotides of the present invention, or nucleic acid constructs and / or vectors of the present invention.

[0065] In one embodiment, the polynucleotide, nucleic acid construct, or vector is incorporated into a cell, tissue, organ, plant part, or plant genome, preferably within the nuclear genome.

[0066] In another embodiment, the present invention provides cereal plant cells, seeds, or tissues therefrom, comprising at least one mitochondrial polypeptide at a reduced level and / or activity relative to the corresponding wild-type cereal plant cell, wherein the mitochondrial polypeptide at a reduced level and / or activity is at least one of mitochondrial single-stranded DNA-binding (mtSSB) polypeptide, RECA3 polypeptide, and TWINKLE polypeptide.

[0067] In one embodiment, the cell, the seed or tissue therefrom is or includes the endosperm, seed coat, alleuron, or embryonic cell.

[0068] In one embodiment, the cells are aleurone cells.

[0069] In another embodiment, the present invention provides a cereal plant that produces the grain of the present invention and / or comprises one or more or all of the polypeptides, polynucleotides, nucleic acid constructs and / or vectors of the present invention, or cells, seeds or tissues of the present invention.

[0070] In one embodiment, the plant of the present invention has approximately the same height as the corresponding wild-type plant.

[0071] In one embodiment, the plant of the present invention is a fertile male and female.

[0072] In one embodiment, the plant of the present invention exhibits delayed grain maturation.

[0073] Furthermore, a population of at least 100 of the cereal plants of the present invention, which grow in a field, is provided.

[0074] In another aspect, the present invention provides a method for producing the cells of the present invention, comprising the step of introducing the genetic variant of the present invention, the polynucleotide of the present invention, or the nucleic acid construct and / or vector of the present invention into cells, preferably cereal plant cells.

[0075] In another aspect, the present invention relates to a cereal plant or a method for producing grains therefrom, i) The step of introducing the genetic alteration of the present invention, the polynucleotide of the present invention, or the nucleic acid construct and / or vector of the present invention into cereal plant cells, ii) A step of obtaining a cereal plant containing genetic variation or polynucleotides from cells obtained from step i), iii) Optionally, a step of harvesting grain from the plant of step ii), wherein the grain contains genetic variation or is transgenic with respect to polynucleotides, nucleic acid constructs or vectors. iv) optionally a step of producing one or more generations of offspring plants from grain, wherein the offspring plants include genetic variation or are transgenic with respect to polynucleotides, nucleic acid constructs or vectors, This provides a method for producing cereal plants or grains.

[0076] In another aspect, the present invention relates to a cereal plant or a method for producing grains therefrom, i) A step of introducing a mutation to an endogenous gene into a cereal plant cell, wherein the endogenous gene encodes a mitochondrial single-stranded DNA binding (mtSSB) polypeptide, a RECA3 polypeptide, or a TWINKLE polypeptide, thereby introducing a cell having a reduced level and / or activity of the mitochondrial single-stranded DNA binding (mtSSB) polypeptide, a RECA3 polypeptide, or a TWINKLE polypeptide compared to the corresponding wild-type cereal plant cell. ii) obtaining a cereal plant from the cells of step i), wherein the cereal plant includes a mutation in an endogenous gene, iii) Optionally, a step of harvesting grain from the plant of step ii), wherein the grain contains mutations. iv) A step of optionally producing one or more generations of offspring plants from grain, wherein the offspring plants include a step of producing mutations, This provides a method for producing cereal plants or grains.

[0077] In another aspect, the present invention relates to a method for selecting the cereal plant or grain of the present invention, i) A step of screening a population of cereal plants or grains, wherein each of the population of cereal plants or grains is obtained from precursor cereal plant cells, grains, or plant mutagenesis treatment, and the population of cereal plants or grains is screened for the production of grains according to the present invention, or for the presence of mutations in genes encoding mitochondrial single-stranded DNA binding (mtSSB) polypeptide, RECA3 polypeptide, or TWINKLE polypeptide, ii) A step of selecting cereal plants from the population of step (i), wherein the cereal plants produce the grains of the present invention or contain the mutation in their genes, This provides a method for selecting cereal plants or grains.

[0078] In another aspect, the present invention relates to a method for selecting cereal plants, i) A step of producing one or more offspring plants from a grain, wherein the grain is derived from the cross of two parent cereal plants, ii) A step of screening one or more offspring plants from step i) for grain production according to the present invention, iii) The step of selecting offspring plants that produce grains, This provides a method for selecting cereal plants.

[0079] In one embodiment, step ii) includes analyzing a sample containing DNA from a descendant plant for genetic variation.

[0080] In one embodiment, step ii) includes analyzing the allureon thickness of the grain obtained from the offspring plant.

[0081] In one embodiment, step ii) includes analyzing the nutritional content of a grain or a portion thereof.

[0082] In one embodiment, step iii) includes selecting offspring plants, wherein the offspring plants are homozygous for genetic variation.

[0083] In one embodiment, step iii) select a progeny plant in which the grain of the progeny plant has an increased aleurone thickness compared to the corresponding wild-type grain.

[0084] In one embodiment, step iii) select a progeny plant in which the grain or portion thereof of the progeny plant has a modified nutrient content compared to the corresponding wild-type grain or portion thereof.

[0085] In one embodiment, the method is i) Crossing two parent cereal plants, preferably one of the parent cereal plants producing the grains of the present invention, or ii) backcrossing one or more offspring plants from step i) with plants of the same genotype as the original parent cereal plant that does not produce the grains of the present invention, and a number of times sufficient to produce the present invention, and iii) Further comprising selecting offspring plants that produce grains of the present invention.

[0086] Furthermore, a cereal plant produced using the method of the present invention is provided.

[0087] Furthermore, the use of the polynucleotides or nucleic acid constructs and / or vectors of the present invention for producing cells, cereal plants, or plant parts such as grains is also provided.

[0088] In one embodiment, the use is for producing the grain of the present invention.

[0089] In a further aspect, the present invention is a method for identifying cereal plants that produce grains of the present invention, i) A step of obtaining nucleic acid samples from cereal plants, ii) A method is provided comprising the step of screening a sample for the presence or absence of genetic variation, wherein the genetic variation reduces the level of activity of mitochondrial single-stranded DNA-binding (mtSSB) polypeptide, RECA3 polypeptide, or TWINKLE polypeptide in the plant compared to the corresponding wild-type cereal plant.

[0090] In one embodiment, genetic variation is a) A nucleic acid construct expressing a polynucleotide or a polynucleotide encoded by such construct, which, when present in cereal plants, reduces the expression of genes encoding mitochondrial single-stranded DNA-binding (mtSSB) polypeptide, RECA3 polypeptide, or TWINKLE polypeptide, and b) A gene or mRNA encoded by it that expresses a mutant mitochondrial single-stranded DNA-binding (mtSSB) polypeptide, RECA3 polypeptide, or TWINKLE polypeptide having reduced activity, preferably a truncated mtSSB polypeptide, RECA3 polypeptide, or TWINKLE polypeptide, one or both of the above.

[0091] In one embodiment, the presence of genetic variation indicates that the grains of cereal plants have thickened alleurons compared to the corresponding cereal plants lacking genetic variation.

[0092] In another aspect, the present invention relates to a method for identifying cereal plants that produce grains of the present invention, i) The step of obtaining grain from cereal plants, ii) grain or a portion thereof a) Thickened allureon, b) The amount and / or activity of mitochondrial single-stranded DNA binding (mtSSB) polypeptide, RECA3 polypeptide, or TWINKLE polypeptide in the grain, c) A method is provided which includes the step of screening for the amount of mRNA encoded by a gene encoding a mitochondrial single-stranded DNA binding (mtSSB) polypeptide, a RECA3 polypeptide, or a TWINKLE polypeptide within a grain.

[0093] In one embodiment, the method identifies the cereal plant of the present invention.

[0094] In a further embodiment, the present invention relates to a method for producing parts of cereal plants, a) To grow the cereal plant of the present invention or at least 100 such cereal plants in a field, b) A method is provided which includes harvesting the cereal plant portion from a cereal plant or a group of cereal plants.

[0095] In a further embodiment, the present invention relates to a method for producing processed grains obtained from grains, or flour, bran, whole grain flour, malt, starch, or oil, a) To obtain the grain of the present invention, b) A method comprising processing grains to produce processed grains, flour, bran, whole grain flour, malt, starch, or oil.

[0096] Furthermore, products are provided that are manufactured from the grains or cereal plants of the present invention, or from a part of said grains or cereal plants that includes genetic variation.

[0097] In one embodiment, the product comprises one or more or all of the following: genetic variation, polynucleotides, nucleic acid constructs or vectors, and thickened aleurons.

[0098] In one embodiment, a portion is cooked, boiled, blanched, roasted, baked, polished, cracked, puffed, milled, or flaked grain or bran.

[0099] In one embodiment, the product is a food ingredient, a beverage ingredient, a food product, or a beverage product.

[0100] In one embodiment, the food or beverage component is selected from the group consisting of roasted grains, polished grains, cracked grains, puffed grains, milled grains, flaked grains, whole grain flour, flour, bran, starch, malt, and oil.

[0101] In one embodiment, the food product is selected from the group consisting of processed grains, cooked grains, boiled grains, porridge, fermented or unfermented bread, pasta, noodles, animal feed, breakfast cereals, snack foods, cakes, pastes, and flour-based sauces.

[0102] In one embodiment, the beverage product is tea, a packaged beverage, or a beverage containing ethanol.

[0103] In a further embodiment, the present invention provides a method for preparing a food or beverage component of the present invention, comprising processing grains or bran, flour, whole grain flour, malt, starch, or oil derived from grains of the present invention to produce a food or beverage component.

[0104] In a further embodiment, the present invention provides a method for preparing a food or beverage product of the present invention, which preferably involves processing the grain by cooking, boiling, roasting or flaking the grain of the present invention, or by mixing the grain of the present invention or bran, flour, whole grain flour, malt, starch, or oil derived from the grain with another food or beverage ingredient.

[0105] Furthermore, the use of the grains or a portion thereof of the present invention, or the cereal plants or a portion thereof of the present invention, is provided for use as animal feed or food, or for producing animal feed or food for human consumption.

[0106] In another embodiment, the present invention provides a composition comprising one or more polypeptides of the present invention, polynucleotides of the present invention, nucleic acid constructs and / or vectors of the present invention, or cells of the present invention, and one or more acceptable carriers, preferably another food component.

[0107] Any embodiment described herein shall be construed as applying mutatis mutandis to any other embodiment unless otherwise specifically described.

[0108] The scope of the present invention is not limited by the specific embodiments described herein, which are intended for illustrative purposes only. Functionally equivalent products, compositions, and methods are clearly within the scope of the present invention as described herein.

[0109] Throughout this specification, unless otherwise specifically stated or required by context, references to a single step, composition of a substance, group of steps, or group of compositions of a substance shall be construed as encompassing one or more (i.e., one or more) of these steps, compositions of a substance, groups of steps, or groups of compositions of a substance.

[0110] The present invention is described below by the following non-limiting embodiments and with reference to the accompanying figures. [Brief explanation of the drawing]

[0111] [Figure 1] Mature ta1-1 glumes showed a thick aleurone phenotype. Mature glumes of wild type (ZH11, A) and ta1-1 (B); cross-sections of mature glumes of ZH11 (C) and ta1-1 (D); Lugol's staining of mature glumes of ZH11 (E) and ta1-1 (F), arrows pointing to aleurone; PAS and Coomassie Brilliant Blue (G-250) staining of semi-ultrathin sections of ZH11 glumes at DAP day 5 (G), DAP day 10 (I), and DAP day 30 (K), and semi-ultrathin sections of ta1-1 glumes at DAP day 5 (H), DAP day 10 (J), and DAP day 30 (L). Bars = 2 mm at A and B, 1 mm at C, D, E, and F, and 20 μm at G, H, I, J, K, and L. DAP: Days after pollination. [Figure 2] Mean number of alleuron cell layers in mature grains of wild-type and ta1-1 at different locations on the glume. Values ​​represent mean ± SD (n=15), **P<0.01. [Figure 3] Analysis of changes in grain dry weight over time. DAP: Days after pollination. Data are shown mean ± SD (n=10), **P<0.01. [Figure 4] Nutrient content of mature glumes of ZH11 (wild type) and ta1-1. Total protein (A), crude fat (B), dietary fiber (C), calcium (D), iron (E), zinc (F), vitamin B2 (G), and vitamin B3 (H) content in mature glumes were measured. Data are shown as mean ± SEM, n=3, (*, P<0.05; **, P<0.01). [Figure 5] Alpha-amylase activity assay of ta1-1 endosperm and aleurone from germinated grains after water absorption. Darker bars represent ta1-1 grains. The difference between ZH11 and ta1 was significant when determined by Student's t-test. *P<0.05, **P<0.01. Each bar represents the mean of three samples. [Figure 6] TA1 map-based cloning showing indel markers mapped to chromosome 5 of the US. Each linear map represents an expansion of the segment from the map directly above. n indicates the number of recombinants used at each stage of the mapping process. Indel = numbered insertion or deletion. The numbers below each vertical line indicate the number of recombinants between the indel marker and the ta1-1 mutation. Mb = 1 million base pairs, Kb = 1,000 base pairs. The bottom line is a schematic diagram of the TA1 gene, where the filled rectangular boxes represent exons (Arabic numerals 1-6) within the protein-coding region, and the lines represent introns (Roman numerals I-V) within the protein-coding region. Arrows labeled G-A indicate the location of G-A point mutations within the ta1-1 allele, which are responsible for the thick aluleon phenotype. [Figure 7] Alignment of three nucleotide sequences (SEQ ID NOs: 12-14) from regions of cDNA produced from different ta1-1 RNAs labeled ta1 I, ta1 II, and ta1 III, compared to the nucleotide sequence (SEQ ID NO: 11) of the corresponding region of wild-type TA1 cDNA (ZH11). This region was involved in alternative splicing of transcripts from mutant ta1-1 genes. [Figure 8] Predicted amino acid sequences (SEQ ID NOs: 8, 9, and 10) of polypeptides translated from three different RNAs produced within ta1-1 grains, compared to the wild-type TA1 polypeptide sequence (ZH11, SEQ ID NO: 3). [Figure 9]Alignment of the amino acid sequence of the wild-type OsTA1 polypeptide (SEQ ID NO: 3) with the amino acid sequences of homologs in Zea mays (SEQ ID NO: 16), Sorghum bicolor (SEQ ID NO: 17), barley (Hordeum vulgare, SEQ ID NO: 18), wheat (Triticum aestivum, SEQ ID NO: 19), Brachypodium distachyon (SEQ ID NO: 20), Arabidopsis thaliana (SEQ ID NO: 15), and poplar (SEQ ID NO: 21). The related rice sequence (OsTA1L; SEQ ID NO: 24) was also used in the alignment. Fully conserved amino acids within the nine sequences are indicated by asterisks, mostly conserved amino acids by semicolons, and similar amino acids by dots. Single-stranded DNA-binding (SSB) domains are indicated by solid bars, and predicted cleavage sites for mitochondrial transport peptide (MTP) removal are indicated by arrows. [Figure 10] Relative expression levels of the TA1 gene in different rice tissues. SAM: Shoot apical meristem, DAP: Days after pollination. All expression levels are normalized to actin genes. Three copies were made for each sample and are shown as mean ± SD. [Figure 11] 6xHis-TA1 protein binding to a biotin-labeled 45-nucleotide ssDNA molecule was used as a probe (lane 2). Addition of unlabeled ssDNA as competing ssDNA at 2× (lane 3), 20× (lane 4), and 200× (lane 5) progressively reduced the amount of mobility-shifted biotin-labeled ssDNA in the presence of TA1 protein. [Figure 12] 6xHis-TA1 and its mutant form 6xHis-ta1-1 polypeptide (truncate TA1 polypeptide) were used to examine their binding to ssDNA by EMSA experiments, using a biotin-labeled 45-nucleotide ssDNA molecule as a probe. 2 μg of recombinant TA1 protein was used to perform the assay shown in Figure 11, and gradients of 2 μg, 4 μg, and 8 μg of recombinant 6xHis-ta1-1 polypeptide were used under the same conditions. [Figure 13] Expression of TA1 in the allureons and embryos of glumes at different developmental stages. Spumes from pTA1:TA1-GUS transgenic plants were stained for GUS activity at DAP day 5 (A and G), DAP day 7 (B and H), DAP day 9 (C and I), DAP day 11 (D and J), DAP day 18 (E and K), and DAP day 24 (F and L). Arrows in C, D, I, and J indicate the allureon cell layer. Bars = 0.2 cm in A, B, C, D, E, and F, and 0.1 cm in G, H, I, J, K, and L. DAP: Days after pollination. [Figure 14] A. Number of mitochondria in each section of developing ta1-1 grain alleuron cells at DAP day 15, compared to wild type (n=10). B. ATP content in wild type and ta1-1 alleurons at DAP day 11. Data are shown as mean ± SD. n=3;** indicates P<0.01. [Figure 15] Downward regulation of the RecA3 and TWINKLE genes in rice using RNAi. The top panel shows a schematic map of the RecA3 and TWINKLE genes, with exons shown as black boxes and introns as lines between boxes. Regions of the genes (exons only) selected for the RNAi constructs are shown in b and c. Quantitative RT-PCR was used to measure mRNA levels in grains of three transformed rice plants for each of the RNAi constructs, which showed reduced expression within each of the selected plants. [Figure 16] Phylogenetic analysis of mtSSB proteins from different plant species, primarily cereals. Protein sequences were aligned in ClustalW, and phylogeny was generated in MEGA7 using the neighbor-joining method. [Figure 17] Phylogenetic analysis of TWINKLE proteins from different plant species, including several cereals. Protein sequences were aligned in ClustalW, and phylogeny was generated in MEGA7 using the neighbor-joining method.

[0112] Sequence list key Sequence ID 1 - Nucleotide sequence of the wild-type rice TA1 gene, locus Os05g43440. Nucleotides 1-1024, TA1 promoter and 5'UTR; 1025-1027, ATG translation start codon; the protein coding region consists of nucleotides 1025-1094, 1176-1339, 1425-1633, 1771-1871, 2127-2186, and 2353-2369. Nucleotides 1095-1175, intron 1; 1340-1424, intron 2; 1634-1770, intron 3; 1872-2126, intron 4; 2187-2352, intron 5. Translation termination is at nucleotides 2367-2369.

[0113] The nucleotide sequence of the protein-coding region of the wild-type TA1 gene cDNA containing the SEQ ID NO: 2-TAG stop codon.

[0114] Amino acid sequence of Sequence ID No. 3 - wild-type TA1(OsmtSSB) polypeptide.

[0115] Sequence ID 4 - Nucleotide sequence of the ta1-1 (mutant) gene, locus Os05g43440. The ta1-1 mutation is located at nucleotide 2126 (G2126A), the last nucleotide of intron 4. Nucleotides 1-1024, TA1 promoter and 5'UTR; 1025-1027, ATG translation start codon; the protein coding region consists of nucleotides 1025-1094, 1176-1339, 1425-1633, 1771-1871, 2127-2186, and 2353-2369. Nucleotides 1095-1175, intron 1; 1340-1424, intron 2; 1634-1770, intron 3; 1872-2126, intron 4; 2187-2352, intron 5. Translation termination occurs at nucleotides 2367-2369.

[0116] Sequence ID 5 - Nucleotide sequence of ta1-1 I cDNA from translation start ATG to wild-type TA1 stop codon TAG.

[0117] Sequence ID 6 - Nucleotide sequence of ta1-1 II cDNA from translation start ATG to wild-type TA1 stop codon TAG.

[0118] Sequence ID 7 - Nucleotide sequence of ta1-1 III cDNA from translation start ATG to wild-type TA1 stop codon TAG.

[0119] Predicted amino acid sequence of the sequence number 8-ta1-1 I polypeptide.

[0120] Predicted amino acid sequence of the SEQ ID NO: 9-TA1-1 II polypeptide.

[0121] Predicted amino acid sequence of SEQ ID NO: 10-TA1-1 II polypeptide.

[0122] Sequence ID 11 - Nucleotide sequence of the cDNA region from the wild-type TA1 gene.

[0123] The nucleotide sequence of the cDNA I region from the SEQ ID NO: 12-ta1-1 gene.

[0124] Nucleotide sequence of the cDNA II region from the SEQ ID NO: 13-ta1-1 gene.

[0125] Nucleotide sequence of the cDNA III region from the SEQ ID NO: 14-ta1-1 gene.

[0126] SEQ ID NO: 15 - Amino acid sequence of the TA1 homologous protein in Arabidopsis thaliana.

[0127] Amino acid sequence of the TA1 homologous protein in SEQ ID NO: 16-Zea mays.

[0128] Amino acid sequence of the TA1 homologous protein in SEQ ID NO: 17-Sorghum bicolor.

[0129] Amino acid sequence of the TA1 homologous protein in Sequence ID No. 18 - Hordeum vulgare.

[0130] Predicted amino acid sequence of SEQ ID NO: 19-TamtSSB-1a; D in Triticum aestivum.

[0131] The amino acid sequence of the TA1 homologous protein in SEQ ID NO: 20-Brachypodium distachyon.

[0132] Sequence ID No. 21 - Amino acid sequence of the TA1 homologous protein in Populus trichocarpa.

[0133] Predicted amino acid sequence of SEQ ID NO: 22-TamtSSB-1a; B in Triticum aestivum.

[0134] Predicted amino acid sequence of SimtSSB-1a in SEQ ID NO: 23-Setaria italica.

[0135] SEQ ID NO: 24 - Amino acid sequence of the TA1-like (OsmtSSB-1b) protein in Oryza sativa.

[0136] Predicted amino acid sequence of SimtSSB-1b in SEQ ID NO: 25-Setaria italica.

[0137] Sequence ID 26 - Predicted amino acid sequence of HvmtSSB-1b within the subspecies Hordeum vulgare.

[0138] Predicted amino acid sequence of SEQ ID NO: 27-TamtSSB-1b; A in Triticum aestivum.

[0139] Predicted amino acid sequence of SEQ ID NO: 28-TamtSSB-1b; B in Triticum aestivum.

[0140] Predicted amino acid sequence of SEQ ID NO: 29-TamtSSB-1b; D in Triticum aestivum.

[0141] Sequence ID 30 - Predicted amino acid sequence of OsmtSSB-2 within the Oryza sativa, Japonica group.

[0142] Predicted amino acid sequence of AtmtSSB-2 in SEQ ID NO: 31-Arabidopsis thaliana.

[0143] Predicted amino acid sequence of SbmtSSB-2 in SEQ ID NO: 32-Sorghum bicolor.

[0144] Predicted amino acid sequence of ZmmtSSB-2 in SEQ ID NO: 33-Zea mays.

[0145] Predicted amino acid sequence of SimtSSB-2 in SEQ ID NO: 34 - Setaria italica.

[0146] Sequence ID 35 - Predicted amino acid sequence of HvmtSSB-2 within the subspecies Hordeum vulgare.

[0147] Predicted amino acid sequence of SEQ ID NO: 36-TamtSSB-2; A in Triticum aestivum.

[0148] Predicted amino acid sequence of SEQ ID NO: 37-TamtSSB-2; B in Triticum aestivum.

[0149] Predicted amino acid sequence of SEQ ID NO: 38-TamtSSB-2; D in Triticum aestivum.

[0150] Predicted amino acid sequence of PtmtSSB-2 in sequence number 39 - Populus trichocarpa.

[0151] Predicted amino acid sequence of MmmtSSB in SEQ ID NO: 40 - Mus musculus.

[0152] Predicted amino acid sequence of HsmtSSB in SEQ ID NO: 41-Homo sapiens.

[0153] Sequence ID No. 42 - Predicted amino acid sequence of DmmtSSB in Drosophila melanogaster.

[0154] Predicted amino acid sequence of ScmtSSB in Saccharomyces cerevisiae (SEQ ID NO: 43).

[0155] Sequence ID No. 44 - Predicted amino acid sequence of EcmtSSB in Escherichia coli.

[0156] Sequence ID 45 - Amino acid motif; 42aa.

[0157] Sequence ID 46 - Amino acid motif; 14aa.

[0158] Sequence ID 47 - Amino acid motif; 24aa.

[0159] Sequence ID 48 - Amino acid motif; 9aa.

[0160] The nucleotide sequence used to analyze the expression pattern of SEQ ID NO: 49-TA1. Nucleotides 1-3208 contain the TA1 promoter and 5'UTR; 3209-3211 contain the ATG translation start codon; the protein coding region consists of nucleotides 3209-3278, 3360-3523, 3609-3817, 3955-4055, 4311-4370, and 4537-4553. Nucleotides 3279-3359 contain intron 1; 3524-3608 contain intron 2; 3818-3954 contain intron 3; 4056-4310 contain intron 4; 4371-4536 contain intron 5. Translation termination and the following GUS protein coding region are not included in this sequence.

[0161] Nucleotide sequences of forward primers for detecting the molecular marker Indel 559 for mapping SEQ ID NO: 50-ta1.

[0162] Nucleotide sequences of reverse primers for detecting the molecular marker Indel 559 for mapping SEQ ID NO: 51-ta1.

[0163] Nucleotide sequences of forward primers for detecting the molecular marker Indel 548 for mapping SEQ ID NO: 52-ta1.

[0164] Nucleotide sequences of reverse primers for detecting the molecular marker Indel 548 for mapping SEQ ID NO: 53-ta1.

[0165] Nucleotide sequences of forward primers for detecting the molecular marker Indel 562 for mapping SEQ ID NO: 54-ta1.

[0166] Nucleotide sequences of reverse primers for detecting the molecular marker Indel 562 for mapping SEQ ID NO: 55-ta1.

[0167] Nucleotide sequences of forward primers for detecting the molecular marker Indel 583 for mapping SEQ ID NO: 56-ta1.

[0168] Nucleotide sequences of reverse primers for detecting the molecular marker Indel 583 for mapping SEQ ID NO: 57-ta1.

[0169] Nucleotide sequences of forward primers for detecting transcripts of the SEQ ID NO: 58-TA1 and ta1-1 genes.

[0170] Nucleotide sequences of reverse primers for detecting transcripts of the SEQ ID NO: 59-TA1 and ta1-1 genes.

[0171] Nucleotide sequence of the probe used in the SEQ ID NO: 60-EMSA experiment.

[0172] SEQ ID NO: 61 - Amino acid sequence of the US RECA3 DNA repair protein, Oryza sativa, Japonica group.

[0173] Sequence ID 62 - US RECA3 gene, Oryza sativa, Japonica group, variety Nipponbare, nucleotide sequence of chromosome 1.

[0174] Sequence ID 63 - nucleotide sequence of cDNA for the US RECA3 gene, mitochondrial RECA3, Oryza sativa, Japonica group, variety Nipponbare.

[0175] Sequence ID 64 - Amino acid sequence of the US TWINKLE chloroplast / mitochondrial DNA repair protein, Oryza sativa, Japonica group.

[0176] Sequence ID 65 - Nucleotide sequence of chromosome 6 of the US TWINKLE gene, Oryza sativa, Japonica group, variety Nipponbare.

[0177] Sequence ID 66 - Nucleotide sequence of the cDNA for the chloroplast / mitochondrial TWINKLE gene from Oryza sativa, Japonica group, variety Nipponbare. The protein-coding region is nucleotides 153-2321.

[0178] SEQ ID NO: 67-RECA3 DNA repair protein, mitochondria, amino acid sequence of Brachypodium distachyon.

[0179] The nucleotide sequence of the cDNA for the SEQ ID NO: 68-RECA3 gene, mitochondrial RECA3, Brachypodium distachyon. The protein-coding region is nucleotides 196-1482.

[0180] SEQ ID NO: 69-RECA3 DNA repair protein, mitochondrial, Sorghum bicolor amino acid sequence.

[0181] Sequence ID 70 - Nucleotide sequence of cDNA for the sorghum RECA3 gene, mitochondrial RECA3, and Sorghum bicolor. The protein-coding region is nucleotides 230-1510.

[0182] SEQ ID NO: 71 - Amino acid sequence of the maize RECA3 DNA repair protein, mitochondria, Zea mays.

[0183] Sequence ID 72 - Nucleotide sequence of cDNA for the maize RECA3 gene, mitochondrial RECA3, Zea mays. The protein-coding region is nucleotides 59-1333.

[0184] SEQ ID NO: 73 - Amino acid sequence of barley RECA3 DNA repair protein, mitochondria, Hordeum vulgare, and subspecies vulgare.

[0185] Sequence ID 74 - Nucleotide sequence of cDNA for the barley RECA3 gene, mitochondrial RECA3, Hordeum vulgare, subspecies vulgare. The protein-coding region is nucleotides 122-1408.

[0186] Sequence ID 75 - Amino acid sequence of wheat RECA3 DNA repair protein, mitochondria, Triticum aestivum variety.

[0187] Sequence ID 76 - Nucleotide sequence of the cDNA for the wheat RECA3 gene from Triticum aestivum, variety Chinese Spring. The protein-coding region is nucleotides 112-1416.

[0188] Sequence ID 77 - RECA3 DNA repair protein from Aegilops tauschii, subspecies tauschii, mitochondrial amino acid sequence.

[0189] Sequence ID 78 - Nucleotide sequence of the cDNA for the RECA3 gene encoding mitochondrial RECA3 from the subspecies Aegilops tauschii. The protein-coding region is nucleotides 129-1427.

[0190] SEQ ID NO: 79 - Amino acid sequence of mitochondrial mitochondrial amino acid sequence from Triticum turgidum, subspecies durum.

[0191] TWINKLE homologous protein from SEQ ID NO: 80 - Brachypodium distachyon, chloroplast / mitochondrial amino acid sequence.

[0192] Nucleotide sequence of the cDNA for the TWINKLE gene encoding the chloroplast / mitochondrial TWINKLE protein from SEQ ID NO: 81-Brachypodium distachyon. The protein-coding region is nucleotides 132-2300.

[0193] TWINKLE homologous protein from SEQ ID NO: 82-Sorghum bicolor, chloroplast / mitochondrial amino acid sequence.

[0194] Nucleotide sequence of the cDNA for the TWINKLE gene encoding the chloroplast / mitochondrial TWINKLE protein from SEQ ID NO: 83-Sorghum bicolor. The protein-coding region is nucleotides 154-2436.

[0195] TWINKLE homologous protein from SEQ ID NO: 84-Zea mays, chloroplast / mitochondrial amino acid sequence.

[0196] Nucleotide sequence of the cDNA for the TWINKLE gene encoding the chloroplast / mitochondrial TWINKLE protein from SEQ ID NO: 85-Zea mays. The protein-coding region is nucleotides 144-2351.

[0197] Sequence ID 86 - Aegilops tauschii, a TWINKLE homologous protein from the subspecies tauschii, showing the amino acid sequence of chloroplasts / mitochondria.

[0198] Sequence ID 87 - Nucleotide sequence of the cDNA for the TWINKLE gene encoding the chloroplast / mitochondrial TWINKLE protein from Aegilops tauschii, subspecies tauschii, transcript variant X1. The protein-coding region is nucleotides 32-2209.

[0199] SEQ ID NO: 88 - Panicum hallii, TWINKLE homologous protein from isoform X1, chloroplast / mitochondrial amino acid sequence.

[0200] Sequence ID 89 - Nucleotide sequence of cDNA for the TWINKLE gene encoding the chloroplast / mitochondrial TWINKLE protein from transcript variant X1 of Panicum hallii. The protein-coding region is nucleotides 100-2343.

[0201] SEQ ID NO: 90 - Setaria viridis, TWINKLE homologous protein from isoform X1, chloroplast / mitochondrial amino acid sequence.

[0202] Sequence ID 91-Setaria viridis, nucleotide sequence of the cDNA for the TWINKLE gene encoding the chloroplast / mitochondrial TWINKLE protein from transcript variant X1. The protein-coding region is nucleotides 70-2346.

[0203] TWINKLE homologous protein from SEQ ID NO: 92 - Nicotiana tabacum, chloroplast / mitochondrial amino acid sequence.

[0204] Sequence ID 93 - Nucleotide sequence of the cDNA for the TWINKLE gene encoding the chloroplast / mitochondrial TWINKLE protein from Nicotiana tabacum. The protein-coding region is nucleotides 103-2199.

[0205] SEQ ID NO: 94 - TWINKLE homologous protein from Solanum tuberosum, chloroplast / mitochondrial amino acid sequence.

[0206] Sequence ID 95 - Nucleotide sequence of the cDNA for the TWINKLE gene encoding the chloroplast / mitochondrial TWINKLE protein from Solanum tuberosum. The protein-coding region is nucleotides 92-2176.

[0207] SEQ ID NO: 96 - TWINKLE homologous protein from isoform X1 of Solanum lycopersicum, chloroplast / mitochondrial amino acid sequence.

[0208] Sequence ID 97 - Nucleotide sequence of cDNA for the TWINKLE gene encoding the chloroplast / mitochondrial TWINKLE protein from transcript variant X1 of Solanum lycopersicum. The protein-coding region is nucleotides 138–2228.

[0209] TA1-1F primer used in the Sequence ID No. 98-TILLING assay.

[0210] TA1-1R primer used in the Sequence ID No. 99-TILLING assay. [Modes for carrying out the invention]

[0211] General techniques and definitions Unless otherwise specifically defined, all technical and scientific terms used herein shall be construed to have the same meaning as those commonly understood by those skilled in the art (for example, in cell culture, molecular genetics, plant molecular biology, protein chemistry, and biochemistry).

[0212] Unless otherwise indicated, the recombinant proteins, cell cultures, and immunological techniques used in this invention are standard procedures well known to those skilled in the art. Such techniques are described in J. Perbal, A Practical Guide to Molecular Cloning, John Wiley and Sons (1984), J. Sambrook et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbour Laboratory Press (1989), TA Brown (editor), Essential Molecular Biology: A Practical Approach, Volumes 1 and 2, IRL Press (1991), DMGlover and BDHames (editors), DNA Cloning: A Practical Approach, Volumes 1-4, IRL Press (1995 and 1996), and FMAusubel et al. (editors), Current Protocols in Molecular Biology, Greene Pub. Associates and Wiley-Interscience (1988, including all updates to date), Ed Harlow and David Lane (editors), Antibodies: A Laboratory Manual, Cold Spring Harbour Laboratory, (1988), and JEColigan et al. This is described and explained throughout the literature of sources such as al. (editors) Current Protocols in Immunology, John Wiley & Sons (including all updates to date).

[0213] The term "and / or," for example, "X and / or Y," is understood to mean either "X and Y" or "X or Y," and is interpreted as providing explicit support for both meanings or either meaning.

[0214] As used herein, the term “approximately” means, unless otherwise stated, + / - 10%, more preferably + / - 5%, more preferably + / - 2.5%, and even more preferably + / - 1% of the specified value. The term “approximately” includes the exact specified value.

[0215] Throughout this specification, the word “comprise,” or variations such as “comprises” or “comprising,” is understood to mean the inclusion of the element, integer, or step, or group of elements, integers, or steps described, but not the exclusion of any other element, integer, or step, or group of elements, integers, or steps.

[0216] Selected definition The terms “aleuron” and “aleuron layer” are used interchangeably herein. The aleuron layer is the outermost layer of the endosperm of a grain and, unlike the inner starchy endosperm, surrounds the starchy endosperm and a portion of the embryo. Therefore, the cells that make up the aleuron layer are the outermost cells of the endosperm, which are the starchy components of the grain. Although the aleuron is technically a part of the endosperm and is often referred to as the peristomal endosperm, from a practical standpoint it is considered a part of the bran because when the grain is polished, for example, when rice grains are milled to produce “white rice,” the aleuron is removed along with the bran, pericarp, and seed coat layers. Unlike the cells of the starchy endosperm, aleuron cells remain alive during grain maturation. The aleuron layer is an important part of the nutritional value of the grain, containing minerals, vitamins such as vitamins A and B, phytochemicals, and fiber.

[0217] Embodiments of the present invention relate to a series of "cell layers," at least in part due to the fact that the cell layers observed at any single point within a cross-section or between cross-sections in any one cross-sectional point of the grain of the present invention can vary to some extent. More specifically, for example, an alleuron having seven cell layers does not have to have seven layers surrounding the entire inner starchy endosperm, but has seven layers surrounding at least a portion of the inner starchy endosperm, preferably at least half of the starchy endosperm.

[0218] When used in relation to the grain aleurons of the present invention, the term "thickened" is a relative term used when comparing the grains of the present invention to the corresponding wild-type grains. In this context, the grains of the present invention include genetic modification, and the genetic modification results in a thickened aleuron compared to wild-type grains lacking the genetic modification. The grain aleurons of the present invention have an increased number of cells and / or an increased number of cell layers, preferably both, compared to the aleuron of the corresponding wild-type grain. Thereafter, the aleuron has an increased thickness when measured in μm, for example, when determined by microscopy. In one embodiment, the thickness is increased by at least 50%, preferably at least 100%, and may increase to the same extent as 500% or 600%, each percentage being relative to the thickness of the aleuron of the corresponding wild-type grain. In one embodiment, the increase is 50% to 100%, or 100% to 200%, or 200% to 300%, or 300% to 400% or 500%. In one embodiment, each percentage increase or range of percentage increases is an average increase over at least the ventral side of the grain, preferably over the entire grain. In a preferred embodiment, the thickness of the aleuron layer is determined over the entire cross-section of the grain. In one embodiment, the thickness of the aleuron is determined by analysis at least on the ventral side of the grain. In another embodiment, the grain thickening aleuron of the present invention comprises cells of varying sizes and irregular orientations compared to the cells of the corresponding wild-type grain, in which the aleuron generally has regularly oriented rectangular cells. All combinations of these features of "thickened aleuron" are intended.

[0219] polypeptide The terms “polypeptide” and “protein” are generally used interchangeably herein and refer to polymers of amino acids linked by peptide bonds.

[0220] As used herein, the term “reduced level” or similar phrase for at least one mitochondrial polypeptide relative to the corresponding wild-type grain is a relative term meaning that the total amount of protein is reduced. This can be achieved, for example, by the deletion of part or all of the gene encoding the polypeptide by standard techniques in the art, which results in a grain lacking the polypeptide. Such a mutation is a null mutation. In one embodiment, the level / amount of protein is reduced by at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 99%, or completely absent compared to the corresponding wild-type grain.

[0221] As used herein, the term "reduced activity" for at least one mitochondrial polypeptide or similar phrase is a relative term meaning that the total amount of a particular protein activity is reduced compared to the corresponding polypeptide in the corresponding wild-type grain. In one embodiment, the protein activity is reduced or completely eliminated by at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, or at least 99% compared to the corresponding wild-type grain. In this example, the total amount of protein may be approximately the same in the grain of the present invention compared to the corresponding wild-type grain, but the polypeptide in the grain of the present invention has a difference of at least one amino acid compared to the corresponding polypeptide in the corresponding wild-type grain, thereby reducing the protein function in the grain of the present invention.

[0222] As used herein, the terms “mitochondrial single-stranded DNA binding polypeptide” or “mtSSB” refer to members of a family of proteins that bind to single-stranded DNA and may be found within the mitochondria of grains, and homologous proteins that have been modified and thereby have reduced or no binding activity. Wild-type proteins play a role in DNA replication, recombination, and repair through binding to single-stranded DNA, as modified proteins may do. Mitochondria in grains typically have three distinct subfamilies of mtSSB, referred to as mtSSB-1a, mtSSB-1b, and mtSSB-2, although some grains have only two subfamilies, namely mtSSB-1 and mtSSB-2. We have found that reducing the mtSSB-1a or mtSSB-1 binding activity in grains compared to the wild type results in an increase in aleurone thickness. mtSSB polypeptides include such polypeptides found in wild-type cereal plants, as well as their variants that are artificially produced or found naturally, and may or may not have single-strand DNA binding activity, including mtSSB polypeptides that have some single-strand DNA binding activity, but at a reduced level compared to the corresponding wild-type mtSSB polypeptide. As demonstrated herein, the wild-type mtSSB-1a polypeptide binds not only to ssDNA but also to two other mitochondrial polypeptides, namely TWINKLE and RECA3. In one embodiment, the mtSSB polypeptide of the present invention, comprising an mtSSB variant having reduced activity, binds to the TWINKLE polypeptide. In one embodiment, the mtSSB polypeptide of the present invention, comprising an mtSSB variant having reduced activity, binds to the RECA3 polypeptide. In one embodiment, the mtSSB polypeptide of the present invention is capable of forming an oligomer of mtSSB, in particular a homodimer. In one embodiment, the wild-type grain mtSSB polypeptide comprises an amino acid sequence provided by SEQ ID NO: 3 or any one of SEQ ID NOs from 15 to 39, or an amino acid sequence that is at least 75% identical to one or more of SEQ ID NOs from 3 or 15 to 39.In a preferred embodiment, the wild-type grain mtSSB polypeptide comprises an amino acid sequence that is at least 75% identical to the amino acid sequence provided by any one of SEQ ID NOs: 3, 16-20, or 23, or to one or more of SEQ ID NOs: 3, 16-20, or 23 along the full length of the reference sequence.

[0223] The wild-type mtSSB disclosed herein typically has a length of 200 to 215 amino acid residues when containing a mitochondrial target peptide (MTP) at its N-terminus, and a length of 170 to 190 residues after cleavage by the MTP. The mutant mtSSB polypeptide of the present invention may have an MTP and, in the absence of an insertion within the mtSSB gene, be up to 215 amino acid residues in length, but may be shorter, and even much shorter, if the mutant mtSSB polypeptide is C-terminally shortened or encoded by a mutant gene containing a translation termination mutation. In one embodiment, the mtSSB polypeptide of the present invention lacks at least a portion of the DNA-binding domain, for example, lacking the amino acid GKI at the C-terminus of the DNA-binding domain (see, for example, Figure 8).

[0224] In one embodiment, the grain of the present invention has at least one mtSSB polypeptide, the at least one mtSSB polypeptide having a different amino acid sequence from the corresponding wild-type mtSSB polypeptide, or the grain lacks the wild-type mtSSB polypeptide. In a related embodiment, the grain of the present invention has an endogenous gene, the endogenous gene encoding at least one (mutant) mtSSB polypeptide, and even if the at least one (mutant) mtSSB polypeptide is not expressed in the grain or is unstable and does not accumulate in the grain, this mutant polypeptide has a different amino acid sequence from the corresponding wild-type mtSSB polypeptide.

[0225] As used herein, the term "having a different amino acid sequence from the corresponding wild-type mtSSB polypeptide" or similar phrases is a comparative term meaning that the amino acid sequence of the mtSSB polypeptide in the present invention and / or in the grain of the present invention differs from the amino acid sequence of the naturally occurring protein from which the mtSSB polypeptide is derived and / or most closely related. In one embodiment, the amino acid sequence of the mtSSB polypeptide may have one or more insertions, deletions, or amino acid substitutions (or combinations thereof) compared to the corresponding wild-type amino acid sequence. The mtSSB polypeptide may have two, three, four, five, or six to ten amino acid substitutions compared to the corresponding wild-type mtSSB polypeptide. In a preferred embodiment, the mtSSB polypeptide is C-terminally shortened, for example, lacking 14, 20, or 21 or more amino acids from the C-terminus of the wild-type mtSSB polypeptide (see, for example, Table 4). Such truncated mtSSB polypeptides may be encoded by, for example, an mtSSB gene, which contains a partial translation termination codon within the protein open reading frame relative to the wild-type mtSSB gene from which the mtSSB gene is derived, or by a mutant gene, such as a gene containing a splice site mutation, which produces an RNA transcript that is spliced ​​differently from the wild-type RNA transcript. In another embodiment, the mtSSB polypeptide having reduced activity has only a single insertion, a single deletion, or a single amino acid substitution relative to the corresponding wild-type polypeptide. In this context, “single insertion” and “single deletion” include cases where multiple (e.g., two, three, four, five, six, seven, eight, nine, or more) consecutive amino acids are each inserted or deleted, and “corresponding wild-type polypeptide” means the wild-type polypeptide from which the variant is derived and / or the native polypeptide most closely associated with the variant. As demonstrated in Example 13, such mutations can be located at any position within the protein coding region, preferably at any position within the region of the gene encoding the DNA-binding domain of the mtSSB polypeptide.

[0226] As used herein, the term “mtSSB polypeptide activity” or its variation refers to at least one biological action of a wild-type mtSSB polypeptide or a variant thereof. In one example, the term refers to the strength or lack thereof of binding of a polypeptide or its oligomer to single-stranded DNA. Thus, in one embodiment, the mtSSB polypeptide of the present invention, such as a truncated mtSSB polypeptide, has reduced single-stranded DNA binding activity or no single-stranded DNA binding activity compared to a wild-type mtSSB polypeptide, for example, one containing the amino acid sequence provided in SEQ ID NO: 3 or any one of 15-39. In this context, the comparison is a comparison with a wild-type mtSSB polypeptide whose sequence is the closest to the mtSSB polypeptide of the present invention as determined by amino acid alignment with known mtSSB polypeptide sequences, or a comparison with a wild-type mtSSB polypeptide from which the mtSSB polypeptide of the present invention is derived by mutation. In one embodiment, the mtSSB polypeptide of the present invention lacks at least a portion of its DNA-binding domain (see Figure 9), or has a variant DNA-binding domain (such as a C-terminal truncated variant) that binds to single-stranded DNA more weakly than the corresponding wild-type mtSSB polypeptide (e.g., the one provided in SEQ ID NO: 3). In one example, this term refers to the strength or lack thereof of binding of the polypeptide or its oligomer to the TWINKLE polypeptide of the present invention. In one example, this term refers to the strength or lack thereof of binding of the polypeptide or its oligomer to the RECA3 polypeptide of the present invention.

[0227] Reduced single-stranded DNA binding activity can be readily determined by using standard assays in the art. For example, single-stranded DNA binding can be measured using electrophoretic mobility shift assays (also known as gel mobility shift assays), e.g., those described in Farr et al. (2004) and Ciesielski et al. (2016), or preferably those described in Examples 1 and 9 of this specification. In such assays, the single-stranded DNA substrate and polypeptide are added to the reaction mixture, and gel electrophoresis is used to determine whether the single-stranded DNA substrate and polypeptide assemble into a protein-DNA complex.

[0228] As used herein, the terms “mitochondrial single-stranded DNA-binding polypeptide-1a,” “mtSSB-1a,” or “TA1,” and their variations, refer to a subfamily of mtSSBs in which the wild-type protein of the mtSSB subfamily contains an amino acid sequence that is at least 75% identical to, for example, the amino acid sequence provided by SEQ ID NO: 3 or any one of SEQ ID NOs from 15 to 23, or to one or more of SEQ ID NOs from 3 or 15 to 23 along the full length of the reference sequence. Variations of these terms include the mtSSB-1a polypeptide, which has reduced ssDNA-binding activity or lacks ssDNA-binding activity as a result of a mutation in the endogenous gene encoding the polypeptide. In one embodiment, the wild-type OsmtSSB-1a polypeptide has the following motifs: FRGVHRAI(I / L)CGKVGQ(V / A)P(V / L)QKILRNG(R / H)T(V / I)T(V / I)FT(V / I)GTGGMFDQR (motif I, SEQ ID NO: 45) corresponding to amino acids 73-114 of SEQ ID NO: 3, and P(K / M)PAQWHRI(A / S)(V / I)H( The polypeptide has one or more of the following: N / S)(D / E)(Motif II, SEQ ID NO: 46), AVQ(K / Q)L(V / T)KNS(A / S)VY(V / I)EG(D / E)IE(T / I)R(V / I)YND(Motif III, SEQ ID NO: 47), which corresponds to amino acids 141-164 of SEQ ID NO: 3, and IC(L / V / I)R(R / G)DGKI(Motif IV, SEQ ID NO: 48), which corresponds to amino acids 176-184 of SEQ ID NO: 3. Examples of polypeptides having reduced OsmtSSB-1a polypeptide activity include those having the amino acid sequence described as SEQ ID NO: 8, SEQ ID NO: 9, or SEQ ID NO: 10, or a shortened version thereof, or those having an amino acid sequence that is at least 75% identical to one or more of the amino acid sequences described as SEQ ID NO: 8, SEQ ID NO: 9, or SEQ ID NO: 10 along the full length of the reference sequence.

[0229] As used herein, the terms “mitochondrial single-stranded DNA-binding polypeptide-1b” or “mtSSB-1b” and their variations refer to a subfamily of mtSSBs in which the wild-type protein of the mtSSB subfamily contains an amino acid sequence that is at least 75% identical to, for example, the amino acid sequence provided by any one of SEQ ID NOs. 24–29, or along the full length of the reference sequence, one or more of SEQ ID NOs. 24–29. mtSSB-1a polypeptides are not included in the set of mtSSB-1b polypeptides.

[0230] As used herein, the terms “mitochondrial single-stranded DNA-binding polypeptide-2” or “mtSSB-2” and their variations refer to a subfamily of mtSSBs in which the wild-type proteins of the mtSSB subfamily contain an amino acid sequence that is at least 75% identical to, for example, the amino acid sequence provided by any one of SEQ ID NOs. 30–39, or along the full length of the reference sequence, one or more of SEQ ID NOs. 30–39. mtSSB-1a polypeptides are not included in the set of mtSSB-2 polypeptides.

[0231] As used herein, the term “TWINKLE” refers to a family of proteins and their variants that may be found in the mitochondria of wild-type cereal grains and possess helicase activity. Wild-type TWINKLE proteins play a role in mitochondrial DNA replication. Helicases catalyze the unwinding of double-stranded DNA using energy from nucleotide triphosphate (NTP) hydrolysis. We have found that reducing (but not eliminating) wild-type TWINKLE activity in cereal grains, preferably rice grains, results in an increase in aleurone thickness (see Example 15). TWINKLE polypeptides include such polypeptides found in wild-type cereal plants and their variants that are artificially produced or naturally occurring, all of which may or may not possess helicase activity, including TWINKLE polypeptides that possess helicase activity but at a reduced level compared to the corresponding wild-type TWINKLE polypeptide. In this context, the comparison is a comparison with the wild-type TWINKLE polypeptide that, as determined by amino acid alignment, has the closest sequence to the TWINKLE polypeptide of the present invention, or a comparison with the wild-type TWINKLE polypeptide from which the TWINKLE polypeptide of the present invention is derived by mutation. In one embodiment, the TWINKLE polypeptide binds to the mtSSB polypeptide. In one embodiment, the TWINKLE polypeptide has helicase activity. In one embodiment, the TWINKLE polypeptide is capable of forming polymers of the TWINKLE polypeptide. TWINKLE typically has the following five conserved helicase motifs: (1) the H1 / Walker A motif that stabilizes the NTP phosphate, (2) the H1a involved in NTP binding / hydrolysis, (3) the H2 / Walker B motif containing arginine finger and base stack residues required for the arrangement and stabilization of the bound NTP and the stabilization of the bound Mg2+ ion, (4) the H3 involved in NTP binding / hydrolysis together with the H1a, and (5) the H4 that contributes to DNA binding. Furthermore, the C-terminal region of many twinkle helicases is required for interaction with other factors within the replisome.In one embodiment, the TWINKLE polypeptide comprises an amino acid sequence that is at least 75% identical to one or more of the amino acid sequences provided by any one of SEQ ID NOs: 64, 80, 82, 84, 86, 88, 90, 92, 94, or 96, along with the full length of the reference sequence.

[0232] Reduced helicase activity can be readily determined by using standard assays in the art. For example, helicase activity can be determined by measuring the amount of helicase reaction products such as ADP, inorganic phosphonates, and / or single-stranded DNA. In these assays, a fluorescently labeled protein detects the target molecule, e.g., ADP, inorganic phosphonate, or single-stranded DNA (Toseland et al., 2010). In one example, double-stranded DNA unwinding can be measured to determine helicase activity. This measurement uses a fluorophore (e.g., Cy3) and quencher (e.g., dabusil) pair, with the fluorophore and quencher pair positioned at the ends of the double strand and one on each strand of DNA. During helicase-inducible DNA unwinding, the fluorophore and quencher separate from each other, resulting in increased fluorescence (Toseland et al., 2010). In another example, a helicase substrate is produced consisting of a partially double-stranded DNA substrate with a short 5' single-stranded DNA overhang (Korhonen et al., 2003). The helicase reaction is carried out in a reaction buffer containing the helicase substrate and polypeptide. The fractions of the base-pair substrate and single-stranded DNA product can then be isolated and analyzed by gel electrophoresis.

[0233] As used herein, the term “RECA3” refers to a subfamily of plant recombinant-associated proteins and their mutant variants that may be found in the mitochondria of wild-type cereal grains and that contribute to reducing the occurrence of inappropriate recombination events in mitochondrial DNA. While we do not wish to be bound by theory, current evidence suggests that RECA3 is involved in a surveillance mechanism that allows recombination-dependent replication to be initiated at longer iterations, while directing conversion events between short iterations (Shedge et al., 2007). We have found that reducing (but not eliminating) wild-type RECA3 activity in cereal grains, preferably rice grains, results in increased aleurone thickness. RECA3 polypeptides include such polypeptides found in wild-type cereal plants and their variants that are artificially produced or naturally occurring, all of which may or may not have recombinase activity, including RECA3 polypeptides that have some recombinase activity but at reduced levels compared to the corresponding wild-type RECA3 polypeptide. In one embodiment, the RECA3 polypeptide binds to an mtSSB polypeptide. In one embodiment, the RECA3 polypeptide has recombinase activity. The RECA3 polypeptide typically has a RecA / RAD51 domain, which comprises two highly conserved consensus motifs, Walker A and Walker B, which are present in the ATPase and confer ATP binding and hydrolysis activity. In one embodiment, the RECA3 polypeptide comprises an amino acid sequence described as SEQ ID NOs. 61, 67, 69, 71, 73, 75, 77, or 79, or an amino acid sequence that is at least 75% identical to one or more of SEQ ID NOs. 61, 67, 69, 71, 73, 75, 77, or 79 along the full length of the reference sequence.

[0234] Reduced recombinase activity can be readily determined by using standard assays in the art. In one example, a fluorophore-labeled single-stranded DNA substrate and polypeptide are incubated in a reaction mixture (Silva et al., 2017). Fluorescence quenching occurs upon recombinase binding. Fluorescence analysis can be performed using fluorescence spectroscopy. In another example, recombinase activity can be measured using a strand fusion (or "D-loop") assay (Jayathilaka et al., 2008). In this assay, the polypeptide is first made assembleable onto an ionically labeled single-stranded DNA oligonucleotide. A homology-containing supercoiled target plasmid is then added, allowing the two to form a homology-dependent junction molecule called a "D-loop." The D-loop protein can be isolated and analyzed by gel electrophoresis and fluorescence imaging.

[0235] As used herein, the terms “substantially purified polypeptide” or “purified polypeptide” mean a polypeptide that has been at least partially isolated from the lipids, nucleic acids, other peptides, and other contaminating molecules to which the polypeptide is naturally associated. Preferably, a substantially purified polypeptide is free of at least 90% of the other components to which the polypeptide is naturally associated. In one embodiment, the polypeptide of the present invention has a different amino acid sequence from the naturally occurring cereal mtSSB, TWINKLE, or RECA3 polypeptide, i.e., is an amino acid sequence variant as defined above.

[0236] The grains, plants, and host cells of the present invention may contain an endogenous gene containing a mutation encoding the variant polypeptide of the present invention, or an exogenous polynucleotide encoding the polypeptide of the present invention. In these cases, the grains, plants, and cells produce mutant or recombinant polypeptides. In this context, the term “mutant” means a polypeptide in which the polypeptide has a different amino acid sequence from the wild-type polypeptide from which it is most closely related or from which it is derived by the mutation. Mutant polypeptides may be expressed at different levels, in different cells, or at different times compared to the wild-type polypeptide from which the mutant polypeptide is most closely related and / or from which it is derived. In the context of polypeptides, the term “recombinant” means a polypeptide that is encoded by an exogenous polynucleotide when produced by a cell and has been introduced into a cell or progenitor cell by recombinant DNA or RNA techniques, such as transformation. In one embodiment, the recombinant polypeptide has the same amino acid sequence as the wild-type polypeptide, but the recombinant polypeptide may be expressed at different levels, in different cells, or at different times compared to the wild-type polypeptide. In an alternative embodiment, the recombinant polypeptide has a different amino acid sequence from the wild-type polypeptide from which it is most closely related or from which it is derived. Similarly, this recombinant polypeptide may be expressed at different levels, in different cells, or at different times compared to the wild-type polypeptide. Typically, a cell contains a non-endogenous gene that causes the production of the modified amount of polypeptide. In one embodiment, the “recombinant polypeptide” is a polypeptide produced by the expression of exogenous (recombinant) polynucleotides in plant cells.

[0237] The % identity of polypeptides is determined by GAP (Needleman and Wunsch, 1970) analysis (GCG program) with a gap generation penalty of 5 and a gap elongation penalty of 0.3. In one embodiment, the query sequence is at least 150 amino acids long, and the GAP analysis aligns the two sequences across a region of at least 150 amino acids. In one embodiment, the query sequence is at least 175 amino acids long, and the GAP analysis aligns the two sequences across a region of at least 175 amino acids. In one embodiment, the query sequence is at least 200 amino acids long, and the GAP analysis aligns the two sequences across a region of at least 200 amino acids. In one embodiment, the query sequence is at least 300 amino acids long, and the GAP analysis aligns the two sequences across a region of at least 300 amino acids. In one embodiment, the query sequence is at least 400 amino acids long, and the GAP analysis aligns the two sequences across a region of at least 400 amino acids. In one embodiment, the query sequence is at least 500 amino acids long, and the GAP analysis aligns the two sequences across a region of at least 500 amino acids. In another embodiment, the query sequence is at least 600 amino acids long, and the GAP analysis aligns the two sequences across a region of at least 600 amino acids. In yet another embodiment, the query sequence is at least 700 amino acids long, and the GAP analysis aligns the two sequences across a region of at least 700 amino acids. More preferably, the GAP analysis aligns the two sequences across their entire lengths.

[0238] With respect to the defined polypeptides, it will be understood that a higher percentage identity value than the percentage identity values ​​provided above will encompass preferred embodiments. Therefore, where applicable, it is preferable that the polypeptide contains an amino acid sequence that is at least 75%, more preferably at least 80%, more preferably at least 85%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, more preferably at least 93%, more preferably at least 94%, more preferably at least 95%, more preferably at least 96%, more preferably at least 97%, more preferably at least 98%, more preferably at least 99%, more preferably at least 99.1%, more preferably at least 99.2%, more preferably at least 99.3%, more preferably at least 99.4%, more preferably at least 99.5%, more preferably at least 99.6%, more preferably at least 99.7%, more preferably at least 99.8%, and even more preferably at least 99.9% identical to the designated sequence number in question.

[0239] As used herein, the phrase "at the position corresponding to the amino acid number" or variations thereof refers to the relative position of an amino acid in relation to surrounding amino acids in the context of one or more specific amino acid sequences. In some embodiments, the polypeptides of the present invention may have deletion or substitution mutations, which alter the relative arrangement of amino acids when aligned to, for example, SEQ ID NO: 3. Determining the corresponding amino acid positions between two closely related proteins is well within the capabilities of those skilled in the art.

[0240] The conserved amino acids of mtSSB, TWINKLE, and RECA3 polypeptides can be readily identified by aligning their amino acid sequences with those of wild-type polypeptides, such as those described herein. For example, the rice OsmtSSB-1a(TA1) amino acid sequence (SEQ ID NO: 3) may be aligned with mtSSB-1a polypeptides from other species, or further aligned with mtSSB polypeptides from rice or other species, particularly plant species, such as Arabidopsis thaliana (SEQ ID NO: 15), Sorghum bicolor (SEQ ID NO: 17), Hordeum vulgare (SEQ ID NO: 18), Triticum aestivum (SEQ ID NOs: 19 and 22), Brachypodium distachyon (SEQ ID NO: 20), and Populus trichocarpa (SEQ ID NO: 21) (see, for example, Figure 9).

[0241] Amino acid sequence variants of the polypeptide of the present invention can be prepared by mutagenesis of precursor cereal plant cells, e.g., cereal seeds, either by random mutagenesis with a mutagen, followed by screening of a mutagenesis population for variants in the endogenous gene encoding the polypeptide, or by targeted mutagenesis, e.g., targeted mutagenesis with a gene editing tool. Amino acid sequence variants can also be prepared by introducing appropriate nucleotide changes into the nucleic acid of the present invention. Such variants include, for example, deletions, insertions, or substitutions of residues in the amino acid sequence, and the deletions, insertions, or substitutions can occur at any position along the length of the wild-type polypeptide. Combinations of deletions, insertions, and substitutions can be made to arrive at the final construct, insofar as the final peptide product has the desired characteristics. Preferred amino acid sequence variants have only one, two, three, four, or fewer than ten amino acid changes relative to the reference wild-type polypeptide. The mutant polypeptides of the present invention have "reduced activity" compared to the corresponding wild-type naturally occurring polypeptide, for example, a polypeptide having the amino acid sequence described as SEQ ID NO: 8, SEQ ID NO: 9, or SEQ ID NO: 10, or a shortened version thereof, or a polypeptide having an amino acid sequence that is at least 75%, at least 80%, at least 85%, preferably at least 90%, or more preferably at least 95% identical to one or more of the amino acid sequences described as SEQ ID NO: 8, SEQ ID NO: 9, or SEQ ID NO: 10 along the full length of the reference sequence.

[0242] Mutant (modified) polypeptides can be prepared using any technique known in the art, for example, using directed evolution or rational design strategies. Products derived from mutant / modified DNA can be readily screened using techniques described herein to determine whether the product has reduced activity, for example, by tilling (see Example 1). For example, the method may include producing a transgenic plant expressing mutant / modified DNA and determining (i) the effect of the mutant / modified DNA on aleurone thickness, and (ii) whether the mtSSB, TWINKLE, or RECA3 gene is mutant / modified (for example, using the method described in Example 13). Thus, the polypeptides and polynucleotides of the present invention can be used in screening assays to determine the biological effects of polypeptides and polynucleotides.

[0243] In designing amino acid sequence variants, the location and nature of the mutation depend on the feature being modified. Mutation sites can be modified individually or sequentially, for example, by (1) substitution using non-conservative amino acid selection, (2) deletion of a target residue, or (3) insertion of other residues adjacent to the site where the mutation occurs.

[0244] Amino acid sequence deletions generally range from about 1 to 15 residues, more preferably about 1 to 10 residues, and typically from about 1 to 5 consecutive residues.

[0245] Substitutional mutants have at least one amino acid residue removed from the polypeptide molecule and a different residue inserted in its place. When it is undesirable to maintain or reduce certain activities, non-conservative substitutions are preferred, particularly at highly conserved amino acid positions within the relevant protein family. Examples of conservative substitutions are shown in Table 1, and therefore, non-conservative substitutions are those not shown in Table 1. [Table 1]

[0246] In one embodiment, the mutant / variant polypeptide has one, two, three, or four amino acid changes compared to the spontaneously occurring polypeptide. In a preferred embodiment, the changes are within one or more highly conserved motifs among the different mtSSB, TWINKLE, or RECA3 polypeptides provided herein, particularly within known conserved structural domains. As those skilled in the art will recognize, such changes can be reasonably predicted to reduce the activity of the polypeptide when expressed in cells or grains.

[0247] The primary amino acid sequences of the polypeptides of the present invention can be used to design variants / mutants based on comparison with closely related enzymes. As those skilled in the art will understand, changes to highly conserved residues in closely related proteins are more likely to reduce activity than changes to less conserved residues. In this context, amino acid sequence alignments of mtSSB, TWINKLE, or RECA3 proteins from a range of sources can be used to identify more highly conserved and less conserved amino acid residues.

[0248] Polynucleotides and genes The present invention refers to a variety of polynucleotides. As used herein, “polynucleotide,” “nucleic acid,” or “nucleic acid molecule” means a polymer of nucleotides which may be DNA or RNA, and includes genomic DNA, mRNA, cRNA, dsRNA, and cDNA. This may be DNA or RNA of cellular, genomic, or synthetic origin, for example, DNA or RNA produced in an automated synthesizer, which may be combined with carbohydrates, lipids, proteins, or other materials, may be labeled with fluorescent or other groups, may be mounted on a solid support, or may contain one or more modified nucleotides not found in nature, which are well known to those skilled in the art, in order to perform a particular activity as defined herein. The polymer may be single-stranded, essentially double-stranded, or partially double-stranded. As used herein, base pairing refers to a standard base pairing between nucleotides, including a G:U base pair. “Complementary” means that two polynucleotides can base pair (hybridize) along a portion of the length of the two polynucleotides, or along the full length of one or both. "Hybridized polynucleotide" means that the polynucleotide is actually base-paired with the complement of the polynucleotide. The term "polynucleotide" is used herein interchangeably with the term "nucleic acid." Preferred polynucleotides of the present invention encode the polypeptides of the present invention.

[0249] "Isolated polynucleotide" means a polynucleotide that has been at least partially isolated from a polynucleotide sequence in which the polynucleotide naturally associates or is linked when the polynucleotide is found naturally. Preferably, the isolated polynucleotide contains at least 90% of the other components in which the polynucleotide naturally associates when the polynucleotide is found naturally. Preferably, the polynucleotide is not a spontaneously occurring polynucleotide (chimeric polynucleotide), for example, by covalent bonding of two shorter polynucleotide sequences in a manner not found naturally.

[0250] The present invention includes the reduction of gene activity, as well as the construction and use of chimeric genes. As used herein, the term “gene” includes any deoxyribonucleotide sequence that includes a protein-coding region or is transcribed in a cell but not translated, and associated non-coding and regulatory regions. Such associated regions are typically located adjacent to the coding or transcribed region above both the 5' and 3' ends, extending over a distance of approximately 2 kb on either side. In this regard, a gene may include regulatory signals such as promoters, enhancers, termination and / or polyadenylation signals, or heterologous regulatory signals that naturally associate with a given gene, in which case the gene is referred to as a “chimeric gene.” A sequence located at 5' of the coding region and present on mRNA is referred to as the 5' untranslated sequence. A sequence located at 3' or downstream of the coding region and present on mRNA is referred to as the 3' untranslated sequence. The term “gene” encompasses both the cDNA and genomic forms of a gene.

[0251] An "allele" refers to one specific form of a gene sequence (such as a gene) within a cell, an individual plant, or a population, where a specific form differs from other forms of the same gene in at least one variant site, frequently, two or more variant sites within the gene sequence. These variant sites that differ between different alleles are referred to as "variances" or "polymorphisms." As used herein, "polymorphism" refers to variations in the nucleotide sequence between alleles at the gene locus of the present invention in different species, varieties, lines, or individuals of a plant. A "polymorphic site" is a pre-selected nucleotide site within the gene sequence where the sequence difference occurs. In some cases, genetic polymorphisms cause variations in the amino acid sequence within the polypeptide encoded by the gene, and thus a polymorphic site can result in a location of polymorphism within the amino acid sequence at a given position within the polypeptide sequence. In other cases, polymorphic regions may be within the non-polypeptide coding region of a gene, for example, within the promoter region, thereby affecting the gene expression level. Typical polymorphisms are deletions, insertions, or substitutions. These may consist of a single nucleotide (single nucleotide polymorphism or SNP) or two or more nucleotides.

[0252] As used herein, “mutation” refers to a polymorphism that results in a phenotypic change within a plant or a portion thereof. In this context, a primary phenotypic change is the thickening of the alluleon of a grain compared to the wild-type (non-mutant) morphology. As is known in the art, some polymorphisms are silent, for example, single nucleotide changes within a protein-coding region, which, due to the redundancy of the genetic code, do not alter the amino acid sequence of the encoded polypeptide. Diploid plants typically have one or two different alleles of a single gene, but only one allele if both copies of the gene are identical, i.e., the plant is homozygous for the allele. Polyploid plants generally have two or more homeologs of any particular gene. For example, hexaploid wheat has three subgenomes (often referred to as “genomes”), referred to as A, B, and D genomes, and therefore has three homeologs of most of the genes of hexaploid wheat, with one homeolog in each of the A, B, and D genomes.

[0253] The term “gene” refers to a nucleotide sequence encoding a polypeptide as defined herein. A gene may be an endogenous spontaneous gene, or it may include a genetic variant, preferably an introduced genetic variant, as defined herein. The gene encoding the polypeptide in the grain of the present invention may or may not have introns. In one example, the grain of the present invention is from rice, and at least one allele of the OsmtSSB-1a gene encodes the OsmtSSB-1a polypeptide, the OsmtSSB-1a polypeptide having reduced OsmtSSB-1a polypeptide activity compared to the OsmtSSB-1a polypeptide from the corresponding wild-type rice plant (e.g., one containing the amino acid sequence provided in SEQ ID NO: 3). Examples of such OsmtSSB-1a polypeptides having reduced OsmtSSB-1a polypeptide activity include those having an amino acid sequence consisting of the amino acids provided in SEQ ID NO: 8, SEQ ID NO: 9, or SEQ ID NO: 10, or a shortened version thereof, or one or more amino acid sequences that are at least 75%, at least 90%, or preferably at least 95%, identical to one or more of the amino acid sequences described in SEQ ID NO: 8, SEQ ID NO: 9, or SEQ ID NO: 10, but are not longer.

[0254] In one embodiment, the genetic variation reduces the expression of an endogenous gene encoding a wild-type mitochondrial polypeptide as described herein. As used herein, the phrase or variation thereof, “reduces the expression of an endogenous gene,” means any genetic variation that (partially) reduces or completely prevents the expression of a gene encoding a functional polypeptide as defined herein. Such genetic variations include mutations within the promoter region of a gene that reduce the transcription of the gene by, for example, using gene editing to delete or substitute nucleotides from the gene's promoter, or intron splicing mutations that alter the amount or location of splicing to form mRNA.

[0255] The genomic morphology or clone of a gene containing a transcribed region may be interrupted by non-coding sequences referred to as “introns,” “intervening regions,” or “intervening sequences,” which may be homologous or heterologous to the “exons” of the gene. As used herein, an “intron” is a segment of a gene that is transcribed as part of a primary RNA transcript but is not present in a mature mRNA molecule. Introns are removed from the nucleus or primary transcript, or “spliced ​​off,” and are therefore not present in messenger RNA (mRNA). As used herein, an “exon” refers to a DNA region corresponding to an RNA sequence present in a mature mRNA or mature RNA molecule when the RNA molecule is not translated. mRNA functions during translation to identify the sequence or order of amino acids in a nascent polypeptide. The term “gene” includes a synthetic or fusion molecule encoding all or part of the proteins of the present invention as described herein, and a nucleotide sequence complementary to any one of the above. Genes may be introduced into a vector suitable for extrachromosomal maintenance within a cell, or preferably for integration into a host genome.

[0256] As used herein, “chimeric gene” refers to any gene containing covalently linked sequences that are not naturally found to be linked. Typically, a chimeric gene contains regulatory and transcriptional or protein-coding sequences that are not naturally found together. Thus, a chimeric gene may contain regulatory and coding sequences from different sources, or regulatory and coding sequences from the same source but organized in a manner different from that which is naturally found. In one embodiment, the protein-coding region of a gene is operably ligated to a promoter or polyadenylation / termination region that is heterologous to the gene, thereby forming a chimeric gene. In an alternative embodiment, a gene encoding a polynucleotide, when present in a grain of a cereal plant, de-regulates the production and / or activity of polypeptides within the grain, and this gene is operably ligated to a promoter or polyadenylation / termination region that is heterologous to the polynucleotide, thereby forming a chimeric gene.

[0257] The term “endogenous” is used herein to refer to substances that are normally present or produced in unmodified cereal plants at the same developmental stage as the plant under study. “Endogenous gene” refers to a native gene in its natural location within the genome of an organism. As used herein, “recombinant nucleic acid molecule,” “recombinant polynucleotide,” or variations thereof refers to a nucleic acid molecule constructed or modified by recombinant DNA technology, which is a nucleic acid molecule that is a modified endogenous gene, and the modified endogenous gene is mutated by gene editing technology, for example by TALENS or CRISPR technology. The terms “heterogeneous polynucleotide,” “exogenous polynucleotide,” or “different polynucleotide” refer to any nucleic acid introduced into the genome of a cell by experimental manipulation, including gene editing technology.

[0258] Heterogeneous or exogenous genes may be genes inserted into non-natural organisms, native genes introduced into new locations within a natural host, chimeric genes, or endogenous genes modified by gene editing techniques. A “transgene” is a gene introduced into the genome by a transformation procedure. The term “genetically modified” more broadly includes not only the introduction of genes into cells by transformation or transduction, but also the mutation of genes within cells, for example, the introduction of insertions, deletions, or substitutions into endogenous genes by gene editing techniques, and the alteration or modification of gene regulation in cells or organisms or progenitor cells or organisms in which these actions are performed.

[0259] Furthermore, in the context of polynucleotides (nucleic acids), the term “exogenous” refers to polynucleotides present in cells that do not naturally contain polynucleotides. Cells may include cells containing non-endogenous polynucleotides resulting in altered amounts of the encoded polypeptide, such as exogenous polynucleotides that increase the expression of endogenous polypeptides, or cells that do not naturally produce polypeptides. The increased polypeptide production of the present invention is also referred to herein as “overexpression.” The exogenous polynucleotides of the present invention include polynucleotides that have not been isolated from other components of transgenic (recombinant) cells or cell-free expression systems in which the polynucleotide is present, and polynucleotides produced within such cells or cell-free systems and subsequently purified and isolated from at least some other components. The exogenous polynucleotides (nucleic acids) may be naturally occurring consecutive elongated nucleotides, or they may include two or more consecutive elongated nucleotides from different (spontaneously occurring and / or synthetic) sources that combine to form a single polynucleotide. Typically, such a chimeric polynucleotide comprises at least an open reading frame, the open reading frame encoding the polypeptide of the present invention, and the polypeptide of the present invention is operably ligated to a promoter suitable for driving the transcription of the open reading frame within the target cell.

[0260] The % identity of polynucleotides is determined by GAP (Needleman and Wunsch, 1970) analysis (GCG program) with a gap generation penalty of 5 and a gap elongation penalty of 0.3. In one embodiment, the query sequence is at least 450 nucleotides long, and the GAP analysis aligns the two sequences across a region of at least 450 nucleotides. In one embodiment, the query sequence is at least 525 nucleotides long, and the GAP analysis aligns the two sequences across a region of at least 525 nucleotides. In one embodiment, the query sequence is at least 600 nucleotides long, and the GAP analysis aligns the two sequences across a region of at least 600 nucleotides. In one embodiment, the query sequence is at least 900 nucleotides long, and the GAP analysis aligns the two sequences across a region of at least 900 nucleotides. In one embodiment, the query sequence is at least 1,200 nucleotides long, and GAP analysis aligns two sequences across a region of at least 1,200 nucleotides. In another embodiment, the query sequence is at least 1,500 nucleotides long, and GAP analysis aligns two sequences across a region of at least 1,500 nucleotides. In yet another embodiment, the query sequence is at least 1,800 nucleotides long, and GAP analysis aligns two sequences across a region of at least 1,800 nucleotides. In yet another embodiment, the query sequence is at least 2,100 nucleotides long, and GAP analysis aligns two sequences across a region of at least 2,100 nucleotides. More preferably, GAP analysis aligns two sequences across their entire lengths.

[0261] With respect to the defined polynucleotides, it will be understood that preferred embodiments include % identity values ​​higher than those provided above. Therefore, where applicable, it is preferable that the polynucleotides contain a polynucleotide sequence that is at least 75%, more preferably at least 80%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, more preferably at least 93%, more preferably at least 94%, more preferably at least 95%, more preferably at least 96%, more preferably at least 97%, more preferably at least 98%, more preferably at least 99%, more preferably at least 99.1%, more preferably at least 99.2%, more preferably at least 99.3%, more preferably at least 99.4%, more preferably at least 99.5%, more preferably at least 99.6%, more preferably at least 99.7%, more preferably at least 99.8%, and even more preferably at least 99.9% identical to the designated sequence in question. The % identity is preferably calculated along the full length of the reference sequence. In one embodiment, the polynucleotide of the present invention extends beyond the reference polynucleotide at the 5' end, the 3' end, or both ends.

[0262] The present invention also relates to the use of oligonucleotides, for example, in a method for screening polynucleotides of the present invention, or in a method for encoding polypeptides of the present invention. As used herein, “oligonucleotide” is a polynucleotide up to 50 nucleotides in length. The minimum size of such oligonucleotides is the size required for the formation of a stable hybrid between the oligonucleotide and a complementary sequence on a nucleic acid molecule of the present invention. These can be RNA, DNA, or a combination or derivative of either. Oligonucleotides are typically relatively short single-stranded molecules with a length of 10 to 30 nucleotides, generally 15 to 25 nucleotides. When used as a probe or primer in an amplification reaction, the minimum size of such oligonucleotides is the size required for the formation of a stable hybrid between the oligonucleotide and a complementary sequence on a target nucleic acid molecule. Preferably, oligonucleotides are at least 15 nucleotides, more preferably at least 18 nucleotides, more preferably at least 19 nucleotides, more preferably at least 20 nucleotides, and even more preferably at least 25 nucleotides in length. Oligonucleotides of the present invention used as probes are typically conjugated with labels such as radioisotopes, enzymes, biotin, fluorescent molecules, or chemiluminescent molecules.

[0263] The present invention includes oligonucleotides that can be used, for example, as probes for identifying nucleic acid molecules or primers for producing nucleic acid molecules, or as guide sequences for gene editing. Probes and / or primers can be used to clone homologs of the polynucleotides of the present invention from other species. Furthermore, hybridization techniques known in the art can also be used to screen genomic or cDNA libraries for such homologs.

[0264] The polynucleotides and oligonucleotides of the present invention include those that hybridize under stringent conditions to one or more of the sequences provided as SEQ ID NO: 1, 2, 4-7, 11-14, 49-60, 62, 63, 65, 66, 68, 70, 72, 74, 76, 78, 81, 83, 85, 87, 89, 91, 93, 95, or 97. As used herein, stringent conditions are: (1) conditions using low ionic strength and high temperature for washing, for example, conditions using 0.015 M NaCl / 0.0015 M sodium citrate / 0.1% NaDodSO4 at 50°C; (2) during hybridization, conditions using a denaturing agent such as formamide, for example, 50% (vol / vol) formamide with 0.1% bovine serum albumin, 0.1% ficoll, 0.1% polyvinylpyrrolidone, 50 mM sodium phosphate buffer at pH 6.5 with 750 mM NaCl, 75 mM sodium citrate at 42°C; or (3) conditions using 50% formamide, 5×SSC (0.75 M NaCl, 0.075 M sodium citrate), 50 mM sodium phosphate (pH 6.8), 0.1% sodium pyrophosphate, 5×Denhardt's solution, sonicated salmon sperm DNA (50 μg / ml), 0.1% SDS, and 10% dextran sulfate at 42°C in 0.2×SSC and 0.1% SDS.

[0265] The polynucleotides of the present invention may have one or more mutations compared to naturally occurring molecules, where one or more mutations are deletions, insertions, or substitutions of nucleotide residues. The variants may be naturally occurring (i.e., isolated from natural sources) or synthesized (e.g., by performing site-directed mutagenesis on nucleic acids). Variants of the polynucleotides or oligonucleotides of the present invention include reference polynucleotides or oligonucleotide molecules as defined herein, preferably molecules of various sizes from a cereal genome close to the endogenous gene of the cereal genome, and / or molecules capable of hybridizing into this cereal genome. For example, a variant may contain additional nucleotides (e.g., one, two, three, four or more) or fewer nucleotides, as long as the nucleotides still hybridize into the target region. Furthermore, some nucleotides may be substituted without affecting the oligonucleotide's ability to hybridize into the target region. In addition, variants can be easily designed to hybridize near, for example, within 50 nucleotides, to the region of the plant genome into which a particular oligonucleotide as defined herein hybridizes. In particular, this includes polynucleotides that encode the same polypeptide or amino acid sequence, but whose nucleotide sequence varies due to genetic coding redundancy. The terms “polynucleotide variant” and “variant” include spontaneously occurring allele variants.

[0266] Genetic variation As used herein, the term “genetic variation” means that one or more cells of a grain, preferably cells in at least one or all of the developing endosperm, seed coat, aleurone, and embryo of a developing grain, more preferably cells in one or all of the seed coat, aleurone, and embryo of the developing grain or plant or part thereof of the present invention, have a genetic modification, which may be introduced by humans or occur spontaneously within the cereal plant (e.g., by crossbreeding to produce the plant of the present invention). A grain may contain two, three, four or more genetic variations within the same or different genes. For example, the mtSSB gene may contain two genetic variations, and the two genetic variations reduce the mtSSB polypeptide levels and / or activity within the grain. In another example, a grain contains a genetic variation in the mtSSB gene that reduces the mtSSB polypeptide level and / or activity within the grain, and / or a genetic variation in the TWINKLE gene that reduces the TWINKLE polypeptide level and / or activity within the grain, and / or a genetic variation in the RECA3 gene that reduces the RECA3 polypeptide level and / or activity within the grain. In a preferred embodiment, all cells within the grain or plant or a portion thereof contain the introduced genetic variation. In one embodiment, the cells, grain, or plant of the present invention are homozygous for one or more genetic variations. In an alternative embodiment, the cells, grain, or plant of the present invention are heterozygous for one or more genetic variations, or heterozygous for one genetic variation and homozygous for another genetic variation. As those skilled in the art will understand, many different types of genetic modification can be performed, for example, mutations in endogenous genes encoding polypeptides, which may be located within the protein-coding region of the gene or within expression elements such as promoters, such as mutations introduced by gene editing that reduce the activity of an endogenous gene, or mutations introduced by introducing mutations using tilling and selecting for plants that produce grains with reduced polypeptide activity.Alternatively, genetic modification comprises an introduced nuclear construct encoding an exogenous polynucleotide, wherein the exogenous polynucleotide reduces the expression of a gene, for example, the expression of a dsRNA molecule or a microRNA, or a nuclear construct encoding an exogenous polynucleotide, wherein the exogenous polynucleotide encodes a polypeptide having an amino acid sequence different from the amino acid sequence of the corresponding wild-type polypeptide, and the polypeptide has a reduced polypeptide activity as compared to the corresponding wild-type polypeptide.

[0267] Mutation induction The plants of the present invention can be produced and identified after mutation induction. This can provide non-transgenic plants that are desirable in some markets.

[0268] Mutants can be spontaneously generated (i.e., isolated from natural sources) or synthesized or induced (e.g., by performing mutagenesis on nucleic acids). Generally, precursor cereal plant cells, tissues, seeds, or plants can be subjected to mutagenesis to produce one or more mutations, e.g., nucleotide substitutions, deletions, additions, and / or codon alterations. In the context of this application, “induced mutation” is an artificially induced genetic variation that may result from chemical, radioactive, or biologically based mutagenesis, e.g., transposon or T-DNA insertions. In some embodiments, mutations are null mutations, e.g., nonsense mutations, frameshift mutations, insertion mutations, or splice site variants that completely inactivate a gene. Nucleotide insertion derivatives include 5' and 3' end fusions of one or more nucleotides and intrasequence insertions. Insertion nucleotide sequence variants are those in which one or more nucleotides are introduced into a nucleotide sequence, which may be obtained by random insertions and suitable screening of the resulting products. Deletion variants are characterized by the removal of one or more nucleotides from a sequence. Preferably, the mutant gene has only a single insertion or deletion of a nucleotide sequence compared to the wild-type gene. Substitution nucleotide variants have at least one nucleotide removed from a sequence and a different nucleotide inserted in its place. The preferred number of nucleotides affected by a substitution in the mutant gene compared to the wild-type gene is up to 10 nucleotides, more preferably up to 9, 8, 7, 6, 5, 4, 3, or 2 nucleotides, or just 1 nucleotide. Such substitutions can be "silent" in that the substitution does not change the amino acid defined by the codon. Alternatively, conservative substitutions are designed to change one amino acid to another similarly functioning amino acid. Typical conservative substitutions are made according to Table 1.

[0269] As used herein, the term “mutation” includes only changes in gene sequences that affect gene activity, and does not include silent nucleotide substitutions that do not affect gene activity. The term “polymorphism” refers to any change in a nucleotide sequence that includes such silent nucleotide substitutions.

[0270] In some embodiments, the grain contains at least a portion of the mtSSB gene, the TWINKLE gene, or the RECA3 gene, or a non-conservative substitution or deletion of a frameshift or splice site variation within such gene.

[0271] In some embodiments, one or more variants are located within a conserved region of the gene encoding the mtSSB polypeptide that encodes a conserved motif, such as a conserved motif containing the amino acid sequences described in SEQ ID NOs.45-48. In some embodiments, one or more variants are located within a region of OsmtSSB-1a that encodes the DNA-binding domain of OsmtSSB-1a.

[0272] Mutagenesis can be achieved by chemical or radioactive means, e.g., EMS or sodium azide (Zwar and Chandler, 1995). Chemical mutagenesis tends to favor nucleotide substitutions over deletions. Heavy ion beam (HIB) irradiation is known as an effective technique for mutation breeding to produce new plant varieties; see, for example, Hayashi et al. (2004) and Kazama et al. (2008). Ion beam irradiation has two physical conditions for its biological effect in determining the amount of DNA damage and the size of DNA deletions: dose (gy) and LET (linear energy transfer, keV / um), which can be adjusted according to the desired degree of mutagenesis. HIB produces mutant collectibles, many of which contain deletions, and these can be screened for mutations within the mtSSB gene. Useful mutants identified can be backcrossed with non-mutant plants as recurrent parents to eliminate, and thus reduce, the effect of unconnected mutations in the mutagenesis genome.

[0273] Biopharmaceuticals useful in the production of site-directed mutants include enzymes that stimulate endogenous repair mechanisms by creating double-strand breaks in DNA. These include endonucleases, zinc finger nucleases, transposases, and site-directed recombinases. Zinc finger nuclease technology is outlined in Le Provost et al. (2009), Durai et al. (2005), and Liu et al. (2010).

[0274] The isolation of mutants can be achieved by screening mutagenic plants or seeds. For example, a mutagenic population of cereal plants may be screened by RT-PCR for thick aleurone or for reduced expression of one of the genes, or for a mutation in one of the genes, directly or by PCR or heteroduplex-based assays, or for reduction of proteins, by ELISA or Western blot analysis. Alternatively, mutants can be identified using techniques such as TILLING in a population mutagenic with a drug such as EMS (Slade and Knauf, 2005), or by deep sequencing of the mutagenic pool. Such mutants can then be introduced into the desired genetic background by crossing the mutants with plants of the desired genetic background and performing a suitable number of backcrosses to remove the undesirable parental background.

[0275] The mutation may be introduced directly into the plant by mutagenesis, or indirectly by a hybrid of two parent plants, one of which contains the introduced mutation. The modified plant may be transgenic or non-transgenic. Using mutagenesis, non-transgenic plants having reduced mtSSB-1a levels or activity, or essentially lacking mtSSB-1a, can be produced. The invention also extends to grains or other plant parts produced from plants, and any reproductive material of plants, such as cultured tissues or cells, which can be used to produce plants having desired characteristics. The invention obviously extends to methods for producing or identifying such plants or grains produced by such plants.

[0276] TILLING The plants of the present invention may be produced using a known process known as TILLING (Targeting Induced Local Lesions in Genomes), as described, for example, in Example 13 of this specification. In the first step, the introduced mutation, such as a novel single base pair change, is induced in a plant population by treating seeds (or pollen) with a chemical mutagen and then advancing the plants to a generation in which the mutation is stably inherited. This is typically the M2 generation. DNA is extracted from individual plants or a small pool of plants, and seeds are stored from all members of the population to create a resource that can be repeatedly accessed over time.

[0277] For tilling assays, PCR primers are designed to specifically amplify a single gene target of interest, such as the gene encoding mtSSB-1a, TWINKLE, or RECA3. Specificity is particularly important if the target is a member of a gene family or a portion of a polyploid genome, such as a portion of a polyploid genome in hexaploid or tetraploid wheat. Dye-labeled primers can then be used to amplify PCR products from pooled DNA from multiple individuals. These PCR products are denatured and re-annealed to allow for the formation of mismatched base pairs. Mismatches or heteroduplexes represent both spontaneous single nucleotide polymorphisms (SNPs) (i.e., several plants in a population may possess the same polymorphism) and induced SNPs (i.e., only rare individual plants may exhibit the mutation). After heteroduplex formation, the use of endonucleases such as CelI to recognize and cleave mismatched DNA is key to discovering novel SNPs within the tilling population.

[0278] Using this technique, thousands of plants can be screened to identify any individual with single base changes and small insertions or deletions (1–30 bp) within any gene or any specific region of the genome. The size of the genomic fragments assayed can range from 0.3 to 1.6 kb. With 8x pooling, 1.4 kb fragments (subtracting the ends of fragments where SNP detection would be problematic due to noise), and 96 lanes per assay, this combination allows up to 1 million base pairs of genomic DNA to be screened per assay, making TILLING a high-throughput technique.

[0279] Tilling is further described in Slade and Knauf (2005) and Henikoff et al. (2004).

[0280] In addition to enabling efficient mutation detection, high-throughput tilling technology is ideal for detecting innate polymorphisms. Therefore, by examining unknown homologous DNA through heteroduplication to known sequences, the number and location of polymorphic sites can be determined. Both nucleotide changes and small insertions and deletions are identified, which include polymorphisms of at least a certain number of repeats. This is referred to as ecotiling (Comai et al., 2004).

[0281] Each SNP is recorded by its approximate position within several nucleotides. Therefore, each haplotype can be archived based on the haplotype's mobility. Sequence data can be obtained with relatively little incremental effort using aliquots of the same amplified DNA used for mismatch cleavage assays. Left or right sequencing primers for a single reaction are selected based on the proximity of the sequencing primer to the polymorphism. Sequencing software performed multiple alignments and detected base changes, which in each case were confirmed by gel banding.

[0282] Ecotilling can be performed at a lower cost than full sequencing, which is the method currently used for most SNP discovery. Instead of a pool of DNA from mutagenic plants, plates containing arrays of ecotype DNA can be screened. Detection is performed on a gel with near base pair resolution, and since the background pattern is uniform across lanes, bands of the same size can be matched, and therefore SNPs can be discovered and genotyped in a single step. Thus, the ultimate sequencing of SNPs is simple and efficient, and is made even simpler and more efficient by the fact that aliquots of the same PCR products used for screening can be subjected to DNA sequencing.

[0283] Genome editing using site-specific nucleases Genome editing can be used to modify genes encoding polypeptides as defined herein. Genome editing uses engineered nucleases that are composed of a sequence-specific DNA binding domain fused to a non-specific DNA cleavage module. These chimeric nucleases enable efficient and precise gene modification by inducing targeted DNA double-strand breaks that stimulate the cell's endogenous cellular DNA repair machinery to repair the induced breaks. Such mechanisms include, for example, error-prone non-homologous end joining (NHEJ) and homology-directed repair (HDR).

[0284] In the presence of a donor plasmid with extended homology arms, HDR can result in the introduction of one or more transgenes to correct or replace an existing gene. In the absence of a donor plasmid, NHEJ-mediated repair results in small insertion or deletion mutations at the target that cause gene disruption.

[0285] Engineered nucleases useful in the methods of the invention include zinc finger nucleases (ZFNs), transcription activator-like (TAL) effector nucleases (TALENs), and CRISPR-Cas9 or Cas12 type site-specific nucleases.

[0286] Typically, the nuclease-encoding gene is delivered into cells by plasmid DNA, viral vector, or in vitro transcribed mRNA. The use of a fluorescent surrogate reporter vector also enables enrichment of ZFN-, TALEN-, or CRISPR-modified cells.

[0287] Complex genomes often contain multiple copies of sequences that are identical or highly homologous to the intended DNA target, which can potentially lead to off-target activity and cytotoxicity. To address this, structural (Miller et al., 2007, Szczepek et al., 2007) and selection-based (Doyon et al., 2011, Guo et al., 2010) methods can be used to produce improved ZFN and TALEN heterodimers with optimized cleavage specificity and reduced toxicity.

[0288] In order to target genetic recombination or mutation by a ZFN according to a preferred embodiment of the present invention, two 9 bp zinc finger DNA recognition sequences must be identified in the host DNA. These recognition sites are oriented in opposite directions to each other and separated by approximately 6 bp of DNA. The ZFN is then produced by designing and producing a zinc finger combination that specifically binds to DNA at the target locus, and then ligating the zinc fingers to a DNA cleavage domain.

[0289] Transcription activator-like (TAL) effector nucleases (TALENs) contain a TAL effector DNA-binding domain and an endonuclease domain.

[0290] TAL effectors are proteins of plant pathogenic bacteria that are injected into plant cells by pathogens, translocate to the nucleus, and function as transcription factors to activate specific plant genes. The primary amino acid sequence of a TAL effector indicates the nucleotide sequence to which it binds. Therefore, target sites can be predicted for TAL effectors, and TAL effectors can be manipulated and produced for the purpose of binding to specific nucleotide sequences.

[0291] The sequences fused to the TAL effector coding nucleic acid sequences are nucleases or portions of nucleases, typically sequences encoding nonspecific cleavage domains from type II restriction endonucleases such as FokI (Kim et al., 1996). Other useful endonucleases may include, for example, HhaI, HindIII, Nod, BbvCI, EcoRI, BglI, and AlwI. The fact that some endonucleases (e.g., FokI) function only as dimers can be utilized to enhance the target specificity of TAL effectors. For example, in some cases, each FokI monomer can fuse to a TAL effector sequence that recognizes a different DNA target sequence, and the inactive monomers are combined only when the two recognition sites are in close proximity to create a functional enzyme. Highly site-specific restriction enzymes can be created by requiring DNA binding to activate the nuclease.

[0292] Sequence-specific TALENs can recognize specific sequences within pre-selected target nucleotide sequences present in cells. Therefore, in some embodiments, target nucleotide sequences may be scanned for nuclease recognition sites, and specific nucleases may be selected based on the target sequence. In other cases, TALENs may be engineered to target specific cellular sequences.

[0293] Genome editing (gene editing) using CRISPR Endonucleases can be used to produce single-strand or double-strand breaks in genomic DNA in a sequence-specific manner, i.e., by targeting defined nucleotide sequences. Genomic DNA breaks in eukaryotic cells are repaired using non-homologous end joining (NHEJ) or homology-directed repair (HDR) pathways. NHEJ can result in incomplete repairs that lead to mutation production, often resulting in short deletions, e.g., 1 to 30 base pairs. In contrast, HDR can enable precise gene insertions by using exogenous supplied repair DNA templates. While transcription activator-like effector nucleases (TALENs) and zinc finger nucleases remain useful, CRISPR-related (Cas) proteins have garnered significant interest, and the CRISPR-Cas system offers a simpler, more versatile, and less expensive tool for genome modification (Doudna and Charpentier, 2014).

[0294] The CRISPR-Cas system is classified into two main groups, using various nucleases or combinations of nucleases. Within Class 1 CRISPR-Cas systems (Types I, III, and IV), the effector module consists of a multiprotein complex, while Class 2 systems (Types II, V, and VI) use only one effector protein (Makarova et al., 2015). Cas includes genes that bind to, are near, or are located in the vicinity of adjacent CRISPR loci. Haft et al. (2005) provide an overview of the Cas protein family.

[0295] Nucleases are guided by synthetic small guide RNAs (sgRNAs or gRNAs), which may or may not contain tracRNAs, and tracRNAs result in the simplification of the CRISPR-Cas system to two genes, namely the endonuclease and the sgRNA (Jinek et al. 2012). sgRNAs are typically regulated by Pol III promoters, such as the U3 or U6 micronuclear RNA promoter. sgRNAs generally contain a CRISPR RNA (crRNA) spacer and repeat sequence, as well as a Cas effector protein, together for the complex to recognize protospacer-adjacent motifs (PAMs) present within the target nucleotide sequence. sgRNAs recognize specific genes and gene segments for targeting by sequence homology. Protospacer-adjacent motifs (PAMs) adjacency to target sites, limiting the number of potential CRISPR-Cas targets in the genome, although nuclease expansion also increases the number of available PAMs. Cas nucleases are activated by base pairing between the crRNA space and a complementary target nucleotide sequence. Numerous web tools are available for designing gRNAs, including CHOPCHOP (http: / / chopchop.cbu.uib.no), CRISPR design (https: / / omictools.com / crispr-design-tool), E-CRISP (http: / / www.e-crisp.org / E-CRISP / ), and Geneious or Benchling (https: / / benchling.com / crispr).

[0296] In one example, a guide RNA (gRNA) target sequence of approximately 17, 18, 19, or 20 nucleotides, immediately followed by a PAM (protospacer adjacent motif) sequence of three nucleotides, is identified from the cDNA sequence of a gene encoding one or more polypeptides as defined herein, preferably mtSSB-1 or mtSSB-1a polypeptide, TWINKLE polypeptide, or RECA3 polypeptide.

[0297] The CRISPR-Cas system is the most frequently employed method for modifying plant genes for gene editing, often using Cas9 effector proteins such as RNA-guided Streptococcus pyogenes Cas9 or optimized sequence variants within multiple plant species (Luo et al., 2016). Luo et al. (2016) outline numerous studies in which genes were successfully targeted within various plant species to produce indels and loss-of-function mutant phenotypes within endogenous gene open reading frames and / or promoters. Modified Cas9s, such as xCas9, are available for use when variant PAM sequences are required (Hu et al., 2018). Due to the cell wall on plant cells, delivery of the CRISPR-Cas mechanism into cells and successful transgenic regeneration have typically been achieved using Agrobacterium tumefaciens infection (Luo et al., 2016) or plasmid DNA particle collision or microparticle gun delivery. Suitable vectors for cereal transformation include pCXUNcas9 (Sun et al, 2016) or pYLCRISPR / Cas9Pubi-H (Ma et al., 2015, acceptance number KR029109.1) available from Addgene.

[0298] There are numerous alternative CRISPR-Cas systems, including effector enzymes, which contain the nuclease RuvC domain but lack the HNH domain found in Cas12 enzymes. Cas12 enzymes include Cas12a, Cas12b, Cas12f, Cpf1, C2c1, C2c3, and engineered derivatives. In plants, Cpf1 from Prevotella and Francisella has been successfully used as a substitute for Cas9. Cpf1 produces double-strand breaks in a twisted manner at the distal PAM site and is a smaller endonuclease, which may offer advantages for certain species (Begemann et al., 2017). Other CRISPR-Cas systems include RNA-guided ribonucleases, including Cas13, Cas13a (C2c2), Cas13b, and Cas13c. Alternative CRISPR-Cas systems include complex nuclease and effector systems designed and applied in the context of producing mutations within endogenous plant genes, such as the CRISPR TiD system (Osakabe et al., 2020), or complex nuclease and repair enzyme systems, such as the prime editing system described by Anzalone et al. (2019), which can precisely control cell repair and sequence insertion that occur after DNA cleavage.

[0299] Array insertion or embedding The CRISPR-Cas system can be combined with the provision of nucleic acid sequences to direct homologous repair for sequence insertions into the genome. Targeted genome integration of plant transgenes allows for the sequential addition of transgenes at the same locus. This "cis-gene stacking" greatly simplifies subsequent breeding effort for all transgenes inherited as a single locus. When bound to a CRISPR / Cas9 cleavage at the target site, the transgene can be integrated into this locus by homology-directed repair facilitated by adjacent sequence homology. This technique can be used to rapidly introduce new alleles without linkage drugs or to introduce allele variants that do not exist naturally.

[0300] Nikkaze The CRISPR-Cas II system uses a Cas9 nuclease with two enzyme cleavage domains, namely the RuvC domain and the HNH domain. Mutations have been shown to change double-strand breaks to single-strand breaks, resulting in a technical variant called nickase or nuclease-inactivated Cas9. The RuvC subdomain cleaves non-complementary DNA strands, while the HNH subdomain cleaves this DNA strand complementary to the gRNA. Nickase or nuclease-inactivated Cas9 retains the DNA-binding ability directed by the gRNA. Mutations within the subdomains, e.g., S.pyogenes Cas9 nucleases with D10A or H840A mutations, are known in the art.

[0301] Genome base editing or modification Base editors have been constructed by fusing cytosine deaminase with a Cas9 domain (WO2018 / 086623). By fusing the deaminase, the base editor uses a sequence target directed by gRNA to perform a substitution of target cytidine (C) to uracil (U) by deamination of cytidine in DNA. The cell's mismatch repair mechanism then replaces U with T. Suitable cytidine deaminases include APOBEC1 deaminase, activation-inducible cytidine deaminase (AID), APOBEC3G, and CDA1. Furthermore, Cas9-deaminase fusions may include mutant Cas9 with nickase activity for producing single-strand breaks. Nickase proteins have been suggested to be potentially more efficient in promoting homology-directed repair (Luo et al., 2016).

[0302] Vector-free genome editing or genome modification More recently, methods using vector-free techniques employing Cas9 / sgRNA ribonucleoproteins have been described as successfully reducing off-target events. These methods require in vitro expression of Cas9 ribonucleoprotein (RNP) transformed into cells such as protoplasts. This is independent of the Cas9 coding sequence integrated within the host genome, thereby reducing undesirable nonspecific cleavage that can occur with random integration of the Cas9 gene into specific sites. Only short flanking sequences are required to form stable Cas9 and sgRNA stable ribonucleoproteins in vitro. Woo et al. (2015) produced and introduced pre-assembled Cas9 / sgRNA protein / RNA complexes into Arabidopsis protoplasts, rice, lettuce, and tobacco, observing up to 45% targeted mutagenesis in regenerated plants. In vitro introduction of RNPs has been demonstrated in several species, including dicotyledonous plants (Woo et al., 2015) and monocotyledonous plants such as maize (Svitashev et al., 2016) and wheat (Liang et al., 2017). Genome editing of plants using CRISPR-Cas9 in vitro transcripts or ribonucleoproteins is described in Liang et al. (2018) and Liang et al. (2019).

[0303] Methods for gene insertion Plant embryos can be impaled with a DNA repair template, along with Cas9 and sgRNA genes targeting the insertion site. The DNA repair template may be a synthesized DNA fragment, a polynucleotide of 127 or more units, each encoding the gene to be inserted. For example, the impaled cells are grown on tissue culture medium. The DNA is extracted from the callus or leaf tissue of the regenerated plant using the CTAB DNA extraction method and analyzed by PCR to confirm gene insertion. T1 offspring plants can be selected from plants confirmed to contain the target insertion gene.

[0304] The method involves introducing donor DNA and a target DNA sequence, referred to as an endonuclease, into plant cells. The endonuclease produces cleavage within the target site, which allows the first and second homologous regions of the donor DNA to undergo homologous recombination with their corresponding genomic regions. The cleaved genomic DNA acts as acceptors for the DNA sequence. The resulting DNA exchange between the donor and the genome results in the incorporation of the target polynucleotide of the donor DNA into the strand breaks within the target site in the plant genome, thereby altering the original target site and producing a modified genomic sequence.

[0305] The donor DNA can be introduced by any means known in the art. For example, a plant having a target site is provided. The donor DNA can be provided to the plant by known transformation methods, including Agrobacterium-mediated transformation or particulate gun impact. An RNA-guided Cas or Cpf1 endonuclease is cleaved at the target site, and the donor DNA is inserted into the plant genome.

[0306] Homologous recombination occurs infrequently within plant somatic cells, but the process is thought to be increased / stimulated by the introduction of double-strand breaks (DSBs) at selected endonuclease target sites.

[0307] RNA interference RNA interference (RNAi) is particularly useful for specifically reducing gene expression, which, if the gene codes for a protein, results in reduced production of that particular protein. While not wanting to be constrained by theory, Waterhouse et al. (1998) provide a model for a mechanism by which dsRNA (double-stranded RNA) may be used to reduce protein production. This technique relies on the presence of a dsRNA molecule containing a sequence essentially identical to the mRNA or a portion thereof of the gene of interest. Conveniently, the dsRNA can be produced from a recombinant vector or a single promoter within a host cell, with sense and antisense sequences flanking unrelated sequences, allowing the sense and antisense sequences to hybridize to form the dsRNA molecule, which has unrelated sequences forming a loop structure. Suitable designs and production of dsRNA molecules are well within the capabilities of those skilled in the art, particularly considering Waterhouse et al. (1998), Smith et al. (2000), WO99 / 32619, WO99 / 53050, WO99 / 49029, WO01 / 34815, WO19 / 051563, and WO20 / 024019.

[0308] In one example, DNA is introduced that directs the synthesis of at least partially double-stranded RNA products having homology to a gene encoding one or more polypeptides as defined herein, preferably mtSSB-1 or mtSSB-1a polypeptide, TWINKLE polypeptide, or RECA3 polypeptide. Thus, the DNA includes both sense and antisense sequences, both of which can hybridize to form a double-stranded RNA region when transcribed into the RNA. In one embodiment of the present invention, the sense and antisense sequences are separated by a spacer region, the spacer region containing introns, which are spliced ​​and removed when transcribed into the RNA. This arrangement has been shown to result in higher efficiency of gene silencing (Smith et al., 2000). The double-stranded region may contain one or two RNA molecules transcribed from either one or two DNA regions. The presence of double-stranded molecules is thought to trigger a response from an endogenous system, which efficiently reduces or eliminates the activity of the target gene by disrupting both double-stranded RNA and homologous RNA transcripts from the target gene.

[0309] The length of the sense and antisense sequences to be hybridized should each be at least 19 consecutive nucleotides, preferably at least 30, at least 32, at least 40, or at least 50 consecutive nucleotides, more preferably at least 100 or at least 200 consecutive nucleotides. Generally, sequences of 100 to 1000 nucleotides corresponding to a region of the target gene mRNA are used. Full-length sequences corresponding to the entire gene transcript may be used. The degree of identity of the sense sequence with the target transcript (and therefore, similarly, the identity of the antisense sequence with the complement of the target transcript) should be at least 85%, at least 90%, or 95-100%, and preferably identical to the target sequence. Of course, the RNA molecule may also contain unrelated sequences that can function to stabilize the molecule. The RNA molecule may be expressed under the control of an RNA polymerase II or RNA polymerase III promoter. Examples of the latter include tRNA or snRNA promoters.

[0310] A preferred small interfering RNA ("siRNA") molecule contains a nucleotide sequence identical to approximately 19 to 25 consecutive nucleotides of the target mRNA. Preferably, the siRNA sequence begins with dinucleotide AA and contains approximately 30 to 70% (preferably 30 to 60%, more preferably 40 to 60%, more preferably about 45 to 55%) GC content, and does not have high percentage identity with any other nucleotide sequence in the genome of the organism into which it is introduced, as determined, for example by a standard BLAST search.

[0311] In one embodiment, the dsRNA comprises a “ledRNA” structure as described in WO2019 / 051563 and / or comprises a G:U base pair as described in WO2020 / 024019.

[0312] dsRNAs useful for the present invention can be easily produced using conventional procedures.

[0313] microRNA MicroRNAs (abbreviated as miRNA) are non-coding RNA molecules, which generally have a length of 19 to 25 nucleotides (typically around 20 to 24 nucleotides in plants), and these originate from larger precursors that form incomplete stem loop structures. miRNAs are typically perfectly complementary to the region of the target mRNA whose expression is reduced, but they do not need to be perfectly complementary.

[0314] miRNAs bind to complementary sequences within target messenger RNA transcripts (mRNAs), which typically result in translational repression or targeted degradation and gene silencing. Artificial miRNAs (amiRNAs) can be designed based on natural miRNAs to reduce the expression of any of the target genes, as is well known in the art.

[0315] In plant cells, miRNA precursor molecules are thought to be processed primarily in the nucleus. Pri-miRNA (containing one or more local double-stranded or "hairpin" regions, the usual 5' "cap" and polyadenylated tail of mRNA) is processed into shorter miRNA precursor molecules, which also contain stem-loop or foldback structures and are referred to as "pre-miRNA". In plants, pre-miRNA is cleaved by different DICER-like (DCL) enzymes to obtain miRNA:miRNA* double-stranded molecules. Before transport from the nucleus, these double-stranded molecules are methylated.

[0316] In the cytoplasm, the miRNA strand from the miRNA:miRNA double strand is selectively incorporated into the active RNA-inducible silencing complex (RISC) for target recognition. The RISC complex contains a specific subset of Argonaute proteins that exert sequence-specific gene repression (see, e.g., Millar and Waterhouse, 2005; Pasquinelli et al., 2005; Almeida and Allshire, 2005).

[0317] MicroRNAs useful for the present invention can be readily produced using conventional procedures. For example, the design of the OsmtSSB-1a amiRNA (artificial microRNA) construct can be based on the general method described in Fahim et al. (2012). WMD3 software (www.wmd3.weigelworld.org / ) can be used to identify suitable amiRNA targets within the OsmtSSB-1a gene. The amiRNA target is determined by the following four criteria: 1) relative 5' instability by using a sequence that is AT-rich at the 5' end and GC-rich at the 3' end; 2) U at position 1 and A at the cleavage site (between positions 10 and 11); 3) up to one and four mismatches at positions 1-9 and 13-21, respectively; and 4) -30 kcal mol when the amiRNA hybridizes to the target RNA. -1 Selection is based on having a predicted free energy (ΔG) of less than 1000 (Ossowski et al., 2008). For gene-specific reduction of expression, candidate amiRNA sequences are selected within the region showing the lowest homology during alignment of all OsOsmtSSB-1a homologs, thus reducing the potential for off-target reduction of OsmtSSB-1a homolog and homeolog expression. The precursor of miR395 (Guddeti et al., 2005, Jones-Rhoades and Bartel, 2004, Kawashima et al., 2009) may be selected as the amiRNA backbone for amiRNA sequence insertion. For example, to design and construct constructs, the five endogenous miRNA targets within miR395 are replaced by five amiRNA targets for mtSSB, TWINKLE, or RECA3 knockdown.

[0318] co-inhibition A gene can suppress the expression of related endogenous genes and / or transgenes already present in the genome; this phenomenon is called homology-dependent gene silencing. Most cases of homology-dependent gene silencing fall into two classes: those that function at the transcriptional level of transgenes and those that function post-transcriptionally.

[0319] Post-transcriptional homology-dependent gene silencing (i.e., co-repression) describes the loss of expression of transgenes and associated endogenous or viral genes in transgenic plants. Co-repression often occurs, but not always, when transgene transcripts are abundant and generally thought to be triggered at the levels of mRNA processing, localization, and / or degradation. The Severa1 model exists to explain how co-repression works (see Taylor, 1997).

[0320] Co-repression involves introducing an extra copy of a gene or fragment thereof into a plant in a sense-oriented manner relative to the promoter for the expression of the copy. The size of the sense fragment, the degree of agreement of the sense fragment with the target gene region, and the degree of sequence identity of the sense fragment with the target gene can be determined by those skilled in the art. In some cases, the additional copy of the gene sequence interferes with the expression of the target plant gene. For methods of implementing co-repression techniques, see WO97 / 20936 and EP0465572.

[0321] Antisense polynucleotides The term “antisense polynucleotide” is interpreted to mean a DNA or RNA molecule that is complementary to at least a portion of a specific mRNA molecule encoding an endogenous polypeptide and is capable of interfering with post-transcriptional events such as mRNA translation. The use of antisense methods is well known in the art (see, for example, G. Hartmann and S. Endres, Manual of Antisense Methodology, Kluwer (1999)). The use of antisense techniques in plants is outlined by Bourque (1995) and Senior (1998). Bourque (1995) lists numerous examples of how antisense sequences have been used in plant systems as a method of gene inactivation. Bourque also states that achieving 100% inhibition of any enzyme activity is not always necessary because partial inhibition is more likely to result in measurable changes in the system. Senior (1998) states that antisense methods are now a well-established technique for manipulating gene expression.

[0322] In one embodiment, the antisense polynucleotide hybridizes under physiological conditions, i.e., the antisense polynucleotide (which is entirely or partially single-stranded) can form at least a double-stranded polynucleotide in the cell under normal conditions, with mRNA encoding an endogenous mtSSB, TWINKLE, or RECA3 polypeptide.

[0323] The antisense molecule may contain a sequence corresponding to a structural gene, or a sequence that results in the control of gene expression or splicing events. For example, the antisense sequence may correspond to a target coding region, 5' untranslated region (UTR), or 3'-UTR of an endogenous gene, or a combination thereof. The antisense sequence may be partially complementary to an intron sequence that can be spliced ​​off during or after transcription, and preferably only to an exon sequence of the target gene. Given the generally larger branching of UTRs, targeting these regions provides greater specificity for gene inhibition.

[0324] The length of the antisense sequence should be at least 19 consecutive nucleotides, preferably at least 30 or at least 50 nucleotides, more preferably at least 100, 200, 500, or 1000 nucleotides. A full-length sequence complementary to the entire gene transcript may be used. Its length is most preferably 100 to 2000 nucleotides. The degree of identity of the antisense sequence with the target transcript should be at least 90%, more preferably 95 to 100%, and typically 100% identical. Of course, the antisense RNA molecule may also contain unrelated sequences that can function to stabilize the molecule.

[0325] nucleic acid construct The present invention includes nucleic acid constructs comprising the polynucleotide of the present invention or polynucleotides useful for the present invention, as well as vectors and host cells containing the same, methods for producing and using the same, and the use thereof.

[0326] This invention refers to operably connected or linked elements. “Operatably connected” or “operably linked” refers to the linking of polynucleotide elements in a functional relationship. Typically, operably connected nucleic acid sequences are contiguous and, if necessary, contiguous and within a read frame when two protein-coding regions need to be linked. When RNA polymerase transcribes two coding sequences into a single RNA, the coding sequences are “operably linked” to the other coding sequence, and the RNA, when translated, is then translated into a single polypeptide having amino acids derived from both coding sequences. The coding sequences do not need to be contiguous with each other, as long as the expressed sequence is ultimately processed to produce the desired protein.

[0327] As used herein, the terms “cis-acting sequence,” “cis-acting element,” “cis-regulatory region,” or “regulatory region,” or similar terms, are to be interpreted as meaning any sequence of nucleotides that, when appropriately positioned and ligated to an expressible gene sequence, is capable of at least partially regulating the expression of that gene sequence. Those skilled in the art will recognize that a cis-regulatory region may be capable of activating, silencing, enhancing, repressing, or otherwise altering the level of gene sequence expression and / or cell type specificity and / or developmental specificity at the transcriptional or post-transcriptional level. In preferred embodiments of the present invention, the cis-acting sequence is an activator sequence that enhances or stimulates the expression of an expressible gene sequence.

[0328] To “operably connect” a promoter or enhancer element to a transcribable polynucleotide means to place the transcribable polynucleotide (e.g., a protein-coding polynucleotide or other transcript) under the regulatory control of the promoter, and then the promoter controls the transcription of this polynucleotide. In constructing heterologous promoter / structural gene combinations, it is generally preferable to position the promoter or its variant at a certain distance from the transcription start site of the transcribable polynucleotide, such that this distance is approximately the same as the distance between the promoter and the protein-coding region controlled by the promoter in its natural context, i.e., the gene from which the promoter originates. As is known in the art, some variation in this distance may be tolerated without loss of function. Similarly, the preferred placement of a regulatory element (e.g., an operator, enhancer, etc.) to a transcribable polynucleotide under its control is defined by the placement of the element in its natural context, i.e., the placement of the gene from which the element originates.

[0329] As used herein, “promoter” or “promoter sequence” refers to a region of a gene, generally upstream (5') of the RNA coding region, that controls the initiation and level of transcription within the cell of interest. A “promoter” includes transcriptional regulatory sequences of classical genomic genes, such as TATA and CCAAT box sequences, as well as additional regulatory elements (i.e., upstream activators, enhancers, and silencers) that alter gene expression in response to developmental and / or environmental stimuli or in a tissue-specific or cell-type-specific manner. Promoters are typically located upstream of the structural genes whose expression they regulate, but not always (e.g., some Pol III promoters). Furthermore, regulatory elements, including promoters, are typically located within 2kb of the transcription initiation site of the gene. Promoters may contain additional specific regulatory elements located more distally to the initiation site, further enhancing intracellular expression and / or altering the timing or inducibility of expression of structural genes to which the additional specific regulatory elements are operably connected.

[0330] A “constitutive promoter” refers to a promoter that directs the expression of a functionally linked transcription sequence in many or all tissues of an organism, such as a plant. As used herein, the term constitutive indicates that a gene is expressed in a wide range of cell types, although some variation in levels is often detectable, and this does not necessarily mean that the gene is expressed at the same level in all cell types. As used herein, “selective expression” refers, for example, to expression in a plant in a nearly exclusive specific organ, such as the endosperm, embryo, leaf, fruit, tuber, or root. In a preferred embodiment, the promoter is selectively or preferentially expressed in the grain of a cereal plant, such as a rice plant. Selective expression may thus be in contrast to constitutive expression, which refers to expression in many or all tissues of a plant under most or all of the conditions the plant experiences.

[0331] Selective expression can also result in compartmentalization of gene expression products within specific plant tissues, organs, or developmental stages. Compartmentation at specific intracellular locations, such as plastids, cytosols, vacuoles, or apoplast spaces, may be achieved by incorporating signals appropriate for transport to the required cellular compartment, such as signal peptides, into the structure of the gene product, or, in the case of semi-autonomous organelles (plastids and mitochondria), by directly incorporating transgenes with appropriate regulatory sequences into the organelle genome.

[0332] A "tissue-specific promoter" or "organ-specific promoter" is a promoter that is preferentially expressed in one tissue or organ, for example, in relation to many other tissues or organs within a plant, preferably to most, if not all, other tissues or organs. Typically, the promoter is expressed at a level 10 times higher in a particular tissue or organ than in other tissues or organs.

[0333] A seed-specific promoter for the present invention, including a promoter that is preferred and results in seed-specific expression in cereals known in the art. Notable preferred promoters are the barley LPT2 or LPT1 gene promoters (WO95 / 15389 and WO95 / 23230), or the promoter described in WO99 / 16890 (promoter from the barley hordein gene). Other promoters include those described by Broun et al. (1998), Potenza et al. (2004), US2007 / 0192902, and US2003 / 0159173. In one embodiment, the seed-specific promoter is preferentially expressed in a defined portion of the seed, e.g., the endosperm, preferably in the developing aleuron. In a further embodiment, the seed-specific promoter is not expressed or is expressed only at low levels after seed germination.

[0334] In one embodiment, the promoter is active at least between flowering and 30 days post-flowering, or is active throughout this entire period. Examples of such promoters include the OsmtSSB-1a gene promoter, the TWINKLE promoter, the RECA3 promoter, or the TA2 promoter (WO2017 / 083920).

[0335] The promoters intended by the present invention may originate from the host plant being transformed, or from an alternative source in which the region is functional within the host plant. Numerous promoters functional within monocots are well known in the art, and non-limiting methods for evaluating promoter activity are disclosed by Medberry et al. (1992 and 1993), Sambrook et al. (1989, above), and US5,164,316.

[0336] Alternatively, or in addition, the promoter may be an inductive promoter or a developmentally regulated promoter, which can drive the expression of the introduced polynucleotide at an appropriate developmental stage in the cereal plant. Other cis-acting sequences that may be used include transcriptional and / or translational enhancers. Enhancer regions are well known to those skilled in the art and may include an ATG translation start codon and adjacent sequences. If included, the start codon should match the reading frame of the coding sequence associated with the heterogeneous or exogenous polynucleotide to ensure translation of the entire sequence if the entire sequence is translated. The translation start region may be derived from a source of transcription start regions or from heterogeneous or exogenous polynucleotides. Sequences may also originate from a source of a promoter selected to drive transcription and may be specifically modified to increase mRNA translation.

[0337] The nucleic acid constructs of the present invention may contain a 3' untranslated sequence of about 50 to 1,000 nucleotide base pairs, which may contain a transcription termination sequence. The 3' untranslated sequence may contain a transcription termination signal, which may contain or may not contain any other regulatory signals that can result in polyadenylation signals and mRNA processing. The polyadenylation signal functions for the addition of a polyadenylate pathway to the 3' end of the mRNA precursor. The polyadenylation signal is generally recognized by the presence of homology with the standard morphology 5'AATAAA-3', although variation is not uncommon. An example of a preferred 3' untranslated sequence is a 3' untranslated region containing a polyadenylation signal from the octopine synthase (ocs) gene or nopalin synthase (nos) gene of Agrobacterium tumefaciens (Bevan et al., 1983). A suitable 3' untranslated sequence may also be derived from a plant gene such as the ribulose-1,5-bisphosphate carboxylase (ssRUBISCO) gene, but other 3' elements known to those skilled in the art may also be used.

[0338] When a DNA sequence inserted between the transcription start site and the start of the coding sequence, i.e., an untranslated 5' leader sequence (5'UTR), is translated and transcribed, a specific leader sequence may also be used, as the 5'UTR can affect gene expression. A suitable leader sequence includes one that contains a sequence selected to direct the optimal expression of heterogeneous or endogenous DNA sequences. For example, such a leader sequence may include a preferred consensus sequence, which can increase or maintain mRNA stability and prevent improper translation initiation, as described, for example, by Joshi (1987).

[0339] vector The present invention includes the use of vectors for the manipulation or transfer of gene constructs. “Chimera vector” means a nucleic acid molecule, preferably a DNA molecule, which is, for example, derived from a plasmid or plant virus and can be inserted into or cloned within a plasmid or plant virus. The vector is preferably double-stranded DNA, contains one or more specific restriction sites, and may be capable of autonomous replication within a defined host cell, including a target cell or tissue or its progenitor cell or tissue, or may be capable of integration into a defined host genome so that the cloned sequence is reproducible. Thus, the vector may be an autonomously replicating vector, i.e., a vector existing as an extrachromosomal entity, where the replication of the vector is independent of chromosomal replication, e.g., linear or closed circular plasmids, extrachromosomal elements, minichromosomes, or artificial chromosomes. The vector may include any means to ensure self-replication. Alternatively, the vector may be a vector that, upon introduction into a cell, is integrated into the genome of the recipient cell and replicates together with the chromosome into which the vector is integrated. A vector system may include a single vector or plasmid, two or more vectors or plasmids, or a transposon, all containing the total DNA to be introduced into the host cell's genome. Vector selection typically depends on the vector's compatibility with the cell into which it is introduced. Vectors may also include selection markers, such as antibiotic resistance genes, herbicide resistance genes, or other genes that can be used for selecting a suitable transformant. Examples of such genes are well known to those skilled in the art.

[0340] The nucleic acid constructs of the present invention can be introduced into vectors such as plasmids. Plasmid vectors typically include additional nucleic acid sequences that provide easy selection, amplification, and transformation of expression cassettes in prokaryotic and eukaryotic cells, and include, for example, pUC-derived vectors, pSK-derived vectors, pGEM-derived vectors, pSP-derived vectors, pBS-derived vectors, or binary vectors containing one or more T-DNA regions. The additional nucleic acid sequences include a replication origin for providing autonomous replication of the vector, selectable marker genes, preferably selectable marker genes encoding antibiotic or herbicide resistance, a plurality of unique cloning sites providing a plurality of sites for inserting nucleic acid sequences or genes encoded in the nucleic acid construct, and sequences that enhance the transformation of prokaryotic and eukaryotic cells (particularly plant cells).

[0341] A "marker gene" refers to a gene that confers a different phenotype to cells expressing the marker gene, thus enabling such transformed cells to be distinguished from cells without the marker. Selectable marker genes confer traits that enable "selection" based on resistance to selectors (e.g., herbicides, antibiotics, radiation, heat, or other treatments that damage untransformed cells). Screenable marker genes (or reporter genes) confer traits that enable identification by observation or testing, i.e., by "screening" (e.g., β-glucuronidase, luciferase, GFP, or other enzyme activity not present in untransformed cells). The marker gene and the target nucleotide sequence do not need to be ligated.

[0342] To facilitate the identification of transformants, nucleic acid constructs preferably include, or in addition to, heterogeneous or exogenous polynucleotides, selectable or screenable marker genes. The actual selection of the marker is not important, as long as the marker is functional (i.e., selective) in combination with the plant cells of selection. For example, as described in US4,399,216, cotransformation of unlinked genes is also an efficient process in plant transformation, so the marker gene and the heterogeneous or exogenous polynucleotide of target do not need to be linked.

[0343] Examples of bacterial selectable markers are those that confer antibiotic resistance, such as ampicillin, erythromycin, chloramphenicol, or tetracycline resistance, preferably kanamycin resistance. Exemplary selectable markers for the selection of plant transformants include the hyg gene encoding hygromycin B resistance, the neomycin phosphotransferase (nptII) gene conferring resistance to kanamycin, paromomycin, and G418, for example, the glutathione-S-transferase gene from rat liver conferring resistance to glutathione-derived herbicides, as described in EP256223, for example, the glutamine synthase gene conferring resistance to glutamine synthase inhibitors such as phosphinotricin when overexpressed, as described in WO87 / 05327, for example, the acetyltransferase gene from Streptomyces viridochromogenes conferring resistance to the selective agent phosphinotricin, as described in EP275957, e.g., Hinchee et al. As described by al. (1988), genes encoding 5-enolpyruvirshikimic acid-3-phosphate synthase (EPSPS) that confer resistance to N-phosphonomethylglycine, for example, the bar gene that confers resistance to bialaphos as described in WO91 / 02071, nitrilase genes such as bxn from Klebsiella ozaenae that confer resistance to bromoxyn (Stalker et al., 1988), and dihydrofolate reductase (DHFR) genes that confer resistance to methotrexate (Thillet et al. This includes, but is not limited to, mutant acetolactic acid synthase genes (ALS) (EP154,204) that confer resistance to imidazolinone, sulfonylurea, or other ALS inhibitory chemicals, mutant anthranilate synthase genes that confer resistance to 5-methyltryptophan, or darrapon dehalogenase genes that confer resistance to herbicides (al., 1988).

[0344] Preferred screenable markers include, but are not limited to, the uidA gene encoding a β-glucuronidase (GUS) enzyme with a variety of known chromogenic substrates, a β-galactosidase gene encoding an enzyme with a known chromogenic substrate, an aequorin gene (Prasher et al., 1985) that can be used in calcium-sensitive bioluminescence detection, a green fluorescent protein gene (Niedz et al., 1995) or its derivatives, a luciferase (luc) gene (Ow et al., 1986) that enables bioluminescence detection, and other known in the art. As used herein, “reporter molecule” means a molecule that provides an analytically identifiable signal by its chemical properties, the analytically identifiable signal facilitates the determination of promoter activity by reference to a protein product.

[0345] Preferably, the nucleic acid construct is stably incorporated into the genome, for example, into the genome of the plant or cell of the present invention. Therefore, the nucleic acid contains appropriate elements that enable the molecule to be incorporated into the genome, or the construct is placed in an appropriate vector into which it can be incorporated into the chromosome of a plant cell.

[0346] One embodiment of the present invention comprises a recombinant vector comprising at least one polynucleotide molecule of the present invention, the at least one polynucleotide molecule of the present invention being inserted into any vector capable of delivering the nucleic acid molecule into a host cell. Such a vector contains heterologous nucleic acid sequences, i.e., nucleic acid sequences not naturally found adjacent to the nucleic acid molecule of the present invention, and preferably derived from a species other than the species from which the nucleic acid molecule originates. The vector can be either RNA or DNA, prokaryotic or eukaryotic, and is typically a virus or plasmid.

[0347] Numerous vectors suitable for stable transfection of plant cells or for establishing transgenic plants are described, for example, in Pouwels et al., Cloning Vectors: A Laboratory Manual, 1985, 1987; Weissbach and Weissbach, Methods for Plant Molecular Biology, Academic Press, 1989; and Gelvin et al., Plant Molecular Biology Manual, Kluwer Academic Publishers, 1990. Typically, plant expression vectors include, for example, one or more cloned plant genes under transcriptional control of 5' and 3' regulatory sequences, as well as a dominant selectable marker. Such plant expression vectors may also contain promoter regulatory regions (e.g., regulatory regions that control inducible or constitutive expression, environmentally or developmentally regulated expression, or cell or tissue-specific expression), transcription start sites, ribosome binding sites, RNA processing signals, transcription termination sites, and / or polyadenylation signals.

[0348] The levels of mtSSB, TWINKLE, or RECA3 polypeptides can be altered by reducing the expression level of protein-coding genes in cereal plants, which results in increased aleurone thickness. Gene expression levels can be altered by changing the copy number per cell, for example, by introducing synthetic gene constructs comprising a coding sequence and transcriptional regulatory elements operably linked to the coding sequence and functional within the cell. Multiple transformants can be selected and screened for those exhibiting a preferred level and / or specificity of transgene expression resulting from the influence of endogenous sequences near the transgene integration site. The preferred level and pattern of transgene expression results in increased aleurone thickness. Alternatively, populations of plants from a mutagenic seed population or breeding program can be screened for individual lines exhibiting increased aleurone thickness.

[0349] Recombinant cells Another embodiment of the present invention includes recombinant cells, which include a mutant endogenous gene, for example, a gene modified by gene editing, or a host cell or its progeny transformed with one or more recombinant molecules of the present invention. Various types of mutagenesis, including gene editing, are described above and may be used to produce recombinant cells. Transformation of nucleic acid molecules into cells may be achieved by any method in which the nucleic acid molecule can be inserted into the cell. Transformation techniques include, but are not limited to, transfection, electroporation, microinjection, lipofection, adsorption, and protoplast fusion. Recombinant cells may still be unicellular or may grow into tissues, organs, or multicellular organisms, such as transgenic plants. The transformed nucleic acid molecules of the present invention may still be extrachromosomal or may be incorporated into one or more sites within the chromosome of the transformed cell in a manner that preserves the ability of the transformed nucleic acid molecules to be expressed. Preferred host cells are plant cells, more preferably grain cells.

[0350] Plants with genetic variation When used herein as a noun, the term “plant” refers to the entire plant or any member of the Plant Kingdom; when used as an adjective, it refers to any substance present in, obtained from, derived from, or related to a plant, such as plant organs (e.g., leaves, stems, roots, flowers), single cells (e.g., pollen), seeds, and plant cells. Sprouted plantlets with roots and shoots and germinated seeds are also included in the meaning of “plant.” When used herein, the term “plant part” refers to one or more plant tissues or organs obtained from a plant and containing the plant’s genomic DNA. Plant parts include vegetation structures (e.g., leaves, stems), roots, floral organs / structures, seeds (including embryos, cotyledons, and seed coats), plant tissues (e.g., vascular tissue, and basic tissues), cells, and their offspring. When used herein, the term “plant cell” refers to a cell obtained from or within a plant, including plant-derived protoplasts or other cells, gamete-producing cells, and cells that regenerate the whole plant. Plant cells may be cells within a culture, i.e., in vitro cells. "Plant tissue" means a collection of various forms of plant cells within a culture, such as differentiated tissue ("explant") within or obtained from a plant, or undifferentiated tissue derived from immature or mature embryos, seeds, roots, shoots, fruits, tubers, pollen, and callus. Exemplary plant tissues within or obtained from seeds are cotyledons, embryos and hypocotyls, or blastodisc, endosperm, or alleurons. Accordingly, the present invention includes plants and plant parts, and products containing them.

[0351] The terms “grain” and “seed” are used interchangeably herein. “Grain” may, depending on the context, refer to a mature grain within a plant, a developing seed within a plant, a harvested grain, or a processed grain, such as one after milling or polishing, in which most of the grain remains intact, or a grain after water absorption or germination. Mature grains generally have a water content of less than about 18–20% by weight, typically about 8–12% by weight. In one embodiment, the developing grain of the present invention is at least about 10 days post-pollination (DAP). In one embodiment, the developing seed of the present invention is a seed between pollination and 30 days post-pollination, which may be contained within the plant or removed.

[0352] As used herein, “transgenic plant” means a plant having one or more genetic variations and containing one or more exogenous polynucleotides not found in the wild-type plant of the same species, variety, or cultivar. That is, a transgenic plant (transformed plant) contains genetic material (transgenes) that the transgenic plant did not contain before transformation. Transgenes may include gene sequences obtained from or derived from plant cells or other plant cells or non-plant sources, or synthetic sequences. Typically, transgenes are introduced into plants by human manipulation, for example, by transformation, but any method may be used, as will be recognized by those skilled in the art. Transgenes are preferably stably incorporated into the plant's nuclear genome. Transgenes may include sequences that occur spontaneously within the same species but in a rearranged order or in different arrangements of elements, for example, antisense sequences. Plants containing such sequences are included herein as “transgenic plants.”

[0353] "Non-transgenic plants" are plants that have not been genetically modified through the introduction of genetic material using recombinant DNA techniques.

[0354] As used herein, “wild-type” means cells, polypeptides, genes, tissues, grains, or plants that have not been modified according to the present invention. Wild-type cells, tissues, or plants may be used as a control to compare the level of endogenous gene expression, the amount of polypeptides or other polypeptides of the present invention, exogenous nucleic acids, or the degree and nature of the modification, in particular the phenotype of aleurone thickness, with cells, tissues, grains, or plants modified as described herein.

[0355] As used herein, the term “corresponding wild-type” cereal plant or grain or similar phrase means a cereal plant or grain that comprises at least 75%, more preferably at least 95%, more preferably at least 97%, more preferably at least 99%, and even more preferably 99.5% of the genotype of the cereal plant or grain of the present invention, but each does not contain genetic variations (such as introduced mutations) and / or thickened aleurons that reduce the activity of polypeptides within the plant or grain. In preferred embodiments, the grain or plant of the present invention is an isogenic grain or plant with respect to the wild-type grain or plant, except for one or more genetic variations (such as introduced mutations). Preferably, the corresponding wild-type plant or grain is of the same or a variant of the precursor of the plant / grain of the present invention, or of a sibling plant line often referred to as a “segregate” that lacks one or more genetic modifications and / or does not have thickened aleurons. In one embodiment, the rice plant or grain of the present invention has a genotype that is less than 50% identical to the genotype of the wild-type rice variety Zhonghua 11 (ZH11). ZH11 has been commercially available since 1986.

[0356] As defined in the context of the present invention, a transgenic plant includes offspring of a cereal plant genetically modified according to the present invention, the offspring containing a genetic variation, e.g., a mutation of interest or a transgene. Such offspring may be obtained by self-fertilization of a primary transgenic plant or by crossing such a plant with another cereal plant. This generally involves altering the production of at least one protein as defined herein within the desired plant or its grain. A transgenic plant portion includes all parts and cells of the transgenic plant containing the transgene, e.g., cultured tissue, callus, and protoplast, preferably grain, etc.

[0357] As used herein, “cereals” refers to any plant of the Poaceae family, commonly known as herbaceous plants, that is cultivated for the edible components of its grain. Thus, cereals are a family of monocotyledonous flowering plants. Examples of cereal plants / grains of the present invention include, but are not limited to, rice, wheat, barley, rye, maize, sorghum, wild oats, and rye.

[0358] As used herein, the term “rice” refers to any plant or part thereof, including a lineage, variety, or cultivar of plants of the genus Oryza, which is cultivated for the edible components of its grain. The rice plant is preferably of the Oryza sativa species.

[0359] As used herein, “brown rice” means the whole grain of rice, including the bran and embryo (germ), but excluding the outer layer that is usually removed during harvest. That is, brown rice is not polished to remove the allureon and embryo. “Brown” refers to the presence of brown or yellowish-brown pigment in the bran. Brown rice is considered the whole grain. As used herein, “white rice” (polished rice) means the rice grain from which the bran and germ have been removed, i.e., essentially the starchy endosperm remaining of the whole grain. Both of these classes of rice grain can be in the form of short, medium, or long grains. Compared to white rice, brown rice has a higher content of protein, minerals, and vitamins, as well as a higher lysine content in the protein content of brown rice.

[0360] As used herein, the term “wheat” refers to any plant or part thereof, including a lineage, variety, or cultivar of plants of the genus Triticum, which is cultivated for the edible components of its grain, and includes its precursors and its offspring produced by hybridization with other species. Wheat includes “hexaploid wheat” having a genome configuration of AABBDD consisting of 42 chromosomes, and “tetraploid wheat” having a genome configuration of AABB consisting of 28 chromosomes. Hexaploid wheat includes T. aestivum, T. spelta, T. macha, T. compactum, T. sphaerococcum, T. vavilovii, and their interspecific hybrids. The preferred species of hexaploid wheat is T. aestivum, subspecies aestivum (also known as “bread wheat”). Tetraploid wheat includes T. durum (also referred herein as durum wheat or Triticum turgidum, subspecies durum), T. dicoccoides, T. dicoccum, T. polonicum, and their interspecific hybrids. In addition, the term “wheat” includes potential precursors of hexaploid or tetraploid Triticum species, such as T. uartu, T. monococcum, or T. boeoticum for the A genome, Aegilops speltoides for the B genome, and T. tauschii (also known as Aegilops squarrosa or Aegilops tauschii) for the D genome. Particularly preferred precursors are those for the A genome, and more preferably, the A genome precursor is T. monococcum. Wheat varieties for use in the present invention may belong to any of the species listed above, but are not limited to these. Furthermore, conventional techniques include plants produced by using Triticum species as parents in sexual hybridization with non-Triticum species (such as rye [Secale cereale]), including, but not limited to, Triticale.

[0361] As used herein, the term “barley” means any plant or part thereof, including a lineage, variety, or cultivar of plants of the genus Hordeum, which is cultivated for the edible components of its grain, and this includes its precursors and its offspring produced by hybridization with other species. The plant is preferably of the species Hordeum vulgare.

[0362] As used herein, “colored” refers to grains containing atypical color. Examples include black rice, red rice, red wheat, purple rice, purple barley, and purple corn. Black rice and red rice, respectively, contain pigments, particularly anthocyanidins and anthocyanins, within their allureon layers. Colored rice has a higher riboflavin content than uncolored rice, but a similar thiamine content. “Black rice” has a black or nearly black bran layer due to the concentration of anthocyanins and can turn a deep purple when cooked. “Purple rice” (also known as “purple-black rice”) is a short-grain variant of black rice and is included in black rice as defined herein. Purple rice is purple when uncooked and a deep purple when cooked. "Red rice" contains various anthocyanins that give the bran its red / chestnut color, and these anthocyanins include cyanidin-3-glucoside (chrysanthemin) and peonidin-3-glucoside (oxycoccicy-anin).

[0363] Each of these types of grains may be treated to prevent germination, for example, by cooking (boiling) or by drying and heating (roasting). For example, brown rice and colored rice are typically cooked for 10 to 40 minutes, depending on the desired texture, while white rice is typically cooked for 12 to 18 minutes. Cooking or heating reduces the levels of anti-nutrient factors in the grain, such as trypsin inhibitors, oryzacystatin, and hemagglutinin (lectin), by denaturing these proteins, but does not reduce the levels of phytate content. The grains may also be soaked in water before cooking, as is known in the art, or cooked slowly for a longer period of time. The grains may also be cracked, boiled, or heat-stabilized. Each of these forms of grains belongs to the class of processed grains, which cannot germinate and are not used to produce viable plants. Bran may be steam-treated at 100°C for about 6 minutes to stabilize it.

[0364] In one embodiment, the grains of the present invention have delayed grain maturation compared to the corresponding wild-type grains. The plants of the present invention may have a reduced fruiting rate (%) compared to wild-type plants, the fruiting rate being calculated by determining the percentage of florets in the plant that are filled with seeds at the mature grain growth stage.

[0365] In one embodiment, the grains of the present invention have reduced germination ability compared to the corresponding wild-type grains. For example, the grains have about 50% of the germination ability of the corresponding wild-type grains when cultured in a growth chamber at 28°C under a 12-hour light / 12-hour dark cycle without humidity control. As used herein, the term “germination” is defined as when the roots are visibly emerging through the seed coat.

[0366] In one embodiment, the plant of the present invention has one or more or all of the following characteristics compared to a wild-type parental variety, such as an isogenic plant containing the OsmtSSB-1a polypeptide having the amino acid sequence provided as Sequence ID No. 3: normal plant height, fertility (male and female), seed length, seed width, and seed thickness. In one embodiment, the grain of the present invention can produce a cereal plant having one or more or all of the following characteristics compared to a wild-type parental variety: normal plant height, fertility (male and female), seed length, seed width, and seed thickness. As used herein, the term “normal” can be determined by measuring the same traits in a wild-type parental variety grown under the same conditions as the plant of the present invention. In one embodiment, to be normal, the plant of the present invention has + / -20%, more preferably + / -10%, more preferably + / -5%, and even more preferably + / -2.5% of the level / number of defined characteristics compared to a wild-type parental variety.

[0367] As defined in the context of the present invention, a transgenic plant includes a plant (as well as parts and cells of the plant) and its offspring that have been genetically modified using recombination techniques to induce the production of at least one polypeptide of the present invention within a desired plant or plant organ. Transgenic plants can be produced using techniques known in the art, such as those outlined in A. Slater et al., Plant Biotechnology - The Genetic Manipulation of Plants, Oxford University Press (2003), and P. Christou and H. Klee, Handbook of Plant Biotechnology, John Wiley and Sons (2004).

[0368] In preferred embodiments, the plants of the present invention are homozygous for all introduced genetic variations, genes, nucleic acid constructs (transgenes), or mutations, and therefore the offspring of the plants of the present invention do not segregate for the desired phenotype. Transgenic plants may also be heterozygous for introduced genetic variations, genes, or nucleic acid constructs, for example, in F1 offspring grown from hybrid seeds. Such plants may offer advantages such as hybrid vigor, which are well known in the art.

[0369] In one embodiment, the method for selecting plants according to the present invention further comprises analyzing a DNA sample from the plant for at least one “other genetic marker.” As used herein, “other genetic marker” may be any molecule linked to a desired trait of the plant. Such markers are well known to those skilled in the art and include molecular markers linked to genes that determine traits such as disease resistance, yield, plant morphology, grain quality, dormancy trait, grain color, gibberellic acid content in seeds, plant height, and powder color. An example of such a gene is the Rht gene, which determines semi-dwarf growth habit and, therefore, lodging resistance.

[0370] The following four common methods for direct delivery of genes into cells have been described: (1) chemical methods (Graham et al., 1973), (2) physical methods, e.g., microinjection (Capecchi, 1980), electroporation (see, e.g., WO87 / 06614, US5,472,869, 5,384,253, WO92 / 09696, and WO93 / 21335), and gene guns (see, e.g., US4,945,050 and US5,141,131), (3) viral vectors (Clapp, 1993, Lu et al., 1993, Eglitis et al., 1988), and (4) receptor-mediated mechanisms (Curiel et al., 1992, Wagner et al., 1992).

[0371] Possible acceleration methods include, for example, microprojectile impaction. One example of a method for transformation that delivers nucleic acid molecules to plant cells is microprojectile impaction. This method is outlined by Yang et al., Particle Bombardment Technology for Gene Transfer, Oxford Press, Oxford, England (1994). Microprojectiles are non-biological particles that can be coated with nucleic acids and delivered into cells by propulsion. Exemplary particles include those composed of tungsten, gold, and platinum. In addition to being an effective means of reproducibly transforming monocotyledonous plants, an advantage of microprojectile impaction is that it does not require the isolation of protoplasts or susceptibility to Agrobacterium infection. A suitable particle delivery system for use in this invention is the helium-accelerated PDS-1000 / He gun, available from Bio-Rad Laboratories. For impact purposes, immature embryos or target cells derived from immature embryos, such as blastodiscs or callus, may be placed on a solid culture medium.

[0372] In another alternative embodiment, plastids can be stably transformed. Methods disclosed for plastid transformation in higher plants include particle gun delivery of DNA containing a selectable marker and targeting of the DNA to the plastid genome by homologous recombination (US5,451,513, US5,545,818, US5,877,402, US5,932479, and WO99 / 05265).

[0373] Agrobacterium-mediated transposition is a widely applicable system for introducing genes into plant cells, thereby bypassing the need for the regeneration of intact plants from protoplasts, as DNA can be introduced into the entire plant tissue. The use of Agrobacterium-mediated plant integration vectors for introducing DNA into plant cells is well known in the art (see, e.g., US5,177,010, US5,104,310, US5,004,863, US5,159,135). Furthermore, T-DNA integration is a relatively precise process that results in minimal rearrangement. The region of DNA to be transposed is defined by boundary sequences, and the intervening DNA is typically inserted into the plant genome.

[0374] Transgenic plants formed using the Agrobacterium transformation method typically contain a single gene locus on a single chromosome. Such transgenic plants may be described as hemizygous with respect to the added gene. More preferable are transgenic plants that are homozygous with respect to the added structure gene, i.e., transgenic plants that contain two added genes, with one gene located at the same locus on each chromosome of the chromosome pair. Homozygous transgenic plants can be obtained by sexual cross-pollinating (self-pollinating) independent segregated transgenic plants containing a single added gene, germinating a portion of the resulting seeds, and analyzing the resulting plants for the gene of interest.

[0375] Other methods of cell transformation may also be used, including, but are not limited to, introducing DNA into a plant by direct DNA transfer into pollen, direct injection of DNA into the reproductive organs of a plant, or direct injection of DNA into cells of an immature embryo followed by rehydration of the dried embryo.

[0376] The regeneration, development, and cultivation of plants from single plant protoplast transformants or from various transformed explants are well known in the art (Weissbach et al., Methods for Plant Molecular Biology, Academic Press, San Diego, (1988)). This regeneration and growth process typically involves the step of selecting transformed cells, and culturing these individualized cells through the normal stages of embryonic development and through the rooted plant stage. Transgenic embryos and seeds are similarly regenerated. Thus, the resulting rooted transgenic shoots are then planted in a suitable plant growth medium such as soil.

[0377] The development or regeneration of plants containing heterologous exogenous genes is well known in the art. Preferably, the regenerated plants are self-pollinated to provide homozygous transgenic plants. Otherwise, pollen obtained from the regenerated plants is cross-pollinated with seed-producing plants of agriculturally important strains. Conversely, pollen from these important strains is used to pollinate the regenerated plants. The transgenic plants of the present invention containing the desired exogenous nucleic acids are cultivated using methods well known to those skilled in the art.

[0378] To confirm the presence of transgenes in transgenic cells and plants, polymerase chain reaction (PCR) amplification or Southern blot analysis can be performed using methods known to those skilled in the art. Transgene expression products can be detected by any of a variety of methods, depending on the nature of the product, including Western blotting and enzyme assays. One particularly useful method for quantifying protein expression and detecting replication in different plant tissues is to use a reporter gene such as GUS. Once transgenic plants are obtained, they can be grown to produce plant tissues or parts having the desired phenotype. Plant tissues or parts can be harvested, and / or seeds can be collected. Seeds can serve as a source for growing additional plants with tissues or parts having the desired characteristics.

[0379] Marker support selection Marker-assisted selection is a well-recognized method for selecting heterozygous plants required when backcrossing with recurrent parents in classical breeding programs. The plant population in each backcross generation is heterozygous for the target gene, which is typically present in a 1:1 ratio in the backcross population, and molecular markers can be used to distinguish between the two alleles of the gene. Early selection of plants for further backcrossing is achieved by extracting DNA, for example, from young shoots, and testing for the desired traits with specific markers, while concentrating energy and resources on plants with fewer resources. To further expedite the backcross program, embryos from immature seeds (25 days post-flowering) may be excised and grown on nutrient medium under sterile conditions, rather than allowing for complete seed maturation. This process, referred to as "embryonic rescue," is used in combination with DNA extraction at three leaf stages and analysis of at least one genetic variation that alters mtSSB, TWINKLE, or RECA3 activity and confers increased aleurone thickness to the plant. It allows for the rapid selection of plants possessing the desired traits, which can then be raised to maturity in a greenhouse or field for subsequent further backcrossing with recurrent parents.

[0380] Any molecular biological technique known in the art may be used in the methods of the present invention. Such methods include, but are not limited to, the use of nucleic acid amplification, nucleic acid sequencing, nucleic acid hybridization with suitably labeled probes, single-strand higher-order structure analysis (SSCA), denaturant concentration gradient gel electrophoresis (DGGE), hetero-double-strand analysis (HET), chemical cleavage analysis (CCM), catalytic nucleic acid cleavage, or a combination thereof (see, for example, Lemieux, 2000 and Langridge et al., 2001). The present invention also includes the use of molecular marker techniques for detecting polymorphisms linked to alleles of the mtSSB, TWINKLE, or RECA3 genes, where the mtSSB, TWINKLE, or RECA3 genes alter mtSSB, TWINKLE, or RECA3 activity, respectively, and confer increased aleurone thickness to plants. Such methods include the detection or analysis of restriction fragment length polymorphisms (RFLPs), RAPDs, amplified fragment length polymorphisms (AFLPs), and microsatellite (simple sequence repeat, SSR) polymorphisms. Closely coupled markers can be readily obtained by methods well known in the art, such as bulk isolation individual analysis outlined by Langridge et al. (2001).

[0381] In one embodiment, the linked locus for marker-assisted selection is within at least 1 cM, 0.5 cM, 0.1 cM, or 0.01 cM of the gene encoding the polypeptide of the present invention.

[0382] A polymerase chain reaction ("PCR") is a reaction in which replicated copies are produced from a target polynucleotide using a primer pair or set of primers consisting of upstream and downstream primers, and a polymerization catalyst, such as DNA polymerase, and typically a thermostable polymerase enzyme. Methods for PCR are known in the art and are taught, for example, in "PCR" (MJ McPherson and SG Moller (editors), BIOS Scientific Publishers Ltd, Oxford, (2000)). PCR can be performed on cDNA obtained by reverse transcribing mRNA isolated from plant cells expressing the mtSSB, TWINKLE, or RECA3 gene or allele into plants with increased aleurone thickness. However, PCR is generally easier when performed on genomic DNA isolated from plants.

[0383] Primers are oligonucleotide sequences that can hybridize to a target sequence in a sequence-specific manner and be extended during PCR. Amplicons or PCR products, or PCR fragments or amplification products, are extension products containing primers and newly synthesized target sequence copies. Multiplex PCR systems contain multiple sets of primers, which result in the simultaneous production of two or more amplicons. Primers may be a perfect match to the target sequence, or they may contain internal mismatch bases that can lead to the introduction of restriction enzyme or catalytic nucleic acid recognition / cleavage sites into a particular target sequence. Primers may also contain additional sequences and / or modified or labeled nucleotides to facilitate the capture or detection of amplicons. Repeated cycles of DNA thermal denaturation, primer annealing to complementary sequences, and extension of the annealed primers with polymerase result in exponential amplification of the target sequence. The terms target, target sequence, or template refer to the amplified nucleic acid sequence.

[0384] Methods for direct sequencing of nucleotide sequences are well known to those skilled in the art and can be found, for example, in Ausubel et al. (above) and Sambrook et al. (above). Sequencing can be carried out by any preferred method, such as dideoxy sequencing, chemical sequencing, or a variation thereof. Direct sequencing has the advantage of determining variations within any base pair of a particular sequence.

[0385] grain processing Due to the thickened aleurone, the grains of the present invention, as well as the flour and bran therefrom, have improved nutritional content. The isolated aleurone tissue should contain low levels of starch and pericarp, representing the majority of the physiologically beneficial substances of the grain for human nutrition. For example, the grains of the present invention and / or flours produced therefrom, compared by weight to the corresponding wild-type grains and / or flours produced therefrom, are as follows: i) Higher fat content, for example, at least about 10%, at least about 20%, or at least about 30%, or about 30% higher than the wild type, up to about 50% higher in fat content. ii) A higher ash content, for example, an ash content that is at least about 5%, at least about 10%, at least about 15%, or at least about 20%, or about 20%, and up to about 25%, higher than the wild type. iii) Higher fiber content, for example, total fiber content that is at least approximately 70%, at least approximately 80%, or at least approximately 94%, or approximately 94%, and up to approximately 150% higher than that of the wild type. iv) A lower starch content, for example, a starch content reduced by approximately 1% to 10% by weight compared to the starch content of the corresponding wild-type grain. v) A higher mineral content, for example, a mineral content that is at least 10%, at least 15%, at least 20%, or at least about 25% higher than the wild type, up to a maximum of about 40%, preferably the mineral content being one or more of the following: zinc (e.g., at least about 10% or at least about 15% higher than the wild type, up to a maximum of about 30%), iron (e.g., at least about 2.5% or at least about 5% higher than the wild type, up to a maximum of about 10%), potassium (e.g., at least about 20% or at least about 25% higher than the wild type, up to a maximum of about 40%), magnesium (e.g., at least about 18% or at least about 23% higher than the wild type, up to a maximum of about 40%), phosphorus (e.g., at least about 17% or at least about 22% higher than the wild type, up to a maximum of about 40%), and sulfur (e.g., at least about 5% or at least about 10% higher than the wild type, up to a maximum of about 20%). vi) Higher antioxidant content, for example, total phenolic compounds at least about 20%, at least about 25%, or at least about 30% more than the wild type, and / or antioxidant capacity at least about 35%, at least about 46%, and up to about 60% higher antioxidant content. vii) A higher phytate content, for example, at least about 10% or at least about 15% higher than the wild type, and up to about 25% higher. viii) Higher content of one or more of the following vitamins: B3 (e.g., at least 5% or at least 9%), B6 ​​(e.g., at least 100% or at least 120% higher than the wild type, up to approximately 200% higher), and B9 (e.g., at least 50% or at least 61% higher than the wild type, up to approximately 100% higher), ix) Higher sucrose content, for example, at least 60% or at least 76% higher than the wild type, and up to approximately 100% higher. x) A higher neutral non-starch polysaccharide content, for example, a neutral non-starch polysaccharide content that is at least about 38% or at least about 48% higher than the wild type, and up to about 80% higher. xi) a higher monosaccharide content (e.g., arabinose, xylose, galactose, glucose content), for example, a monosaccharide content that is at least about 42% or at least about 59% higher than the wild type, and up to about 100% higher, xii) Contains one or more or all of the same nitrogen levels.

[0386] Each of these nutritional components of the grain can be determined using conventional techniques, such as those outlined in Examples 1 and 4.

[0387] In one embodiment, the grain contains an increased proportion of amylose in the total starch content of the grain compared to the corresponding wild-type grain. Methods for producing such grains are described, for example, in WO2002 / 037955, WO2003 / 094600, WO2005 / 040381, WO2005 / 001098, WO2011 / 011833, and WO2012 / 103594.

[0388] In one embodiment, the grain of the present invention contains an increased proportion of oleic acid and / or a decreased proportion of palmitic acid in the total fatty acid content of the grain compared to the corresponding wild-type grain. Methods for producing such grains are described, for example, in WO2008 / 006171 and WO2013 / 159149.

[0389] In further embodiments, the grain or plant of the present invention further comprises a ROS1a gene encoding a ROS1a polypeptide and one or more genetic variations, each of which reduces the activity of at least one ROS1a gene in the plant compared to the corresponding wild-type plant. Such grains and plants are described in WO2017 / 083920. Preferably, such grains or plants are rice grains or rice plants, respectively.

[0390] The grains / seeds of the present invention, or other plant parts of the present invention, can be processed using any technique known in the art to produce food ingredients, food or non-food products.

[0391] As used herein, the term “other food or beverage ingredients” means any substance suitable for animal consumption, preferably, any substance suitable for human consumption, when served as part of a food or beverage. Examples include, but are not limited to, grains from other plant species, sugar, and other materials, except water.

[0392] In one embodiment, the product is whole grain flour, for example, ultrafine milled whole grain flour, or flour made from about 100% of the grain. The whole grain flour includes refined components (refined flour or refined flour) and coarse components (ultrafine milled coarse components).

[0393] Refined flour may be a powder prepared, for example, by grinding and sieving washed grains. The particle size of refined flour is described as powder that passes through a cloth having an opening no larger than the opening of a woven wire mesh specified as "212 micrometers (US wire mesh 70)" for 98% or more of the particles. Coarse grain contains at least one of bran and germ. For example, germ is the embryonic part found within the grain. Germ contains lipids, fiber, vitamins, proteins, minerals, and phytonutrients, such as flavonoids. Bran contains several cell layers and has significant amounts of lipids, fiber, vitamins, proteins, minerals, and phytonutrients, such as flavonoids. Furthermore, coarse grain may contain an aleurone layer, which also contains lipids, fiber, vitamins, proteins, minerals, and phytonutrients, such as flavonoids. The aleurone layer, technically considered part of the endosperm, exhibits many of the same characteristics as bran and is therefore typically removed along with the bran and germ during the milling process. The aleurone layer contains proteins, vitamins, and phytonutrients, such as ferulic acid.

[0394] Furthermore, the coarse grain can be blended with the refined grain component. The coarse grain can be mixed with the refined grain component to form whole grain flour, thus providing whole grain flour with increased nutritional value, fiber content, and antioxidant capacity compared to the refined grain. For example, the coarse grain or whole grain flour can be used in various amounts as a substitute for the refined grain or whole grain flour in baked foods, snack products, and food products. The whole grain flour of the present invention (i.e., ultrafine milled whole grain flour) can also be marketed directly to consumers for use in consumers' homemade baked products. In exemplary embodiments, the granulation profile of the whole grain flour is such that 98% by weight of the particles of the whole grain flour are less than 212 micrometers.

[0395] In further embodiments, enzymes found in the bran and germ of whole grain flour and / or coarse grain are inactivated to stabilize the whole grain flour and / or coarse grain. Stabilization is a process that uses steam, heat, radiation, or other treatments to inactivate enzymes found in the bran and germ layers. The stabilized flour retains the cooking characteristics of the flour and has a longer shelf life.

[0396] In additional embodiments, whole grain flour, coarse grain flour, or refined grain flour may be components (ingredients) of a food product and may be used to manufacture a food product. For example, a food product may be bagels, biscuits, bread, buns, croissants, dumplings, English muffins, muffins, pita bread, quick bread, chilled / frozen dough products, dough, baked beans, burritos, chili, tacos, tamales, tortillas, pot pies, prepared cereals, prepared foods, stuffings, microwave ovenable foods, brownies, cakes, cheesecakes, coffee cakes, cookies, desserts, pastries, sweet rolls, candy bars, pie crusts, pie fillings, baby food, baking mixes, batters, breadings, gravy mixes, meat fillers, meat substitutes, seasoning mixes These may include buckwheat, soup mix, gravy, roux, salad dressing, soup, sour cream, noodles, pasta, ramen noodles, chammen noodles, romi noodles, ice cream contents, ice cream bars, ice cream cones, ice cream sandwiches, crackers, croutons, donuts, egg rolls, extruded snacks, fruit and grain bars, microwaveable snack products, nutrition bars, pancakes, pre-baked bakery products, pretzels, puddings, granola-based products, snack chips, snack foods, snack mixes, waffles, pizza crusts, animal foods, or pet foods. Preferred food products include cooked rice, rice porridge, rice noodles, and bars containing processed rice grains, and a preferred beverage is rice tea. See Example 19 of this specification.

[0397] In alternative embodiments, whole grain flour, refined flour, or raw grain may be components of a dietary supplement. For example, a dietary supplement may be a product added to a diet and may contain one or more additional ingredients, typically including vitamins, minerals, herbs, amino acids, enzymes, antioxidants, herbs, spices, probiotics, extracts, prebiotics, and fiber. The whole grain flour, refined flour, or raw grain of the present invention contains vitamins, minerals, amino acids, enzymes, and fiber. For example, the raw grain contains a concentrated amount of dietary fiber, as well as other essential nutrients, such as B-vitamins, selenium, chromium, manganese, magnesium, and antioxidants, which are essential for a healthy diet. For example, 22 grams of the raw grain of the present invention delivers 33% of the recommended daily intake of fiber for an individual. A dietary supplement may contain any known nutrients that support the overall health of an individual, including, but are not limited to, vitamins, minerals, other fiber components, fatty acids, antioxidants, amino acids, peptides, proteins, lutein, ribose, omega-3 fatty acids, and / or other nutrients. Supplements may be delivered in the following forms: instant beverage mixes, prepared beverages, nutrition bars, wafers, cookies, crackers, gel shots, capsules, chews, chewable tablets, and pills, but are not limited to these. One embodiment delivers the fiber supplement in the form of a flavored shake or malt-type beverage, which may be particularly appealing as a fiber supplement for children.

[0398] In additional embodiments, the milling process may be used to produce multi-grain flour or multi-grain coarse flour. For example, bran and germ from one type of grain may be ground and blended with ground endosperm or whole grain flour from another type of grain. Alternatively, bran and germ from one type of grain may be ground and blended with ground endosperm or whole grain flour from another type of grain. The present invention is intended to encompass the mixing of any one or more combinations of bran, germ, endosperm, and whole grain flour from one or more grains. This multi-grain method may be used to produce custom flours and to produce a single flour by utilizing the qualities and nutritional content of multiple types of grains.

[0399] The whole grain flour, coarse grain, and / or grain products of the present invention are intended to be produced by any milling process known in the art. An exemplary embodiment involves grinding the grain in a single flow without separating the endosperm, bran, and germ of the grain into separate flows. The washed and tempered grain is conveyed to a first pass mill, such as a hammer mill, roller mill, pin mill, impact mill, disc mill, air attrition mill, or gap mill. After grinding, the grain is discharged and conveyed to a sieve. Furthermore, the whole grain flour, coarse grain, and / or grain products of the present invention are intended to be modified or enhanced by a number of other processes, such as fermentation, instantizing, extrusion, encapsulation, toasting, or roasting. [Examples]

[0400] Example 1. General materials and methods Observation of aleurones by staining with Sudanred solution A staining solution was prepared by adding 1 g of Sudan Red IV to 50 ml of polyethylene glycol solution (average molecular weight 400, Sigma, catalog number 202398), incubating at 90°C for 1 hour, and mixing with an equal volume of 90% glycerol. After removing the fruit peel (inner and outer glumes) from each grain, the mature rice grains were incubated in distilled water for 5 hours, and then thinly sectioned transversely or longitudinally using a razor blade. The sections were stained in Sudan Red solution at room temperature for 24–72 hours. The sections were then counterstained with Lugol's stain (Sigma, 32922) at room temperature for 20 minutes and observed under a dissecting microscope (Sreenivasulu, 2010).

[0401] Dyeing of allureon with Evans Blue An Evans blue staining solution was prepared by dissolving 0.1 g of Evans blue (Sigma, E2129) in 100 ml of distilled water. After removing the fruit husk from each grain, the mature rice grains were thinly sectioned transversely using a razor blade. The sections were incubated in distilled water at room temperature for 30 minutes, stained, and left at room temperature for 2 minutes. The staining solution was then discarded, the sections were washed twice with distilled water, and observed under a dissecting microscope.

[0402] Optical microscope observation of rice endosperm Rice grains were fixed in a formalin-acetic acid alcohol (FAA) solution (60% ethanol, 33% H2O, 5% glacial acetic acid, and 2% formaldehyde; v / v / v / v), degassed for 1 hour, dehydrated in a series of alcohol solutions containing 70%, 80%, 95%, and then 100% ethanol, impregnated with LR white resin (Electron Microscopy Sciences, 14380), and polymerized at 60°C for 24 hours. Microtome sectioning was performed using a Leica UC7 microtome. The sections were stained in 0.1% toluidine blue solution (Sigma, T3260) at room temperature for 2 minutes, then washed twice with distilled water and examined by optical microscopy. Alternatively, sections were stained in 0.01% chalcoflor white solution (Sigma, 18909) at room temperature for 2 minutes and examined by optical microscopy under UV excitation (excitation at 365 nm and emission at approximately 440 nm).

[0403] Staining with Schiff periodate (PAS) reagent and Coomassie blue. Fixed sections on slides were incubated in preheated 0.4% periodic acid (Sigma, 375810) at 57°C for 30 minutes, and then rinsed three times with distilled water. Schiff's reagent (Sigma, 3952016) was applied, and the slides were incubated at room temperature for 15 minutes, and then rinsed three times with distilled water. The sections were then incubated in 1% Coomassie blue (R-250, Thermo Scientific, 20278) at room temperature for 2 minutes, and then rinsed three times with distilled water. A series of alcohol solutions containing 30%, 50%, 60%, 75%, 85%, 95%, and 100% ethanol were used for 2 minutes each to achieve dehydration of the sections, and then each slide was cleared in 50% xylene and 100% xylene solutions (Sigma, 534056) for 2 minutes each. Next, Eukitt® rapid-setting mounting medium (Fluka, 03989) was placed on a coverslip, and the section was observed under a light microscope.

[0404] DNA extraction and PCR conditions For DNA extraction from plant leaf samples, two methods were used: a rapid DNA extraction method to provide less pure DNA samples, and a more comprehensive DNA extraction method for purer DNA, modified from Kim et al. (2016). In the first method, four glass beads with a diameter of 2 mm (Sigma, 273627), 1-2 mg of rice leaf tissue, and 150 μl of extraction buffer (10 mM Tris, pH 9.5, 0.5 mM EDTA, 100 mM KCl) were added to each well of a 96-well PCR plate. The plate was sealed, and the mixture was homogenized for 1 minute using a Mini-Beadbeater-96 mixer (GlenMills, 1001). After centrifuging the plate at 3000 rpm for 5 minutes, aliquots of the supernatant containing the extracted DNA were used in the PCR reaction.

[0405] In the second method, each 0.2 g leaf sample was cooled in liquid nitrogen for 10 minutes in a 1.5 ml Eppendorf tube with two 2 mm diameter glass beads. The samples were then homogenized in a Mini-Beadbeater-96 for 1 minute, and 600 μl of DNA extraction buffer (2% SDS, 0.4 M NaCl, 2 mM EDTA, 10 mM Tris-HCl, pH 8.0) was added to each tube. The mixtures were incubated at 65°C for 1 hour. After cooling, 450 μl of 6 M NaCl was added to each tube. The tubes were vortexed and centrifuged at 12000 rpm for 20 minutes. The supernatants were transferred to new tubes, and the DNA was precipitated using an equal volume of 2-propanol at -20°C for 1 hour. The DNA was recovered by centrifugation at 2400 rpm at 4°C for 20 minutes, and the pellet was washed twice with 75% ethanol. The pellets were air-dried at room temperature, and each was resuspended in 600 μl of distilled water containing 10 ng / μl of ribonuclease (Thermo Scientific, EN0201) for use in the PCR reaction.

[0406] In the PCR reaction, 5 μl of 2× PCR buffer containing Taq polymerase (Thermo Scientific, K0171), 5' and 3' oligonucleotide primers, and 1 μl of DNA sample were used in a total volume of 10 μl. Amplification was performed using 35 cycles of 30 seconds at 94°C, 30 seconds at 55°C, and 30 seconds at 72°C. The amplified products were analyzed by gel electrophoresis using a 3% agarose gel. In the control PCR reaction, DNA preparations from homozygous Zhonghua 11 (ZH11) plants or grains, which are the parent wild-type Japonica rice variety, DNA preparations from homozygous NJ6 plants, which are the wild-type Indica rice variety, and a mixture of DNA from ZH11 and NJ6 were used.

[0407] For gene mapping of the ta1 allele, PCR amplification of the gene marker was performed using the following primer pairs (5' to 3' sequences): Indel 559 (positions 25, 149, and 249 on chromosome 5), forward primer TTATCAGCTTCTCGGTTCATCCAA (SEQ ID NO: 50), reverse primer AAACAGGGTTAGCAATTTCGTTTT (SEQ ID NO: 51); Indel 548 (positions 25, 265, and 533 on chromosome 5), forward primer TCTGTCCCATATATACAACCG (SEQ ID NO: 52), reverse primer ATTTGTGTTTCAATCCTATATA (SEQ ID NO: 53); Indel 562 (positions 25, 237, and 218 on chromosome 5), forward primer GGTCCTTTCAAACACTCCACA (SEQ ID NO: 54), reverse primer CCAACTTTGCCTTAGCATTCA (SEQ ID NO: 55); Indel 583 (positions 25, 265, and 326 on chromosome 5), forward primer ACTACTCCCTATTTCTGTATTCACT (SEQ ID NO: 56), and reverse primer GAGCGTCATGGTTCACCTCTT (SEQ ID NO: 57) were used.

[0408] TILLING SAVE The primers used in the tilling assay had the following nucleotide sequences: TA1-1F:CATTCATAATGACCAGCTAGGTGCT (SEQ ID NO: 98) and TA1-1R:GAGTTGAAACATGCCTGTACTCCTG (SEQ ID NO: 99). PCR amplification with ExTaq was performed under the following reaction conditions: for each 1kb amplicon length, 2 minutes at 95°C; 20 seconds at 94°C, 30 seconds at 68°C (decreasing by 1°C per cycle); and 60 seconds at 72°C, followed by 35 cycles for each 1kb amplicon length, 20 seconds at 94°C, 30 seconds at 60°C; and 60 seconds at 72°C, followed by a final extension of 5 minutes at 72°C. The PCR products from wild-type and test samples were mixed and subjected to a complete denaturation-slow annealing program to form heteroduplexes under the following conditions: 10 minutes at 99°C for denaturation, followed by 70 tapering cycles, each starting at 70°C for 20 seconds and decreasing by 0.3°C per cycle, and then held at 15°C to re-anneal the denatured PCR products and form heteroduplexes. The annealed PCR product was digested with CelI in a 15 μL reaction mixture containing CelI buffer (10 mM HEPES, pH 7.5, 10 mM KCl, 10 mM MgSO4, 0.002% Triton X-100, and 0.2 μg / mL bovine serum albumin (BSA)), 4 μL of the PCR product, and, if the PCR product was polymerized by Ex Taq, 1 unit of CelI (10 units / μL), or if the PCR product was polymerized by KOD, 20 units of CelI, at 45°C for 15 minutes, followed by the addition of 2 μL of 0.5 M EDTA (pH 8.0) to stop the reaction. Alternatively, digestion was performed with MBN buffer (20 mM Bis-Tris, pH 6.5, 10 mM MgSO4, 0.2 mM ZnSO4, 0.002% Triton X-100). The reaction was carried out at 60°C for 30 minutes in a 15 μL reaction mixture containing 4 μL of PCR product and 2 units of mangubean nuclease (MBN, 10 units / μL, catalog number M0250S; New England Biolabs, USA) in X-100 and 0.2 μg / mL BSA, followed by the addition of 2 μL of 0.2% SDS to stop the reaction.

[0409] The total CelI digestion PCR products were subjected to electrophoresis in a 2% agarose gel to detect mutations.

[0410] High-resolution DNA melting curve (HRM) analysis Young leaf tissue (2 mm × 2 mm) was homogenized in the wells of a 96-well plate using glass beads (2 mm diameter) in 150 μL of lysis buffer containing 10 mM Tris (pH 9.5), 0.5 mM EDTA, and 100 mM KCl, and homogenization for DNA extraction was performed as described above. PCR was performed in a volume of 10 μL with the following: 5 μL of 2 × master mix (Roche, catalog no. 04909631001), 10 μM forward primer, 10 μM reverse primer, 1.0 μL of 25 mM MgCl2, and 1.5 μL of DNA template. The mixture was cycled at 95°C for 10 minutes, then subjected to 45 cycles at 95°C for 10 seconds each, followed by annealing at 53°C for 15 seconds and 72°C for 15 seconds. Next, the following denaturation program: 95°C for 60 seconds, 40°C for 60 seconds, 65°C for 1 second, 97°C for 1 second; gradient 4.4°C / second, duration 60 seconds, target temperature 95°C.

[0411] Research on the single-strand DNA binding function of TA1 As described below, the TA1 gene product was identified as a mitochondrial targeted single-stranded DNA (mtSSB) binding protein. To study the function of the TA1 polypeptide in single-stranded DNA (ssDNA) binding, purified recombinant TA1 protein fused with a 6xHis tag was analyzed by electrophoretic mobility shift assay (EMSA) to determine the affinity of the purified recombinant TA1 protein to ssDNA.

[0412] Expression of His-tagged TA1 protein in E. coli A 621 bp protein-coding region (SEQ ID NO: 2) of the mature TA1 protein was amplified by PCR and cloned into a pET-30a vector (Novagen, catalog number 69909-3), and the desired orientation of the gene insertion relative to the promoter on pET-30a was confirmed. This construct was named pET-30a-TA1. pET-30a-TA1 contained a 6xHis tag derived from the pET-30a vector, which translated and fused at the N-terminus of the expressed TA1 polypeptide, enabling binding to a nickel column. Recombinant TA1 was expressed in Transetta (DE3) chemical component E. coli cells (Transgen, catalog number CD801) and grown overnight in LB medium. The cells were lysed by heating at 100°C for 5 minutes in 1×SDS loading buffer (12 mM Tris pH 6.8, 5% glycerol, 0.4% SDS, 1% β-mercaptoethanol, 0.02% bromophenol blue). Soluble proteins were fractionated on an SDS-PAGE gel (Bio-Rad) by electrophoresis and transferred to a PVDF membrane (Bio-Rad). Recombinant proteins were then visualized using a monoclonal antibody against the 6xHis tag (Marine Biological Laboratory) by Western blotting.

[0413] Analysis method Grains, food components, and approximations and other major components within food samples were determined using standard methods, for example, as described below.

[0414] The moisture content of the grains was measured according to the Association of Official Analytical Chemists (AOAC) method 925.10. Briefly, approximately 2 g of grain samples were dried in an oven at 130°C for approximately 1 hour until a constant weight was reached.

[0415] The ash content was measured according to AOAC method 923.03. The samples used for moisture content determination were ashed in a muffle furnace at 520°C for 15 hours.

[0416] Protein content of grains, food components, and food samples Protein content was measured according to AOAC method 992.23. Briefly, total nitrogen was analyzed by the Dumas combustion method using an automated nitrogen analyzer (Elementar Rapid N cube, Elementar Analysensysteme GmbH, Hanau, Germany). The protein content (g / 100g) of grain or food samples was estimated by multiplying the nitrogen content by 6.25.

[0417] Sugars, starches, and other polysaccharides The total starch content was measured according to AOAC method 996.11 using the enzymatic method described by McCleary et al. (1997).

[0418] The amount of sugar was measured according to AOAC method 982.14. Briefly, monosaccharides were extracted with aqueous ethanol (80% ethanol) and then quantified using an evaporative light scattering detector by HPLC using a polyamine-bonded polymer gel column with acetonitrile:water (75:25 v / v) as the mobile phase.

[0419] Total neutral non-starch polysaccharides (NNSPs) were measured by a slightly modified gas chromatography procedure of Theander et al. (1995), which included hydrolysis in 1 M sulfuric acid for 2 hours, followed by centrifugation.

[0420] Fructans (fructooligosaccharides) were analyzed using the method detailed in AOAC 999.03. Briefly, fructooligosaccharides were extracted into water and subsequently digested with a sucrase / maltase / invertase mixture. The resulting free sugars were then reduced with sodium borohydride and digested into fructose / glucose with fructanose. The liberated fructose / glucose was measured using p-hydroxybenzoic acid hydrazine (PAHBAH).

[0421] Fiber content Total dietary fiber (TDF) was measured according to AOAC method 985.29, and soluble and insoluble fiber (SIF) was measured according to AOAC method 991.43. Briefly, TDF was determined by the gravimetric technique of Prosky et al. (1985) as detailed in AOAC method 985.29, and SIF was determined by the gravimetric technique as described in AOAC 991.43.

[0422] Total lipids A 5g powder sample was incubated with 1% clarase 40000 (Southern Biological, MC23.31) at 45°C for 1 hour. Lipids were extracted from the sample into chloroform / methanol by multiple extractions. After centrifugation to a separate phase, the chloroform / methanol fraction was removed, and the lipids were recovered by drying at 101°C for 30 minutes. The mass of the remaining residue represented the total lipids in the sample (AOAC method 983.23).

[0423] Lipid fatty acid profile Lipids were extracted from the milled powder in chloroform according to AOAC method 983.23. After adding an aliquot of heptadecanoic acid as an internal standard, a portion of the chloroform fraction containing lipids was evaporated under a stream of nitrogen. The residue was suspended in 1% sulfuric acid in dry methanol, and the mixture was heated at 50°C for 16 hours. The mixture was diluted with water and extracted twice with hexane. The combined hexane solution was loaded onto a small Florisil column, washed with hexane and fatty acid methyl esters, and then eluted with 10% ether in hexane. The eluate was evaporated and dried, and the residue was dissolved in isooctane and injected onto a GC. Fatty acid methyl esters were quantified against a standard mixture of fatty acids. GC conditions: Column SGE BPX70 30m × 0.32mm × 0.25μm; Injection 0.5μL; Injector 250°C; 15:1 split; Flow rate constant flow rate 1.723ml / min; Oven 0.5 minutes at 150°C, up to 180°C at 10°C / min, up to 220°C at 1.5°C / min, up to 260°C at 30°C / min, total run time 33 minutes; Detector FID at 280°C.

[0424] Antioxidant activity (ORAC-H) Hydrophilic antioxidant activity (ORAC-H) was determined according to the method of Huang (2002a and 2002b), as modified as described by Wolbang et al. (2010). The sample was extracted for lipophilic antioxidants, followed by hydrophilic antioxidants by weighing 100 mg of the sample three times into a 2 mL microcentrifuge tube. Then, 1 mL of hexane:dichloromethane (50:50) was added, and the mixture was vigorously mixed for 2 minutes, followed by centrifugation at 13,000 rpm for 2 minutes at 10°C. The supernatant was transferred to a glass vial, and the pellet was re-extracted with an additional 2 mL of hexane:dichloromethane mix. The mixing and centrifugation steps were then repeated, and the supernatant was transferred to the same glass vial. The residual solvent from the pellet was evaporated under a gentle stream of nitrogen. Then, 1 mL of acetone:water:acetic acid mix (70:29.5:0.5) was added, and the sample was vigorously mixed for 2 minutes. Next, the mixture was centrifuged as described above, and the supernatant was used in the ORAC-H plate assay. The sample was diluted with phosphate buffer as needed. The area under the curve (AUC) was calculated and compared to the AUC value for the Trolox standard. The ORAC value is reported as μM Trolox equivalent / g sample.

[0425] phenol The total phenol content, as well as phenol in free, conjugated, and bound states, was determined after extraction according to a slightly modified method described by Li et al. (2008). Briefly, free phenol was extracted in 2 mL of 80% methanol by sonication in an 8 mL glass vial for 10 minutes, and then determined in a 100 mg sample. The supernatant was transferred to a second glass vial, and the extraction of the residue was repeated. The combined supernatant was evaporated and dried under nitrogen. The pH was adjusted to approximately 2 by adding 2 mL of 2% acetic acid, and then 3 mL of ethyl acetate was added, and phenol was extracted for 2 minutes with shaking. The vial was centrifuged at 2000 × g for 5 minutes at 10°C. The supernatant was transferred to a clean glass vial, and the extraction was repeated two more times. The combined supernatant was evaporated under nitrogen at 37°C. The residue was dissolved in 2 mL of 80% methanol and refrigerated.

[0426] Samples for conjugated phenol were treated for a free phenol assay for initial 80% methanol extraction. At this point, 2.5 mL of 2 M sodium hydroxide and a magnetic rod were added to the evaporated supernatant in a glass vial, and the glass vial was then filled with nitrogen and tightly capped. The vial was mixed and heated at 110°C for 1 hour with stirring. After cooling the sample on ice, it was extracted with 3 mL of ethyl acetate by shaking for 2 minutes. The vial was centrifuged at 2000 × g for 5 minutes at 10°C. The supernatant was discarded and the pH was adjusted to approximately 2 with 12 M HCl. Phenol was extracted using 3 × 3 mL of ethyl acetate aliquots as described for free phenol. The supernatants were combined, evaporated and dried under nitrogen at 37°C, and the residue was incorporated into 2 mL of 80% methanol and refrigerated.

[0427] The bound phenol was measured from the residue after methanol extraction of free phenol. 2.5 mL of 2 M sodium hydroxide and a magnetic rod were added to the residue, then the vial was filled with nitrogen and tightly capped. The vial was mixed and heated at 110°C for 1 hour with stirring. After cooling the sample on ice, it was extracted with 3 mL of ethyl acetate by shaking for 2 minutes. The vial was centrifuged at 2000 × g for 5 minutes at 10°C. The supernatant was discarded, and the pH was adjusted to approximately 2 with 12 M HCl. Phenol was extracted with 3 × 3 mL of ethyl acetate aliquots as described for free phenol. The supernatants were combined, evaporated and dried under nitrogen at 37°C, and the residue was incorporated into 2 mL of 80% methanol and refrigerated.

[0428] Total phenol was determined by adding 200 μL of 80% methanol to a 100 mg sample to moisten it, followed by hydrolysis. After adding 2.5 mL of 2 M sodium hydroxide and a magnetic rod, the vial was filled with nitrogen and tightly capped. The vial was mixed and heated at 110°C for 1 hour with stirring. After cooling the sample on ice, it was extracted with 3 mL of ethyl acetate by shaking for 2 minutes. The vial was centrifuged at 2000 × g for 5 minutes at 10°C. The supernatant was discarded, and the pH was adjusted to approximately 2 with 12 M HCl. Phenol was extracted with 3 × 3 mL of ethyl acetate aliquots as described for free phenol. The supernatants were combined, evaporated and dried under nitrogen at 37°C, and the residue was incorporated into 4 mL of 80% methanol and refrigerated.

[0429] The amount of phenol in the processed / extracted samples was measured using the Forinciocult assay for phenol determination. Standard curves were prepared using gallic acid standards at 0, 1.56, 3.13, 6.25, 12.5, and 25 μg / mL. 1 mL of the standard was added to a 4 mL glass tube. For each test sample, a 100 μL fully mixed sample aliquot was added to 900 μL of water in a 4 mL glass tube. Then, 100 mL of Forinciocult reagent was added to each tube, and each tube was immediately vortexed. 700 μL of 1 M sodium bicarbonate solution was added after 2 minutes and then mixed by vortexing. Each solution was incubated at room temperature in the dark for 1 hour, and then the absorbance was read at 765 nm. The results were expressed as μg gallic acid equivalents / g sample.

[0430] Fitate The determination of the phytate content of the powder sample was based on the method of Harland and Oberleas, as described in AOAC Official Methods of Analysis (1990). Briefly, 0.5 g of the powder sample was weighed and extracted with 2.4% HCl at room temperature for 1 hour using a rotary wheel (30 rpm). The mixture was then centrifuged at 2000 × g for 10 minutes, the supernatant was extracted, and diluted 20-fold with milli-Q water. An anion exchange column (500 mg Agilent Technologies) was placed on a vacuum manifold and conditioned for use according to the manufacturer's instructions. The diluted supernatant was then loaded onto the column, and non-phytate species were removed by washing with 0.05 M HCl. The phytes were then eluted with 2 M HCl. The collected eluate was digested using a heating block. The sample was cooled and the volume was increased to a maximum of 10 mL with milli-Q water. Phosphorus levels were determined by spectrophotometric analysis using molybdic acid and sulfonic acid staining, with absorbance readings at 640 nm. The phytophosphate was calculated using the following formula: Phytate (mg / g)=P conc*V1*V2 / (1000*sample weight*0.282) In the formula, P conc is the phosphorus concentration (μg / mL) as determined by spectrophotometric method, V1 is the volume of the final solution, V2 is the volume of the extracted phytate solution, and 0.282 is the conversion coefficient from phosphorus to phytate.

[0431] Estimation of total mineral content The total mineral content of the samples was determined by ash assay using AOAC methods 923.03 and 930.22. Approximately 2 g of powder was heated at 540°C for 15 hours, and the mass of the ash residue was then weighed. A 0.5 g whole grain sample was digested with 8 M nitric acid at 140°C for 8 hours using a tube block digester. The zinc, iron, potassium, magnesium, phosphorus, and sulfur content was then analyzed by inductively coupled plasma atomic emission spectrometry (ICP-AES) according to Zarcinas (1983a and 1983b).

[0432] Minerals were analyzed at CSIRO, Urbrae, Adelaide, South Australia; Waite Analytical Service (University of Adelaide, Waite, South Australia); and Dairy Technical Services (DTS, North Melbourne, Victoria). Elements were determined at CSIRO by inductively coupled plasma emission spectrometry (ICP-OES) after digestion with nitric acid solution, or at DTS by ICP-AES after digestion with dilute nitric acid and hydrogen peroxide, or with nitric acid / perchloric acid solution.

[0433] vitamin Vitamin B3 (niacin), B6 ​​(pyridoxine), and total folate analysis were performed by DTS and the National Measurement Institute (NMI). Niacin was measured according to Lahey, et al. (1999) using AOAC Methods 13th Ed (1980) 43.045. Pyridoxine was measured according to Mann et al. (2001). The method incorporated phosphorylation into pyridoxine (pyridoxol) and pre-column conversion of the free vitamin B6 form. Pyridoxamine was converted to pyridoxal by dephosphorylation using acid phosphatase hydrolysis, followed by deamination with glyoxylic acid in the presence of Fe2+. Pyridoxal was then reduced to pyridoxine with sodium borohydride.

[0434] Folic acid was measured according to the VitaFast Folic Acid Kit, using the manufacturer's instructions, or according to the AOAC Method 2004.05.

[0435] Example 2. Isolation and Characterization of Thick Aleuron (ta) Mutants Establishment and cultivation of mutagenic rice populations Approximately 8,000 grains (referred to as M0 grains) from the wild-type rice variety Zhonghua 11 (ZH11) were mutagenicated using standard conditions by treatment with 60 mM ethyl methanesulfonate (EMS). The mutagenic grains were sown in the field, and the resulting plants were cultivated to produce M1 grains. The M1 grains were harvested and then sown in the field to produce M1 plants. 8,925 panicles were harvested from 1,327 individual M1 plants. From these plants, 36,420 M2 grains were screened, each panicle containing at least four grains.

[0436] Mutant screening by staining of half-grains The pericarp (endothelium and ectothelium) of M2 rice grains was removed. Each of the 36,420 grains was divided transversely. The half containing the embryo was stored in a 96-well plate for subsequent germination, and each half without an embryo was stained with Evans blue and observed under a dissecting microscope to detect mutant grains with thickened aleurons compared to the wild type. The staining was based on the principle that Evans blue can penetrate and stain only non-viable cells, such as starchy endosperm cells, and that no color change is observed within the viable aleuron layer. From initial Evans blue staining and histological analysis, individual grains showing a significant increase in aleuron thickness and grains showing significant thickening of the ventral aleuron of the seed were observed. Other grains showed an increase in aleuron thickness, but to a lesser degree. The unstained ventral region of each seed was specifically examined for the thickness of the aleuron layer. Furthermore, variants exhibiting an increased thickness of the aleuron layer on the dorsal side of the grain were observed. Only variants with a significant increase in aleuron layer thickness across the entire cross-section were selected for further analysis.

[0437] Compared to wild-type semi-grains, semi-grains with thicker unstained areas in Evans Blue were selected. Of the 36,420 grains examined, 219 grains (0.60%) exhibiting differences in alleuron thickness were identified and selected. These were obtained from 162 spikes from 140 individual M1 plants, and therefore, the majority represented independent mutants. In particular, one mutant grain with a mutation in the gene referred to as thick alleuron 1 (ta1) was identified and further characterized as described below. The corresponding wild-type gene is referred to as TA1, and this name is used herein. The mutant allele was referred to as ta1-1, as it was the first mutation identified within the TA1 gene.

[0438] To maintain the presumed mutant lines, each corresponding embryonated semi-grain was germinated on a medium containing semi-intensity MS salt medium (Murashige and Skoog, 1962) solidified with 1% Bacto agar (Bacto, 214030), and cultured at 25°C under a light intensity of 1500-2000 lux in a 16-hour light / 8-hour dark cycle. The small plants were transplanted to soil at the stage of 2-3 leaflets, and the resulting plants were grown to maturity. During the germination and cultivation of the corresponding embryonated semi-grains, 115 seeds (52.5% survival rate) were grown to produce mature, fertile plants.

[0439] Candidate mutant plants that showed little to no defects in general agricultural traits, such as normal plant height, fertility (male and female fertility), grain size, and grain weight per 1,000 grains compared to the wild-type parental variety, and that showed stable inheritance of the thickened aleuron trait, were identified, selected, and further analyzed. Of these, M3 generation grains showing 3 to 5 cell layers within at least a portion of the aleuron were selected and analyzed in detail, and the M3 generation grains had the ta1-1 mutant allele. Wild-type ZH11 grains showed 1 to 2 cell layers of aleuron around most of the grain, as expected.

[0440] Histological analysis of ta1-1 mutant grains We studied developing grains from wild-type ZH11 and homozygous ta1-1 mutant plants and compared their morphological changes 1 to 30 days post-pollination (DAP). The grain filling stage of rice can be described as having three stages: the milky grain stage, the dough grain stage, and the mature grain stage. In the dough grain stage, grains in wild-type panicles begin to change from green to yellow, followed by the gradual destruction of the vesicle tissue connecting the stalk and the spikelet. The color change was delayed in grains in ta1-1 panicles. Microscopic examination of cross-sections of rice grains also showed an increased degree of chalkiness (opacity) in ta1-1 mutant grains. Next, scanning electron microscopy (SEM) was used to study the structure of the starch granule tissue within the central portion of the starchy endosperm. In wild-type grains, starch granules were tightly packed, exhibiting a smooth surface and regular shape, while in ta1-1 grains, a looser packing of irregularly shaped starch granules was observed. In summary, at least three changes—delayed grain maturation, increased degree of grain chalkiness, and increased starch granule structure—were observed in plants and grains with the ta1-1 mutation.

[0441] Developing mutant and wild-type grains at DAP days 6, 7, 8, 9, 10, 12, 15, 18, 21, 24, 27, and 30 were stained with Evans blue, and the aleuron layer was examined by light microscopy. No significant difference in the thickness of the developing aleuron layer was observed between wild-type and ta1-1 mutant grains until DAP day 10. After DAP day 10, the aleuron layer of the ta1-1 mutant was thicker than that of the wild-type grain, and the difference reached its maximum at approximately DAP day 20. Figure 1 shows staining of seed sections with Lugol's reagent to highlight the starchy endosperm (Figure 1, panels E and F), as well as staining of near-ultrathin sections of seeds with PAS and Coomassie brilliant blue (G-250) to demonstrate the development of aleuron in wild-type (ZH11) and ta1-1 mutant grains at three developmental time points.

[0442] Wild-type and ta1-1 mutant grains (DAP day 30) were further examined for histological differences by thin sectioning (1 μm), staining, and light microscopy. After staining with 0.1% toluidine blue, which stains nucleic acids blue and polysaccharides purple, a single layer of large, regularly oriented rectangular cells was observed within the wild-type aleuron. In contrast, sections of ta1-1 mutant grains had an aleuron layer with 3 to 5 cell layers, and the cells also varied in size and irregular orientation. These observations indicated that the thickened aleuron within ta1-1 grains was primarily caused by an increase in the number of cell layers rather than an enlargement of individual aleuron cells.

[0443] Further staining with 0.01% chalcoflor white, a fluorescent cell wall stain, did not reveal any difference in cell wall thickness between wild-type and ta1-1 mutant grains within the aleuron layer. In both wild-type and ta1-1 grains, the cell walls of aleuron cells were thicker than the cell walls within the starchy endosperm.

[0444] Mature wild-type and ta1-1 grains were sectioned transversely and stained with PAS as described in Example 1. For 15 grains of each genotype, the thickness of the aleuron at the dorsal, superior, lateral, inferior, and ventral positions of the grain was calculated and counted as the number of cell layers, and statistically analyzed. The results are shown in Figure 2. For both wild-type and mutant grains, the number of cell layers was not uniform at five different positions on the mature grain, but at all positions, the number of cell layers for mutant grains was significantly greater than that for wild-type grains (P<0.01).

[0445] Grain filling during plant growth and development was examined by measuring the dry weight of the grain at DAP days 3, 6, 9, 12, 18, 26, 34, and 42, and compared with wild-type grains. The results (Figure 3) showed reduced grain filling for ta1-1 grains.

[0446] Analysis of the agricultural characteristics of ta1 mutant plants and grains The ta1-1 mutant plants were backcrossed in the field with wild-type (ZH11) plants for three generations to obtain BC3F3 generations, thereby removing any additional disconnected mutations that may have resulted from the mutagenic treatment, and analyzed for several agricultural traits. The ta1-1 mutant plants and their grains did not differ significantly from the wild-type plants and their grains in terms of plant height, length, width, and thickness, as well as grain size and glume morphology (Table 2). In contrast, the wild-type plants showed a fruiting rate of 98.90%, while the homozygous ta1-1 mutant plants showed a decrease in fruiting rate of 89.32%. Fruiting rate was calculated as the percentage of florets in the plant filled with seeds at the mature grain stage. Furthermore, ta1-1 mutant grains showed a 49.8% reduction in germination ability compared to 97.3% of wild-type grains when cultured in a growth chamber at 28°C under a 12-hour light / 12-hour dark cycle without humidity control. Germination was defined as the visible emergence of the root through the seed coat. [Table 2]

[0447] Example 3. Genetic analysis of the ta1-1 mutation Crosses were performed to determine the genetic control of the ta1 mutation, particularly whether the mutation was dominant or recessive, and whether it was inherited from one or both of the male and female parents. Two genetic experiments were performed to determine whether the thick aleurone phenotype was maternally determined. First, a test cross was performed between maternal homozygous ta1-1 plants and pollen from wild-type ZH11 plants. F2 offspring grains were obtained. Of the F2 grains, 24.1% (n=1093) showed the thick aleurone phenotype, which is consistent with the 3:1 (wild-type:mutant) ratio predicted for Mendelian inheritance of recessive nuclear-coded mutations in the F2 population. 98.7% (n=218) of the F1 seeds were observed to have the wild-type aleurone phenotype, while the remaining 1.3% of the seeds, though difficult to score, were found to have the wild-type aleurone in the F2 generation. Secondly, cross-pollination was performed using pollen from ta1-1 plants, which were applied as the female parent to the wild-type plants. From the cross-pollination, 99.7% (n=325) of the F1 seeds exhibited the wild-type alleuron phenotype. These data indicated that the thick alleuron phenotype of ta1-1 was controlled by a single nuclear gene in which the mutant allele was recessive relative to the wild-type allele.

[0448] Example 4. Analysis of nutritional components in ta1-1 mutant grains To measure the composition of mutant grains, particularly their nutritionally important components, ZH11 and homozygous ta1-1 plants were grown simultaneously in the field under the same conditions. Whole grain flour samples, also referred to herein as whole grain flour or brown rice flour, were prepared from grains harvested from the plants and used for compositional analysis using the method described in Example 1. The results of the approximate analysis of the flours are shown in Table 3, representing the average of the double-repeated measurements.

[0449] Approximate analysis showed an approximately 30% increase in total fat content in ta1-1 mutant flour. Total nitrogen analysis did not show a significant change in protein levels between ta1-1 mutant grains and wild-type grains. Ash assay, which measured the amount of material remaining after burning dehumidified flour samples, demonstrated a 20% increase in ta1-1 grains compared to wild-type. Total fiber levels increased by approximately 94% in ta1-1 grains. Starch content decreased by 5% in ta1-1 grains compared to wild-type. These data demonstrate that the increased thickness of the aleurone layer in the ta1-1 mutant led to increased levels of aleurone-rich nutrients, such as lipids, minerals, and total dietary fiber, without altering seed size. To understand these and other changes in more detail, extensive analyses were performed as follows. [Table 3]

[0450] Further compositional analysis was recorded in Figure 4, and this analysis confirmed a statistically significant increase in protein, dietary fiber, calcium, iron, zinc, vitamin B2, and vitamin B3 in the brown rice flour.

[0451] mineral To measure mineral content, ICP-AES, a combination of inductively coupled plasma (ICP) and atomic emission spectrometry (AES) techniques, was used (Example 1). This is a standard method for measuring mineral content and provided high-sensitivity, high-throughput quantification of multiple elements in a single analysis. Data obtained from the analysis showed that ta1-1 mutant grains had zinc levels that increased by approximately 15%, from 13.9 mg / kg to 15.68 mg / kg. In the same sample of ta1-1 whole grain flour grown in the field, iron increased by 5%, from 12.43 mg / kg to 13.03 mg / kg.

[0452] Furthermore, increases in potassium, magnesium, phosphorus, and sulfur were observed, rising by approximately 26%, 23%, 22%, and 10%, respectively. These results are consistent with the increased ash content in ta1-1 grains, which is largely due to the measurement of minerals.

[0453] antioxidants Antioxidants are biomolecules capable of counteracting the negative effects of oxidation in animal tissues, and therefore protect against oxidative stress-related diseases, such as inflammation, cardiovascular disease, cancer, and age-related disorders (Huang, 2005).

[0454] The antioxidant capacity of whole grain flour obtained from ta1-1 mutant and wild-type rice grains was measured by the oxygen radical absorption capacity (ORAC) assay, as described in Example 1. In the ORAC assay, antioxidant capacity is represented by the cokinetics between endogenous radical-scavenging biomolecules and the oxidizable molecule fluorescent probe fluorescein against synthetic free radicals produced by AAPH (2,2'-azobis(2-amidino-propane) dihydrochloride). Antioxidant capacity was calculated by comparing the area under the motion curve (AUC) representing the fluorescence degradation kinetics of the molecular probe fluorescein for grains with the AUC generated by the Tororox standard (Prior, 2005). An alternative method for quantifying antioxidant capacity is the method using the Forin-Siocart reagent (FCR), which represents antioxidant capacity by measuring the antioxidant capacity of the total phenolic compounds in the food sample. The FCR assay was relatively simple, convenient, and reproducible. However, the more time-consuming ORAC assay measured more biologically relevant activities. Because antioxidants include a broad range of polyphenols, reducing agents, and nucleophiles, measurements by both FCR and ORAC provide better coverage of total antioxidant capacity and can represent total antioxidant capacity more comprehensively. As reported by Prior (2005), the results of FCR assays and ORAC measurements are usually in agreement.

[0455] Both FCR and ORAC assays demonstrated increased antioxidant capacity in flour from ta1-1 mutant whole grain flour compared to wild-type ZH11 whole grain flour. ORAC demonstrated an approximately 46% increase in antioxidant capacity and a 30% increase in total phenols within ta1-1 mutant grains.

[0456] Fitate When grown under conditions with adequate phosphorus, approximately 70% of the total phosphorus content in rice grains is in the form of phytates or phytic acid (myo-inositol-1,2,3,4,5,6-hexaphosphate). Dietary phytes can also play a beneficial role in health as potent antioxidants (Schlemmer, 2009). Total phytate analysis showed an approximately 15% increase in phytate content in ta1-1 grains, from approximately 10.8 mg / g to approximately 12.4 mg / g compared to wild-type ZH11 grains.

[0457] B vitamin The levels of vitamins B3 (niacin), B6 ​​(pyridoxine), and B9 (forate) in ta1-1 flour were approximately 9%, 120%, and 61%, respectively, higher than in wild-type flour. Since the aleurone is known to be richer in vitamins B3, B6, and B9 than the endosperm (Calhoun, 1960), the increased aleurone thickness in ta1-1 mutant grains may have resulted in a more potent sink for these vitamins and possibly other vitamins.

[0458] carbohydrates On a weight basis, there was a 6% decrease in starch content in ta1-1 grains. In contrast, sucrose levels increased by 76% in the mutant grains. Compared to the wild type, neutral non-starch polysaccharides (NNSPs) increased by 48%, and all monosaccharide components of NNSPs (arabinose, xylose, galactose, glucose) increased by 42% to 59%.

[0459] conclusion Nutritional analysis showed that whole grain flour produced from field-grown ta1-1 grains, and therefore whole grain flour, showed significant increases in most aleurone-rich nutrients compared to wild-type flour, including macronutrients such as lipids and fiber, micronutrients such as minerals including at least iron, zinc, potassium, magnesium, phosphorus, and sulfur levels, B vitamins such as B3, B6, and B9, antioxidants, and aleurone-related biomolecules such as phenolic compounds and phytes. There was also a significant increase in free sucrose. Accompanying these increases in nutrients and micronutrients was a small decrease in starch content within the ta1-1 mutant, expressed as a relative percentage by weight.

[0460] Example 5. α-amylase activity assay of ta1-1 mutant grains During cereal seed germination, α-amylase produced from the aleurone layer after water absorption plays a crucial role in the hydrolysis of endosperm starch into metabolizable sugars, providing energy for root and seedling growth (Akazawa and Hara-Mishimura, 1985; Beck and Ziegler, 1989). Since ta1 mutant grains had an increased aleurone cell layer, the α-amylase activity of germinated rice grains was assayed over several days. The assay was performed using an amylase activity assay kit (Sigma, MAK009), and the detailed procedure was as follows.

[0461] Sample preparation Each 100 mg germinated rice grain was dissected, and seedlings were removed. The remaining endosperm and aleurone tissue were homogenized in 0.5 mL of amylase assay buffer, and the mixture was centrifuged at 13,000 g for 10 minutes to remove insoluble material. 1–50 μL of the sample was added to each well of a 96-well plate, and each sample was diluted to a volume of 50 μL with amylase assay buffer. For the positive control, 5 μL of amylase positive control solution was used and adjusted to 50 μL with amylase assay buffer. Standards consisting of 0, 2, 4, 6, 8, and 10 μL of 2 mM nitrophenol standard per well were diluted to a volume of 50 μL to produce standards of 0, 4, 8, 12, 16, and 20 nmol / well.

[0462] Assay reaction 1. The master reaction mix was prepared by mixing 50 mL of amylase assay buffer with 50 mL of amylase substrate mix.

[0463] 2,100 μL of the master reaction mix was added to each of the sample, standard, and positive control wells, and each sample was mixed by pipetting.

[0464] 3.2-3 minutes later (Tinitial), the absorbance was measured at 405 nm and referred to as (A405)initial.

[0465] 4. The plates were incubated at 25°C, and the absorbance (A405) was measured every 5 minutes. The plates were protected from light during incubation.

[0466] 5. Measurements were taken until the value of the most active sample exceeded the value of the highest-performing standard (20 nmol / well). At this point, the most active sample was near the edge of the linear range of the standard curve.

[0467] 6. The final absorbance measurement [(A405)final] used to calculate enzyme activity was the value obtained just before the most active sample was near the edge of the linear range of the standard curve. The time of the penalty metric reading was referred to as Tfinal.

[0468] The final measurement value (A405)final obtained for the nitrophenol standard was corrected for the background by subtracting it from the (A405)final measurements of the standard and sample. The change in absorbance from Tinitial to Tfinal was calculated as follows: ΔA405 = (A405)final - (A405)initial

[0469] The ΔA405 of each sample was compared with a standard curve to determine the amount of nitrophenol (B) produced by amylase between the initial and final stages. The amylase activity of each sample was determined by the following formula: Amylase activity = B × sample dilution factor (Reaction time) × V B = Amount of nitrophenol produced between Tinitial and Tfinal (nmol) Reaction time = Tfinal - Tinitial (minutes) V = Sample volume added to the well (mL)

[0470] The amylase activity for each sample was reported as nmol / min / mL (milliliters). One unit of amylase was defined as the amount of amylase produced by cleaving ethylidene-pNP-G7 and producing 1.0 μmol of p-nitrophenol every minute at 25°C.

[0471] The assay results (Figure 5) showed that germinated ta1-1 grains exhibited higher α-amylase activity compared to ZH11 from day 3 onwards, with the degree of increase increasing over time and reaching its maximum on day 7 after the start of water absorption (DAG).

[0472] Example 6. Identification of the TA1 gene and ta1-1 mutations by gene mapping and sequence analysis. Identification and use of SSR and Indel markers for gene mapping For gene mapping, F2 populations of plants were produced from genetic crosses between plants containing the ta1-1 mutation within the genetic background of the Japonica variety ZH11 and plants of the Indica variety NJ6. A set of PCR experiments were performed on leaf DNA samples from homozygous ZH11 plants, homozygous NJ6 plants, and a 1:1 mixture of DNA to identify polymorphic genetic markers between ZH11 and NJ6 that could then be used in gene mapping. Analysis of PCR products by gel electrophoresis allowed for comparison of products from ZH11, NJ6, and the mixture to identify polymorphic markers. Primer pairs were selected for gene mapping only if amplification on separate ZH11 and NJ6 DNA showed separate and distinct amplification products, and the mixed DNA showed a combination of both products. A total of 124 primer pairs were selected, including 54 insertion-deletion polymorphisms (INDELs) and 70 short sequence repeat (SSR) polymorphisms. These gene markers were distributed along the US genome at intervals of approximately 3–4 Mbp, providing good coverage for gene mapping.

[0473] For gene mapping of the ta1-1 allele, 132 plants from the F2 population were scored using 124 polymorphic markers. Homozygosity or heterozygosity of individual F2 plants within the mapping population for alleuron phenotype was carefully assessed by phenotyping of F3 offspring grains obtained from each F2 plant. Leaf DNA was extracted as described in Example 1. PCR amplification was performed as described in Example 1, and the products were separated via 3% agarose by gel electrophoresis. From the results, it was concluded that the ta1 locus was located between markers Indel 537 and Indel 541 on chromosome 5 (Figure 6), which corresponds to a physical distance of approximately 400 kb from the rice genome sequence.

[0474] Another 8000 F2 plants were screened for this marker pair. 1076 individuals showing recombination between the Indel 537 and Indel 541 markers were identified and selected. When these recombinant plants were phenotyped, the ta1 locus was mapped to a 28kb region located between the Indel 562 and Indel 583 markers (Figure 6).

[0475] To obtain the nucleotide sequence of this region in ta1-1 mutant plants and compare it with the wild-type sequence, primers adjacent to the genomic region were designed and DNA sequencing was performed to identify the mutation corresponding to the ta1-1 allele. Genomic DNA sequence comparison identified single nucleotide polymorphisms (SNPs) within the sequenced region of the gene annotated as Os05g0509700 on the US genome sequence (EnsemblPlants). This gene is located at chromosome 5: 25, 254, 990~25, 259, 747, and its reverse strand was annotated with a mitochondrial ssDNA-binding protein. For the protein linked to the Japonica gene Os05g0509700, the same gene was annotated as LOC_Os05g43440 on the UniPARC genome sequence. The A polymorphism from a single nucleotide G (wild type) was identified at nucleotide position Chr5:25257622, ​​referencing the Japonica variety EnsemblPlants US genome sequence. Referring to Sequence ID No. 4, this nucleotide substitution G2126A was the last nucleotide of intron IV between exons 4 and 5 of the gene Os05g0509700 on chromosome 5 (Figure 6, bottom line). Intron numbering was performed from the protein-coding region annotation of Os05g0509700, but did not include the long intron in the 5'-UTR of the gene. Since the mutation involves the last nucleotide of an intron within a splice site, the inventors believed the mutation involved a disruption of splicing in the TA1 gene. Subsequent experiments described below confirmed that this polymorphism is a ta1-1 mutation.

[0476] This experiment also showed that the ta1-1 mutation can be introduced into different genetic backgrounds, such as the Indica variant, and still conferred the thick aleurone phenotype.

[0477] Example 7. Properties of the ta1-1 mutation To analyze the expression and splicing of the ta1-1 gene, RNA was extracted from leaves and grains were developed from ta1-1 plants, as described in Example 1. The RNA was combined and reverse transcribed to obtain the nucleotide sequences of individual cDNAs. Three different cDNA sequences were obtained from the ta1-1 cDNA, designated ta1-1 cDNA I, II, and III, and each of ta1-1 cDNA I, II, and III had a sequence different from the wild-type cDNA sequence from ZH11. Comparison of the ta1-1 cDNA nucleotide sequence with the wild-type cDNA (SEQ ID NO: 2) showed that the G-to-A polymorphism (G2126A) in intron IV at nucleotide position 2126 associated with three different mature mRNAs in the ta1-1 grain. From this analysis and further analyses described below, the inventors concluded that these variants arose due to alternative splicing of the ta1 transcript.

[0478] Three ta1-1 transcripts were further analyzed by RT-PCR using oligonucleotide primers (SEQ ID NOs. 58 and 59) targeting the mutation site, and therefore the alternative splicing region. The PCR products were then recovered and cloned into a Blunt vector, followed by nucleotide sequencing of the individual clones. Figure 7 shows the aligned sequences of the cDNA regions targeting the mutation site, aligned with the wild-type cDNA sequence. cDNAs I, II, and III had identical nucleotide sequences to the wild-type cDNA up to the end of exon 4, i.e., the start of intron IV. However, differences were then observed at either the insertion of the last 31 nucleotides in intron IV within cDNA I, or the deletion of the exon 5 sequence (cDNA II), or the deletion of a single nucleotide from the start of exon 5 (cDNA III). ta1-1 cDNA I (SEQ ID NO: 12) had a 31 bp insertion immediately before exon 5, so this cDNA encoded the polypeptide (SEQ ID NO: 8). This polypeptide (SEQ ID NO: 8) resulted from a translational frameshift at amino acid position 182 relative to the amino acid sequence of the wild-type TA1 protein (SEQ ID NO: 3), resulting in a translational termination codon at position 193. ta1-1 cDNA II (SEQ ID NO: 13) had a deletion of the entire exon 5, so this cDNA encoded the polypeptide (SEQ ID NO: 9). This polypeptide (SEQ ID NO: 9) resulted from a translational frameshift at amino acid position 182, resulting in a translational termination at position 186. ta1-1 cDNA III (SEQ ID NO: 14) had a deletion of the first G nucleotide in exon 5, so this cDNA encoded a polypeptide (SEQ ID NO: 10), which, compared to the wild-type TA1 protein, resulted from a translational frameshift at position 182 and led to premature translation termination at amino acid position 185. In Figure 8, the predicted full-length amino acid sequence was compared with the wild-type TA1 sequence.

[0479] The relative abundances of ta1-1 I, II, and III cDNAs were 67%, 29%, and 4% of the total transcript, respectively. Wild-type transcripts were not detected in the leaves and developing grains of ta1-1 mutant plants by cDNA analysis, leading the inventors to conclude that this wild-type splicing had disappeared from the absence of wild-type mRNA in the mutant plants. These data, confirmed by the experiments described below, led to the conclusion that a polymorphism in intron IV of the ta1-1 gene caused the change, i.e., the ta1-1 mutation in this plant and its grains. Furthermore, it was concluded that the mutation resulted in a change in the splicing pattern of the RNA transcript of the ta1-1 gene compared to the wild-type TA1 gene, thereby causing the ta1 mutant phenotype for the ta1-1 allele.

[0480] The gene at position Os05g0509700 on chromosome 5 of the US genome is annotated with the US mtSSB-1a gene (OsmtSSB-1a), which is a homolog of the Arabidopsis thaliana mtSSB-1 gene (AtmtSSB-1) encoding a mitochondrial target single-stranded DNA binding protein (Edmondson et al., 2005).

[0481] The nucleotide sequence of the wild-type rice mtSSB-1a (TA1) gene is provided as Sequence ID No. 1, which includes a promoter and 5'-UTR (untranslated region) of 1024 nucleotides, a protein-coding region from nucleotides 1025-2369 containing five introns, and a 3'-UTR of 411 nucleotides. The nucleotide positions of the five introns are provided in the legend of Sequence ID No. 1. The nucleotide sequence of the cDNA corresponding to the wild-type TA1 (OsmtSSB-1a) gene is provided as Sequence ID No. 2, and the amino acid sequence of the 206-amino acid encoded wild-type TA1 polypeptide is provided as Sequence ID No. 3.

[0482] Description of structural characteristics within the wild-type rice TA1 polypeptide. After finding that the US TA1 gene is identical to OsmtSSB-1a, we examined the amino acid sequence of the OsTA1(OsmtSSB-1a) polypeptide. We identified a typical single-stranded DNA-binding domain corresponding to amino acids 73-184 of SEQ ID NO: 3 (Figure 9). We compared the amino acid sequence to the most homologous sequence encoded by the genomes of seven other plant species, generally representative of angiosperms, namely Zea mays (SEQ ID NO: 16), Sorghum bicolor (SEQ ID NO: 17), Hordeum vulgare (SEQ ID NO: 18), Triticum aestivum (SEQ ID NO: 19), and the cereal-related model monocotyledon Brachypodium distachyon (SEQ ID NO: 20), the model dicotyledon Arabidopsis thaliana (SEQ ID NO: 15), and the model tree poplar (SEQ ID NO: 21) (see Example 12). Fully assembled and annotated genome sequences were available for these species. When the mtSSB amino acid sequences were aligned (Figure 9), the SSB domain was found to be more conserved than the N-terminal and C-terminal adjacent sequences, exhibiting at least 80% identity across 112 amino acids of the OsTA1 SSB domain. The overall amino acid sequence identity with the full length of Sequence ID No. 3 was at least 60% and included at least 79% for monocotyledonous TA1 sequences.The SSB domains for the nine TA1 polypeptides shown in Figure 9 are the conserved amino acid motif FRGVHRAI(I / L)CGKVGQ(V / A)P(V / L)QKILRNG(R / H)T(V / I)T(V / I)FT(V / I)GTGGMFDQR (motif I, SEQ ID NO: 45) corresponding to amino acids 73-114 of SEQ ID NO: 3, and P(K / M)PAQWHRI(A / The motifs included S)(V / I)H(N / S)(D / E) (Motif II, SEQ ID NO: 46), AVQ(K / Q)L(V / T)KNS(A / S)VY(V / I)EG(D / E)IE(T / I)R(V / I)YND (Motif III, SEQ ID NO: 47), corresponding to amino acids 141-164 of SEQ ID NO: 3, and IC(L / V / I)R(R / G)DGKI (Motif IV, SEQ ID NO: 48), corresponding to amino acids 176-184 of SEQ ID NO: 3. These four motifs were completely conserved within all nine aligned TA1 sequences, with spacing between each motif except for the poplar sequence (Figure 9). It was concluded that the four motifs and their spacing may be necessary for the complete function of the TA1 polypeptide in plants.

[0483] When the amino acid sequence of OsmtSSB-1a (SEQ ID NO: 3) was analyzed using Mitofates software with a plant setting, the mitochondrial protease cleavage site was predicted between amino acids 28 and 29 of SEQ ID NO: 3 (Figure 9). This predicted the presence of a 28-amino acid mitochondrial transport peptide at the N-terminus of the polypeptide, which is removed upon entry into mitochondria within rice cells to produce a mature polypeptide of 178 amino acids. This predicted site was aligned to a single amino acid residue by comparing it with the prediction for the Arabidopsis sequence of AtmtSSB-1 (Edmondson et al., 2005).

[0484] It was found that the last three amino acids (GKI) of the DNA-binding domain of the wild-type OsTA1 (OsmtSSB-1a) polypeptide were missing from the predicted translation products of ta1-1 cDNA I, II, and III (Figure 6), as well as from the C-terminal region of the TA1 polypeptide after the DNA-binding domain.

[0485] Example 8. Expression of the TA1 gene in the US Experiments were conducted to analyze the expression of the TA1 gene in different rice tissues, specifically the embryo, starchy endosperm, and aleurone, within developing grain segments. In the first experiment, TA1 mRNA was detected in rice tissue sections by insight hybridization, as described by Brewer et al. (2006). Briefly, various rice tissues were fixed in FAA fixative for 8 hours at 4°C after vacuum immersion, dehydrated using a stepwise series of ethanol followed by a series of xylene, and embedded in Paraplast Plus (Sigma-Aldrich) as described in Example 1. Microtome sections with a thickness of 8 μm were placed on Probe-On Plus microscope slides (Fisher).

[0486] Hybridization signaling concluded that the TA1 gene is expressed in the developing seed coat, aleurone tissue, and embryo of the grain, but not in the vascular bundles. TA1 was also expressed in the developing inflorescence, but not in the leaves and stems.

[0487] Relative expression levels in different plant tissues were assayed using real-time reverse transcription polymerase chain reaction (RT-PCR). Expression levels were normalized to the expression of actin genes, which are constitutively expressed genes within the same tissue. Surprisingly, the results showed the highest relative expression in pollen, followed by relative expression in the embryo, shoot apical meristem, and aleurone tissue (Figure 10). Specific expression of TA1 in active growth tissues was thought to be involved in cell division. As a predictive SSB protein, the TA1 protein was thought to function in these active growth tissues to protect single-stranded DNA and recruit other related proteins during DNA replication, recombination, transcription, and DNA repair.

[0488] Example 9. ssDNA binding activity of TA1 protein Purification of TA1 fusion protein To test the DNA-binding activity of the TA1 polypeptide in vitro, a recombinant TA1 fusion protein (6xHis-TA1) having a 6xHis tag at its N-terminus was produced from an expression vector in E. coli as described in Example 1. The incorporation of the 6xHis tag allowed for rapid and simple purification of the fusion protein by binding to a nickel column. E. coli cells expressing the fusion protein were disrupted by freezing in liquid nitrogen, thawing on ice, and sonicating for 30 minutes (5-second pulses at 10-second intervals). The 6xHis-TA1 protein was enriched by 40% ammonium sulfate precipitation in potassium phosphate buffer. The precipitated protein was resuspended and dialyzed overnight in sodium phosphate buffer (50 mM NaPO4, 500 mM NaCl, pH 7.8). The protein was then loaded onto a nickel column (Bio-Rad) and broadly washed with sodium phosphate buffer containing 10 mM imidazole to remove unbound proteins. The purified 6xHis-TA1 protein was isolated from the column using a linear gradient of imidazole in sodium phosphate buffer ranging from 10 to 500 mM. The protein concentration in each fraction was determined by spectrophotometric analysis, and the samples were separated by SDS-PAGE and subsequently stained with Coomassie blue. The purified 6xHis-TA1 protein was transferred to storage buffer (50 mM Tris-HCl pH 7.4, 1 mM EDTA, 1 mM DTT, 0.2 M NaCl, 50% (v / v) glycerol) and stored at -80°C.

[0489] Electrophoretic mobility shift assay (EMSA) The affinity of purified 6xHis-TA1 protein to ssDNA was determined using EMSA (Thermo, catalog no. 20148X) as schematically described by Reddy et al. (2001). A single-stranded oligonucleotide of 45 nucleotides (SEQ ID NO: 60) was labeled at its 3' end with biotinylated CTP (Thermo, catalog no. 89818) according to the manufacturer's instructions. Recombinant 6xHis-TA1 protein (2 μg) was added to 750 atmoles of biotin-labeled oligonucleotide, and the mixture was incubated at room temperature for 10 minutes. A control sample lacking 6xHis-TA1 protein was applied to lane 1 in Figure 11. A separate reaction was performed in the presence of 60 bp double-stranded DNA (dsDNA; control fragment from the Thermo EMSA kit) to determine if the mobility shift was specific to ssDNA. The binding reaction products were separated by electrophoresis in a 5% natural polyacrylamide gel in 0.5×TBE (Bio-Rad) and transferred to a nylon membrane (Bio-Rad). DNA bands were visualized using streptavidin conjugate horseradish peroxidase (Thermo). As shown in Figure 11, the binding of 6xHis-TA1 protein to ssDNA was reduced due to competition with unlabeled ssDNA. dsDNA did not compete for the binding of the TA1 protein to single-stranded DNA (ssDNA), indicating that the protein is specific to ssDNA, consistent with its name as a single-stranded DNA-binding (SSB) protein.

[0490] To examine whether the mutant ta1-1 I polypeptide retained its ability to bind to ssDNA, a similar gene construct was created that encoded a predicted polypeptide encoded by ta1-1 cDNA I, had a 6xHis tag at the N-terminus, and was expressed in E. coli. The cDNA I sequence was selected because the corresponding mRNA is the dominant splicing transcript from the mutant ta1-1 gene and represents approximately 70% of the total transcription from the ta1-1 gene. The mutant 6xHis-ta1-1 fusion polypeptide was purified using the same method as for the wild-type 6xHis-TA1 protein. The purified 6xHis-ta1-1 I fusion polypeptide was used in EMSA experiments, as described above for the corresponding wild-type protein, to compare the binding of the wild-type and mutant polypeptides to ssDNA. The binding experiments showed that the mutant (shortened) polypeptide bound to ssDNA, but only with reduced efficiency compared to the wild-type TA1 protein, with an efficiency approximately 3-4 times lower (Figure 12). Both TA1 and its truncated form (6xHis-ta1-1 I) were able to bind to the ssDNA probe, but the binding activity of 6xHis-TA1 was higher than that of its truncated form (6xHis-ta1-1 I). 2 μg of 6xHis-TA1 showed similar probe intensity to 8 μg of the truncated 6xHis-ta1-1 I polypeptide. From this data, the inventors concluded that at least the ta1-1 I polypeptide retained some SSB activity, and that the ta1-1 allele was not a null allele. The ta1-1 gene was thought to have at least 67% reduced activity compared to the wild-type TA1 gene.

[0491] Example 10. Complementarity analysis of ta1-1 mutants To reinforce the conclusion that mutations within the TA1 gene were responsible for the thickened aleurone and associated phenotypes found in ta1-1 mutants, two complementation experiments were performed. In the first experiment, a wild-type copy of the TA1 gene containing the native TA1 promoter was introduced into ta1-1 mutant plants by Agrobacterium-mediated transformation. The DNA sequence to be introduced was amplified from ZH11 genomic DNA using a series of oligonucleotide primers and then assembled into the binary vector pPLV15. This vector also contained a hygromycin resistance gene as a selectable marker gene. The transformation plasmid and a control plasmid (empty vector) were introduced into Agrobacterium tumefaciens system EHA105, respectively, and these were used to transform ta1-1 rice recipient cells using the method described in Nishimura et al. (2006). A total of 53 T0 transgenic plants were regenerated from transformation with the wild-type TA1 gene. These plants were transplanted into soil and grown to maturity in a growth chamber. Thirty-four transformant lines were identified when PCR was used to test for the presence of the hygromycin resistance gene, and transformant lines carrying the hygromycin gene were selected. These were grown to maturity, and grains (T1 seeds) were harvested from each plant. As demonstrated by PCR assays, each of these plants contained T-DNA from a vector containing the wild-type TA1 gene.

[0492] The grains harvested from these plants were examined for the allureon phenotype by staining them with Evans blue. Eight independent transgenic plants were tested, and all of them produced grains with normal allureon, similar to the wild type, which demonstrated the positive expression of the introduced gene and thus the complementarity of the ta1-1 mutation. In conclusion, this revealed that the mutation within the TA1 gene caused the mutant phenotype.

[0493] In a second complementation experiment, and to allow observation of expression from the TA1 promoter, a second gene construct was prepared and used for transformation. This construct contained a GUS reporter sequence that had been translated and fused with the TA1 protein-coding sequence after it was isolated from the wild-type rice genome. The gene construct contained a 4,550 nucleotide DNA fragment (the nucleotide sequence provided as SEQ ID NO: 49), which contained, in order, a 3208 bp upstream sequence thought to contain the promoter of the TA1 gene, the entire TA1 protein-coding region including all introns, then the GUS reporter coding region translated and fused to the C-terminus of the TA1 sequence, and finally the nos 3' polyadenylation / transcription termination region. This GUS translation fusion was designed to test whether the TA1-GUS fusion protein was expressed and in which tissues of the transformed plant it was expressed.

[0494] This second construct was introduced into ta1-1 plants by Agrobacterium-mediated transformation, as described above. Various tissues of the transformed plants, including developing seeds, were stained for GUS activity. The expression patterns of the TA1-GUS fusion gene in the alleuron and embryo of transgenic plants are shown in Figure 13. GUS activity was observed in the alleuron and embryo of developing rice grains of transgenic plants, particularly at DAP days 5–11. Strong GUS expression was still observed in the embryo at DAP days 18 and 24, while weaker expression was observed in the alleuron at these time points. Only very low levels of expression were found in the endosperm.

[0495] Furthermore, a gene construct encoding a TA1-GUS fusion polypeptide under the control of the natural TA1 promoter was complementary to the ta1-1 mutation, resulting in plants with the normal wild-type allureon phenotype. This further confirmed that the mutation identified in the ta1-1 plants is responsible for the thick allureon phenotype. It was also concluded that the GUS fusion C-terminus to the TA1 polypeptide did not impair TA1 function.

[0496] Example 11. Intracellular localization of TA1 protein A gene construct designed for transient expression in plant cells was constructed by translating and fusion of the protein-coding region of wild-type rice TA1 polypeptide (SEQ ID NO: 3), green fluorescent protein (GFP) in a vector under the control of the CaMV35S promoter, and the nos 3' polyadenylated region / transcription termination factor. This construct was then introduced into tobacco leaves, and the intracellular localization of the fusion protein was determined via GFP fluorescence. Several days later, to enable expression of the introduced fusion gene, the localization of the GFP signal was compared to that of mitochondrial-specific staining using MitoTracker. Confocal fluorescence microscopy revealed that the TA1-GFP fusion protein expressed from the construct in leaf epidermal cells co-localized with MitoTracker staining. It was concluded that the TA1 protein possessed an N-terminal mitochondrial transport peptide (MTP) that provided mitochondrial localization, consistent with the alternative name for the TA1 protein, OsmtSSB-1a. These data and conclusions were consistent with the analysis described in Example 7 regarding the presence of the MTP sequence.

[0497] Example 12. Mitochondrial function and energy homeostasis in ta1 rice allureons Considering the mitochondrial localization of wild-type TA1 protein and its clear function as an SSB protein within the mitochondria of developing grain cells, the inventors examined the mitochondria within the aleurons of developing ta1-1 grains. Examination of aleuron cells on day 15 of DAP by transmission electron microscopy showed that the mitochondria in mutant grains had abnormal shapes and morphologies. Compared to the more elongated shape in wild-type aleurons, the mitochondria were more annular in shape, lacked the same internal structure, and possessed different, well-developed cristae.

[0498] The number of mitochondria was counted in sections of alleuron cells from ta1-1 and wild-type grains at day 15 of DAP. ATP content in wild-type and ta1-1 alleurons at day 11 of DAP was also measured. The results (Figure 14) showed that the number of mitochondria in ta1 alleuron cells increased compared to the wild type, but the ATP content was significantly reduced.

[0499] Furthermore, when comparing the transcriptome of ta1-1 grains with that of wild-type grains, it was observed that numerous genes involved in glycolysis, oxidative phosphorylation, and the citric acid cycle were upwardly regulated within ta1-1 grains.

[0500] From these data, the inventors concluded that mutations in the TA1 gene lead to mitochondrial dysfunction because developing grain cells attempt to compensate for the associated reduced function of the mutant ta1 gene and mtSSB protein. This dysfunction is associated with an increase in the number of mitochondria and upwardly regulated genes, and this increase is linked to mitochondrial function.

[0501] Example 13. Screening for additional mutant alleles within the TA1 gene To provide further mutations, including possible knockout (null) mutations in the TA1 gene, the CRISPR-Cas9 gene editing method was used as follows: Four distinct CRISPR constructs were created by modifying the vector pYLCRISPR / Cas9-MH provided by Dr. Yaoguang Liu (School of Life Science, South China Agricultural University, China). First, four regions of 20 nucleotides each, each immediately followed by a 3-nucleotide PAM (protospacer adjacent motif) sequence, were identified from the TA1 cDNA nucleotide sequence as potential guide RNA (gRNA) target sequences. The gRNA targets, referred to as Casg1, Casg2, Casg3, and Casg4, were selected for the purpose of producing mutations in the second (g1 and g2), third (g3), and fourth (g4) exons, respectively. Next, a gRNA target construct was synthesized in which the gRNA target was incorporated into the gRNA backbone and driven by the U3 promoter from rice. The synthesized DNA was excised using the restriction enzyme BsaI and inserted into a pYLCRISPR / Cas9-MH vector. The synthetic gene construct was then isolated and transformed into Agrobacterium EHA105. Rice transformation was performed according to the method of Nishimura et al. (2006). Transgenic rice plants were regenerated from transformed callus. Seeds of the mutant plants were examined for the aleurone phenotype by thin sectioning of mature glumes, and the number of aleurone layer cells was analyzed.

[0502] Table 4 lists TA1 mutations in 28 lines, including at least 13 independent lines produced using the CRISPR / Cas9 method. All of these lines had frameshift mutations in the protein-coding region, which resulted in a stop codon that caused premature translation termination and were therefore null mutations. Importantly, all seeds of the mutant lines exhibited the thick aleurone phenotype. Some grains of the mutant lines also had other phenotypic changes compared to the wild type, including one or more of the following: chalky endosperm, reduced fruit set, and reduced grain weight per 1000 grains. It was concluded that the null allele of the TA1 gene (encoding SEQ ID NO: 1, SEQ ID NO: 3, and homologous TA1 genes) conferred the thick aleurone and associated phenotypes. Given the current efficiency of gene editing techniques in rice and other plants, including cereals, gene editing using CRISPR or TALENS is a preferred method for obtaining the thick aleurone phenotype. [Table 4]

[0503] Example 14. TA1 protein associates with RECA3 and TWINKLE polypeptide. SSB proteins play crucial roles in DNA replication, homologous recombination between closely related or identical chromosomes, and DNA repair. In bacteria, RecA proteins catalyze homologous strand exchange, and SSB proteins enhance the reaction, possibly by stabilizing DNA strand separation. Mitochondrial SSB proteins are thought to play similar roles in the replication and recombination of multiple mitochondrial genomes in plant cells (Edmondson et al., 2005). Mitochondrial DNA replication requires several nuclear-coding proteins, including DNA polymerases known as plant organelle DNA polymerase or POP (Moriyama and Sato, 2014), primases that act to synthesize RNA primers, DNA topoisomerases also called gyrases, mtSSB, and helicases that unwind double-stranded DNA, also known as TWINKLE. The plant-derived TWINKLE enzyme, localized in mitochondria, possesses both primerase and helicase activity and is capable of synthesizing RNA primers of at least 15 nucleotides in length, extended by E. coli DNA polymerase I, into high molecular weight DNA (Diray-Arce et al., 2013).

[0504] Multiple mitochondrial chromosomes in angiosperms often rearrange and recombinate, particularly the repetitive sequences involved, to produce a variety of sequence duplications, inversions, deletions, and insertions (Gualberto and Newton, 2017). Several nuclear genes are known to regulate mitochondrial DNA recombination and genomic stability. Typically, these genes encode proteins that affect the fidelity of DNA replication, recombination, or repair, and mutants within these genes often result in the accumulation of recombinant alternative configurations of mitochondrial DNA. These proteins include recombinases that catalyze chain exchange, similar to RecA in bacteria. Arabidopsis thaliana possesses three RecA-like proteins (RECA1-RECA3) (Shedge et al., 2007). RECA1 is conserved in all plants and targets plastids. RECA2 is present in flowering plants and mosses and targets both mitochondria and plastids. In contrast, the RECA3 protein targets only mitochondria. Within Arabidopsis thaliana, both recA2 and recA3 mutations trigger increased ectopic recombination across intermediate-sized repeats. The recA2 mutation is typically lethal at the early seedling stage, while recA3 knockout plants are usually phenotypically normal in the first generation but can exhibit effects in subsequent generations.

[0505] Therefore, the inventors tested whether TWINKLE and RECA3 could be involved in the same process as TA1 in the US. The US TWINKLE and RECA3 sequences were identified from the US genome sequence by searching for the Arabidopsis sequence as a query. The amino acid sequences of the US proteins, the nucleotide sequences of the genes encoding these proteins, and the nucleotide sequences of the protein-coding sequences of the cDNA for these genes are provided as Sequence IDs 61-66.

[0506] In a series of experiments, interactions between TWINKLE and RECA3 proteins and TA1 were demonstrated. In one experiment, a split yellow fluorescent protein (YFP) assay was performed in tobacco leaves by co-transformation with a pair of constructs encoding fusion proteins. In each pair, one encoded the N-terminal half of YFP, and the other encoded the C-terminal half of YFP. One construct contained the chimeric gene p35S:TA1-nYPF, and the other contained either p35S:RECA3-cYFP or p35S:TWINKLE-cYPF. Transformed cells were examined under a confocal microscope. Fluorescent dots were observed in the cytoplasm. From this staining and mitochondrial-specific staining, it was concluded that the TA1 protein interacts with both RECA3 and TWINKLE, and that all three are localized in the mitochondria.

[0507] Furthermore, the in vivo interactions between TA1 and RECA3 and TWINKLE were demonstrated by immunoprecipitation experiments in which one polypeptide is specifically recovered and the other polypeptide co-precipitates. To do this, the construct p35S:TA1-MYC was co-infused into tobacco leaves with either the p35S:RECA3-HA construct or the p35S:TWINKLE-HA construct for transient expression of the tagged protein. Total protein was extracted from the infused tissue and subjected to co-immunoprecipitation, and the resulting protein fraction was tested using Western blotting. In a separate experiment, a split luciferase assay was performed in the infused tobacco leaves to show that TA1 interacts with both RECA3 and TWINKLE.

[0508] From each of these experiments, the inventors concluded that the TA1 protein associated with the RECA3 and TWINKLE proteins, and that these proteins were localized within the mitochondria.

[0509] Example 15. Downward regulation of the RECA3 or TWINKLE gene produces thickened allureon in rice. In light of observations indicating that the TA1 protein associates with RECA3 and TWINKLE in mitochondria, we investigated whether reducing the expression of the genes encoding RECA3 and TWINKLE in rice also results in thicker aleurone in the grain. This was tested using RNA interference (RNAi) to reduce the expression of the RecA3 and TWINKLE genes. To construct RNAi constructs, we selected regions of the RecA3 and TWINKLE genes and used these regions to create reverse repeat constructs expressing hairpin RNA. These constructs were used for Agrobacterium-mediated transformation of wild-type rice using standard methods, and transformants were selected. Plants with reduced gene expression in the grain, as indicated by qRT-PCR, were selected (Figure 15). Three lines were selected for each construct.

[0510] When glumes from selected lines were examined microscopically for aleurone thickness stained with PAS in cross-section, all transgenic glumes were observed to have thicker aleurones compared to the wild type. Lines with greater reduction in RecA3 and TWINKLE genes were more affected and had thicker aleurones ranging from 2 to 8 layers in at least some zones of the aleurone. In addition, the starchy endosperm of transgenic grains was observed to have a chalky or opaque appearance.

[0511] Based on these experiments, the inventors developed a model describing the regulation of energy homeostasis within the aleurone cell layer mediated by the TA1-RECA3 / TWINKLE complex. This suppresses aberrant recombination of mtDNA during grain development and thus determines the differentiation of subaleurone cell fate, in which cells that form the outermost cells of the starchy endosperm within the wild-type grain instead retain their identity as aleurone cells, resulting in a thickened aleurone.

[0512] Example 16. Homogenetics of the rice TA1 gene in other cereals Single-stranded DNA-binding (SSB) proteins play crucial roles in DNA replication, homologous recombination, and DNA repair (Moriyama and Sato, 2014). In bacteria, RecA proteins catalyze homologous strand exchange, and SSB proteins enhance this reaction (McEntee et al. 1980, Steffen and Bryant 2001). Plant genes encoding mitochondrial-targeted single-stranded DNA-binding proteins (mtSSBs) have been characterized in Arabidopsis thaliana, providing the earliest direct evidence of the presence of mitochondrial-targeted homologs of RecA, SSBs, or other proteins involved in mitochondrial DNA (mtDNA) recombination in plants (Edmondson et al., 2005). Using Sequence ID No. 3 as a query, the A. thaliana SSB genes, At4g11060 and At3g18580, hereafter referred to as AtmtSSB-1 and AtmtSSB-2, respectively, were identified by a BLAST search of the Arabidopsis genome in The Arabidopsis Information Resource (TAIR) database (http: / / www.arabidopsis.org). The AtmtSSB-1 polypeptide has an amino acid sequence 66% identical to the full length of Sequence ID No. 3, while the AtmtSSB-2 polypeptide is far less homologous, with 26% identity (Table 5). Therefore, A. thaliana has two mtSSB genes. At4g11060 encodes a protein of 201 amino acids (Sequence ID No. 15) containing a putative mitochondrial target peptide (MTP) of 28 residues. At3g18580 encodes a protein of 217 amino acids (Sequence ID No. 31) containing a putative MTP of 23 residues. Furthermore, the model tree species Populus trichocarpa (poplar) possessed two mtSSB sequences, namely PtmtSSB-1 (SEQ ID NO: 21) and PtmtSSB-2 (SEQ ID NO: 39).

[0513] The rice (Oryza sativa, Japonica group) genome was observed to contain two other genes related to Os05g0509700 (encoding OsTA1=OsmtSSB-1a), namely Os04g0363700 and Os01g0642900, hereafter referred to as OsmtSSB-1b and OsmtSSB-2, respectively, identified by a BLAST search of the rice genome and amino acid sequences in the Rice Genome Annotation Project (RGAP) database (http: / / rice.plantbiology.msu.edu / ). OsmtSSB-1b is a sequence close to OsmtSSB-1a with 72% identity to the full length of Sequence ID No. 3, while OsmtSSB-2 is less homologous with 32% identity. Osmt-SSB-1b is also referred to herein as OsTA1-like or OsTA1L. Therefore, rice has three mtSSB genes. Similar to the AtmtSSB protein, all three OsmtSSB polypeptides have an SSB domain, and for OsmtSSB-1b, these included motifs I-IV, which are present in all the plant TA1 polypeptide sequences examined.

[0514] Table 5 provides amino acid sequence identity of the rice TA1 (OsmtSSB-1a; SEQ ID NO: 3) polypeptide and OsTA1L with a series of homologous plant polypeptides. Figure 7 shows some alignments of these plant sequences. The two dicotyledonous species examined, like some of the monocotyledonous species, each had only two mtSSB sequences, while the other monocotyledonous species had three mtSSB sequences, including one closest to OsTA1 (at least 80% identical) and one closer to OsTA1L. Overall, the plant mtSSB-1 sequence had at least 60% identity with SEQ ID NO: 3, and the mtSSB-2 sequence had less than 32% identity with SEQ ID NO: 3.

[0515] Figure 16 provides a phylogenetic tree showing the relevance of homologs of the TA1(OsmtSSB-1a) polypeptide from other plant species, primarily cereal species. In each case, the most homologous amino acid sequence was at least 60% identical to SEQ ID NO: 3 along its full length. The amino acid sequences used in the analysis are provided as SEQ ID NOs: 15-23 for the mtSSB-1 or mtSSB-1a sequences most closely related to OsTA1, SEQ ID NOs: 24-29 for the mtSSB-1b sequences more closely related to OsTA1L than OsTA1, and SEQ ID NOs: 30-39 for the mtSSB-2 sequences.

[0516] The inventors concluded that plant species are expected to have two or three mtSSB sequences, all of which are functional, providing a degree of functional redundancy. This analysis did not address the tissue specificity of different mtSSB genes. [Table 5]

[0517] Example 17. Homogenos of the rice RECA3 and TWINKLE genes in other plant species Using Sequence ID No. 61 (US RE...

Claims

1. A cereal grain comprising aleurone, germ, starchy endosperm, and at least one mitochondrial polypeptide having a reduced level and / or activity relative to a corresponding wild-type cereal grain, wherein the mitochondrial polypeptide having a reduced level and / or activity is at least one of a mitochondrial single-stranded DNA binding (mtSSB) polypeptide, a RECA3 polypeptide, and a TWINKLE polypeptide.

2. 2. The grain of claim 1, wherein the grain comprises a genetic variation that reduces the level and / or activity of the at least one mitochondrial polypeptide in the grain relative to the corresponding wild-type cereal grain.

3. It has thickened aleurone, 3. The grain of claim 1 or 2, wherein the thickened aleurone preferably comprises at least 2, at least 3, at least 4, or at least 5 cell layers, about 3, about 4, about 5, or about 6 cell layers, or from 2 to 8, from 2 to 7, from 2 to 6, from 2 to 5, or from 3 to 5 cell layers, or from 2 to 8, from 2 to 7, or from 2 to 6 cell layers.

4. rice grain, wheat grain, barley grain, corn grain, sorghum grain, or oat grain; The grain according to any one of claims 1 to 3, which is preferably a rice grain.

5. 5. The grain of any one of claims 1 to 4, wherein the wild-type grain comprises an mtSSB polypeptide, and the mtSSB polypeptide comprises an amino acid sequence as provided in any one of SEQ ID NOs: 3 or 15-39, or an amino acid sequence that is at least 75% identical to any one or more of SEQ ID NOs: 3 or 15-39.

6. The grain of claim 5, wherein the mtSSB polypeptide is an mtSSB-1a polypeptide.

7. The grain according to any one of claims 1 to 6, wherein the grain comprises an endogenous gene, the endogenous gene encoding a truncated mtSSB polypeptide, preferably a truncated mtSSB-1a polypeptide.

8. A mutant mitochondrial single-stranded DNA binding (mtSSB) polypeptide, a mutant RECA3 polypeptide, or a mutant TWINKLE polypeptide, which has an amino acid sequence that differs from the amino acid sequence of a corresponding wild-type mitochondrial single-stranded DNA binding (mtSSB) polypeptide, a RECA3 polypeptide, or a TWINKLE polypeptide, respectively, and has reduced activity compared to the corresponding wild-type polypeptide.

9. The polypeptide of claim 8.

10. An isolated and / or exogenous polynucleotide that, when present in the grain of a cereal plant, reduces expression of a gene encoding a mitochondrial single-stranded DNA binding (mtSSB) polypeptide, a RECA3 polypeptide, or a TWINKLE polypeptide.

11. A cereal plant cell, seed or tissue therefrom comprising at least one mitochondrial polypeptide at a reduced level and / or activity relative to a corresponding wild-type cereal plant cell, wherein the mitochondrial polypeptide having reduced level and / or activity is at least one of a mitochondrial single-stranded DNA binding (mtSSB) polypeptide, a RECA3 polypeptide, and a TWINKLE polypeptide.

12. A cereal plant producing grain according to any one of claims 1 to 7 and / or comprising one or more or all of a polypeptide according to claim 8, a polynucleotide according to claim 9 or 10, a nucleic acid construct and / or vector comprising a polynucleotide according to claim 9 or 10, or a cell, seed or tissue according to claim 11.

13. 13. A method for producing a cereal plant or grain therefrom according to claim 12, comprising the steps of: i) introducing into a cereal plant cell a genetic variation according to claim 2, a polynucleotide according to claim 9 or 10, or a nucleic acid construct and / or a vector comprising a polynucleotide according to claim 9 or 10, ii) obtaining a cereal plant comprising said genetic variation or polynucleotide from the cell obtained from step i); iii) optionally harvesting grain from said plant of step ii), said grain comprising said genetic variation or being transgenic for said polynucleotide, nucleic acid construct or vector; iv) optionally producing one or more generations of progeny plants from said grain, said progeny plants comprising said genetic variation or being transgenic for said polynucleotide, nucleic acid construct or vector; whereby said cereal plant or grain is produced.

14. 13. A method for producing a cereal plant or grain therefrom according to claim 12, comprising the steps of: i) introducing into a cereal plant cell a mutation to an endogenous gene encoding a mitochondrial single-stranded DNA binding (mtSSB) polypeptide, a RECA3 polypeptide or a TWINKLE polypeptide, whereby the cell has a reduced level and / or activity of said mitochondrial single-stranded DNA binding (mtSSB) polypeptide, a RECA3 polypeptide or a TWINKLE polypeptide relative to a corresponding wild-type cereal plant cell; ii) obtaining a cereal plant from the cell of step i), said cereal plant comprising said mutation in said endogenous gene; iii) optionally harvesting kernels from the plant of step ii), said kernels comprising said mutation; and iv) optionally producing one or more generations of progeny plants from said kernel, said progeny plants comprising said mutation; whereby said cereal plant or grain is produced.

15. A method for identifying a cereal plant which produces grain according to any one of claims 1 to 7, comprising the steps of: i) obtaining a nucleic acid sample from a cereal plant; ii) screening the sample for the presence or absence of a genetic variation, wherein the genetic variation reduces the level of activity of a mitochondrial single-stranded DNA binding (mtSSB) polypeptide, a RECA3 polypeptide, or a TWINKLE polypeptide in the plant compared to a corresponding wild-type cereal plant.

16. 1. A method for producing processed grain, or flour, bran, wholemeal flour, malt, starch, or oil obtained from grain, comprising the steps of: a) obtaining grain according to any one of claims 1 to 7; b) processing the grain to produce the processed grain, flour, bran, wholemeal flour, malt, starch, or oil.

17. Produced from a grain according to any one of claims 1 to 7, or a cereal plant according to claim 12, or from a part of said grain or cereal plant comprising said genetic variation, The product is a food ingredient, a beverage ingredient, a food product, or a beverage product.

18. 20. A method for preparing the food ingredient, beverage ingredient, food product, or beverage product of claim 17, comprising: i) processing a grain according to any one of claims 1 to 7 or bran, flour, wholemeal, malt, starch or oil therefrom to produce said food or beverage ingredient; or ii) preferably comprising processing the grain according to any one of claims 1 to 7 by cooking, boiling, roasting or flaking the grain or by mixing the grain or the bran, flour, wholemeal, malt, starch or oil therefrom with another food or beverage ingredient.